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Abstract
Atrial fibrillation (AF) is the most common encountered cardiac rhythm disorder (arrhyth-
mia) in clinical practice. It is responsible for about one third of arrhythmia-related hospitaliza-
tions. This arrhythmia, which increases in prevalence with age, leads to severe complications and
subsequently decreases the quality of life for the affected patients. Lifetime risks for developing
AF are ∼ 25% in subjects older than 40 years old. Currently, this arrhythmia is considered as a
major public health concern.
AF is a progressive disease, starting by short and rare episodes which further develop into
longer and more frequent occurrences. When the arrhythmia becomes sustained for more than
one year, it is labelled as long-standing persistent. AF advancement gives rise to an electrical
of the atria (the upper chambers of the heart) resulting from abnormal high frequency atrial
activations.
The main goals of therapeutic management for patients with AF are to prevent severe com-
plications associated with this arrhythmia, and ultimately to restore a normal rhythm. Currently,
the cornerstone of non-pharmacological therapy is the radiofrequency catheter ablation of AF,
which consists in delivering at strategic locations within the atria high-frequency electrical im-
pulses. However, catheter ablation for patients with long-standing persistent AF involves exten-
sive ablation of the atria and the success rate reported in various publications is associated with
conflicting results.
Over the last twenty years, an important effort has been made by the scientific community
to develop signal processing algorithms to quantify the complexity of temporal or spectral cha-
racteristics of AF dynamics in terms of organization. As such, multiple approaches have been
proposed to quantify AF organization either based on time-domain or frequency-domain analy-
sis. All these methods shared one common goal : the development of organization indices which
are interpretable from an electrophyisiological viewpoint. In the context of catheter ablation of
patients with long-standing persistent AF, the success rate appears limited as the "classical" or-
ganization indices are not performant in assessing the amount of ablation required to achieve AF
termination. Thus, there is a strong interest in predicting the procedural outcome from the surface
electrocardiogram (ECG) recorded at baseline, i.e., prior to ablation.
The main objective of this thesis was to derive novel organization indices from surface ECG
and intracardiac signals acquired at baseline which could discriminate patients in whom AF was
terminated from patients in whom AF persisted during catheter ablation within the left atrium.
As the standard surface ECG is not appropriate for measuring the atrial activity, we aimed at
adapting the placement of at least one ECG lead such that additional electrical information from
the atria was provided. In our ECG signals study, we hypothesized that a quantification of the
harmonic structure of AF signals brings more insight into AF complexity. Time-invariant and
time-varying approaches were used to derive the ECG organization indices, and their perfor-
mance for predicting the acute outcome of catheter ablation were compared. In the first scheme,
the harmonic components of AF waves were extracted using linear time-invariant filters. In the
second one, the components were extracted using an adaptive harmonic frequency tracking al-
gorithm. In both schemes, two indices were developed each of which aiming at quantifying the
v
regularity of the oscillations of the AF waves and the morphological regularity of the AF waves.
We have shown that the ability of the organization measures derived from the adaptive scheme
were more robust for predicting the outcome of catheter ablation. We also investigated the im-
pact of epoch durations on these organization indices for predicting the procedural outcome of
catheter ablation. The predictive performance of the organization indices derived from the adap-
tive algorithm were better than that of the measures derived from the time-invariant approach on
more epoch durations and ECG leads.
Before ablation, multiple catheters were inserted within both atria and recordings were ac-
quired sequentially at several atrial segments. A frequency analysis was performed on these ac-
quisitions in order to characterize the frequency of the activation wavefronts within both atria.
We have shown that for patients in whom AF was terminated, the frequency of activations were
significantly lower within both atria than for patients in whom AF was not terminated. We also
studied the correlation between the frequency activity assessed endorcardially with that from the
surface ECG. We have shown that the contribution of the left and right atria during AF can be
independently determined using specific regions of the thorax. From the intracardiac signals we
also derived novel organization indices from a temporal study on the variability of the AF activa-
tion wavefronts. Our results suggest that for patients in whom AF was terminated, the temporal
stability of the activation wavefronts was higher than for patients in whom AF persisted.
Collectively, the results of this thesis showed that patients with long-standing persistent AF
for whom catheter ablation successfully restored a normal rhythm, the electrical remodelling was
less important than that in patients for whom the arrhythmia persisted. The ECG organization
indices derived from the adaptive harmonic frequency tracking algorithm can be used to predict
the outcome of catheter ablation in patients with long-standing persistent AF. The use of such
measures in clinical application would provide an upstream tool for the cardiologists to help
establishing the appropriate therapeutic strategy.
Keywords : atrial fibrillation, catheter ablation, prediction, organization index, ECG, intracar-
diac electrograms, instantaneous frequency, adaptive frequency tracking, adaptive filter, domi-
nant frequency, phase difference, atrial fibrillation cycle length, variability of atrial activation
wavefronts.
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Résumé
La fibrillation auriculaire (FA) est le trouble du rythme cardiaque (arythmie) le plus diagnos-
tiqué en soins cliniques et est la cause d’environ un tiers des hospitalisations liées aux arythmies.
Cette arythmie, dont la prévalence augmente avec l’âge, engendre des complications sévères
et diminue considérablement la qualité de vie des patients. Au-delà de 40 ans, les risques de
développer une FA sont d’environ 25%. Cette arythmie est considérée actuellement comme un
problème majeur de santé publique.
La FA est une maladie progressive, commençant par des épisodes brefs et rares devenant
progressivement longs et fréquents. Lorsque l’arythmie devient soutenue pendant plus d’une an-
née, elle est classifiée comme FA chronique. L’avancement de la FA provoque une réorganisation
électrique des oreillettes (les chambres supérieures du cœur) résultant en l’activations anormale
des oreillettes à une fréquence élevée.
Les objectifs principaux de la gestion thérapeutique des patients atteints de FA sont d’em-
pêcher les graves complications associées à cette arythmie et de restaurer un rythme cardiaque
normal. Actuellement, la pierre angulaire des thérapies non-médicamenteuses est l’ablation par
radiofréquence de la FA, consistant à délivrer par le moyen de cathéters introduits à l’intérieur
des oreillettes des impulsions électriques à haute fréquence. Cependant, chez les patients souf-
frant de FA chronique, l’ablation par cathéter implique la création de lésions importantes dans
l’oreillette. Par ailleurs, les taux de succès publiés dans la littérature sont contradictoires.
Durant les vingt dernières années, un effort conséquent a été entrepris par la communauté
scientifique pour développer des algorithmes de traitement des signaux afin de quantifier la com-
plexité des caractéristiques temporelles ou spectrales de la dynamique de la FA. Ainsi, dans le
domaine fréquentiel, plusieurs approches basées sur des méthodes invariantes ou variantes dans
le temps ont été proposées pour quantifier l’organisation de la FA. Toutes ces méthodes avaient
un but commun : le développement d’indices d’organisation qui peuvent être interprétés d’un
point de vue électrophysiologique. Dans le contexte de l’ablation par cathéter chez les patients
souffrant de FA chronique, le taux de succès apparaît limité étant donné que les indices d’organi-
sation "classiques" ne sont pas assez performants pour évaluer la quantité d’ablation requise pour
terminer la FA. En conséquence, il y a un fort intérêt à pouvoir prédire l’issue procédurale à partir
de signaux provenant de l’électrocardiogramme de surface (ECG) enregistrés avant l’ablation.
L’objectif principal de cette thèse a été de définir des nouveaux indices d’organisation à par-
tir de signaux d’ECG ou intracardiaques enregistrés avant l’ablation, dans le but de discriminer
les patients chez qui la FA a été terminée des patients chez qui la FA a persisté pendant l’abla-
tion par cathéter dans l’oreillette gauche. Étant donné que l’ECG de surface n’est pas approprié
pour mesurer l’activité auriculaire, nous avions pour but d’adapter le placement standard des
électrodes de surface afin de disposer d’une meilleure résolution spatiale de l’activité électrique
atriale. Dans notre étude des signaux ECG, nous avons fait l’hypothèse que la structure har-
monique des signaux de FA améliore la quantification de la dynamique de FA. Des méthodes
invariantes et variantes dans le temps ont été utilisées pour définir des indices d’organisation,
et leurs performances pour la prédiction de l’issue procédurale de l’ablation ont été comparées.
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Dans la première approche, les composantes harmoniques des signaux de FA ont été extraites
avec des filtres linéaires et invariants dans le temps. Dans la deuxième approche, les compo-
santes ont été extraites par le biais d’un algorithme adaptatif de poursuite en fréquence. Dans les
deux approches, deux mesures d’organisation furent développées chacune d’elle quantifiant res-
pectivement la régularité des oscillations des signaux de FA et leur la régularité morphologique.
Nous avons montré que les indices d’organisation définis à partir de l’algorithme adaptatif sont
plus robustes pour prédire le succès de l’ablation. Nous avons aussi étudié l’impact de la durée
d’enregistrement sur les performances statistiques de ces mesures d’organisation. Les perfor-
mances de prédictions ont été meilleures, sur plus de durées et d’électrode ECG, pour les indices
d’organisation issus de l’algorithme adaptatif que pour les indices issus de la méthode invariante
dans le temps.
Avant l’ablation, plusieurs cathéters sont introduits dans les deux oreillettes afin d’enregis-
trer séquentiellement des signaux à divers endroits anatomiques. Une analyse fréquentielle a été
effectuée sur ces signaux afin de caractériser la fréquence d’activation des fronts d’ondes de la
FA. Nous avons montré que chez les patients pour qui la FA termina pendant l’ablation, cette
fréquence était significativement plus basse dans les deux oreillettes que chez les patients pour
qui l’ablation fut un échec. Nous avons aussi étudié la corrélation entre le contenu fréquentiel
intracardiaque et celui mesuré depuis l’ECG de surface. Nous avons montré que la contribution
des oreillettes gauche et droite peut être déterminée à partir de régions spécifiques du thorax.
Pour finir, à partir des signaux intracardiaques, nous avons développé de nouveaux indices d’or-
ganisation dans le but de mesurer la variabilité temporelle des fronts d’activation de la FA. Nos
résultats ont montré que, pour les patients chez qui la FA terminait, les fronts d’activations étaient
plus stables au cours du temps que pour les patients chez qui l’ablation fut un échec.
Pris collectivement, les résultats de cette thèse montrent que chez les patients atteints de FA
chronique, pour qui l’ablation par cathéter a rétabli avec succès un rythme cardiaque normal, la
réorganisation électrique des oreillettes est moins avancée que chez les patients pour qui l’abla-
tion fut un échec. Les indices d’organisation définis à partir de l’algorithme adaptatif peuvent
être utilisés afin de prédire l’issu procédurale de l’ablation par cathéter de la FA chronique. Dans
un contexte clinique, l’utilisation de ces indices peut permettre à l’électrophysiologue d’établir
en amont une thérapie appropriée dans le but de restaurer un rythme cardiaque normal.
Mots-clés : fibrillation auriculaire, ablation par cathéter, prédiction, indice d’organisation, ECG,
électrogramme intracardique, fréquence instantanée, poursuite adaptative de fréquence, filtre
adaptatif, fréquence dominante, différence de phase, variabilité des fronts d’activations.
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Introduction 1
1.1 Motivation and problem statement
Clinical importance of atrial fibrillation
Atrial fibrillation (AF) is the most commonly encountered cardiac disorder (arrhythmia) in
clinical practice and is responsible for about one third of arrhythmia-related hospitalizations. In
contrast to a regular rhythm, the so-called sinus rhythm (SR), an AF episode is characterized by
rapid and irregular activation of the upper chambers of the heart (the atria). AF is complicated
by a severe impairment of the atrial and ventricular (lower chambers) contractile functions re-
sulting in a decrease of the cardiac output. The loss of the contractile functions promotes the
formation of blood clots and, thus, considerably increases the risks for stroke. The conditions
associated with AF may lead to a severe decrease in quality of life for affected patients. World-
wide epidemiological data on AF suggest that this disease can be considered as an emergent
global epidemic [1]. Lifetime risks for developing AF are ∼ 25% in subjects older than 40 years,
independently of gender [2]. As life expectancy increases, AF prevalence is estimated to double
in the next fifty years [1]. Consequently, AF is considered as a major public health concern [3].
The natural time-course of the evolution of AF starts by short and rare episodes (usually
the arrhythmia self-terminates within 48 hours, and in this case AF is classified as paroxysmal),
to longer and more frequent occurrences (the arrhythmia becomes persistent). The numerous
conditions associated with AF contribute to a progressive process in the development of the
disease by favoring either the occurrence responsible to its initiation (the focal triggers) and/or
the formation of a substrate responsible for its perpetuation. These mechanisms are not mutually
exclusive and are likely to be present simultaneously at various times of the disease, in particular
when the arrhythmia becomes persistent [4]. When the arrhythmia becomes sustained for a
duration greater than one year, it is labelled as long-standing persistent AF (also termed chronic
AF).
AF advancement gives rise to an electrical and structural remodellings of the atria that may,
in turn, favor the maintenance of the arrhythmia. More precisely, the electrical remodelling
results from abnormal high frequency atrial activations. The structural remodelling engenders
a significant enlargement of the atria. The electrical and structural remodelling affect the atrial
function and structure at different stages of the disease. In the development of sustained AF, the
atrial remodelling is important and may quench therapeutic success.
1
2 Introduction
Management of atrial fibrillation
The main goals of therapeutic management for patients with AF are to reduce the symptoms,
to prevent severe complications associated with AF, and ultimately to restore a normal SR. These
objectives may be pursued in parallel. Nowadays, pharmacological and non-pharmacological
treatments constitute the most prevailing options. Most commonly, pharmacological therapies
involve the prescription of drugs, such as beta-blockers. Pharmacological approaches, however,
suffer from poor efficacy, in particular in patients with long-standing persistent AF. When a phar-
macological approach fails to reduce the heart rate or to terminate AF, a non-pharmacological
strategy should be considered. Currently, radiofrequency catheter ablation of AF is the cor-
nerstone of non-pharmacological therapy. This approach consists in delivering high-frequency
electrical impulses endocardially (within the atria) in order to eliminate the trigger(s) and/or alter
the arrhythmogenic substrate and ultimately restore a normal SR.
Various ablation strategies have been deployed in order to terminate AF in different patient
populations. For patients with paroxysmal AF, it has been reported that ablation procedures in-
volving eliminations of the focal triggers achieved 70% of AF termination, whereas in patients
with non-paroxysmal AF the success dropped to 30% [5]. Once AF becomes sustained, ab-
lation of the triggers alone is not sufficient for terminating the arrhythmia, suggesting that the
triggers play a less critical role in maintaining AF and that some level of structural or electrical
remodelling enables the atria to perpetuate the AF independently of the triggers. Consequently,
in patients with a sustained form of AF, some additional ablation strategy targeting the substrate
responsible for the maintenance of AF should be considered, notably for patients with long-
standing persistent AF. These approaches consist of performing linear ablations and/or ablation
of complex fractionated electrograms (CFAEs). These electrograms are characterized by low-
voltage with multiple potentials signals and are visually identified by the operator during the ab-
lation procedure, which can be challenging and highly subjective. CFAEs are currently believed
to be involved in AF maintenance as fractionated and continuous activity may be indicative of
the presence of fibrillatory wave collisions. CFAEs ablation, however, results in extensive atrial
lesions that may preclude any recovery of atrial contractile function despite SR restoration. For
patients with long-standing persistent AF, some groups have reported the benefit of using a step-
wise approach consisting in performing a sequential ablation strategy involving the ablation of
the focal triggers, linear and CFAEs ablations [6–8].
The success rate of stepwise catheter ablation of long-standing persistent AF reported in
various publications is associated with conflicting results, and usually requires several attempts
in order to restore a long-term SR [6–8]. Originally, this sequential approach has been proposed
by the Bordeaux group which reported in one study the termination of persistent AF in 87% of
patients [6], whereas in another study the single-procedure success rate was 55% [7]. Outside
of this group, Rostock et al. achieved a lower single-procedure success rate of 38% [8]. There
is therefore a clear need for additional studies from different research centers to validate this
ablation strategy for patients with long-standing persistent AF.
The concept of atrial fibrillation organization
For a long time, the atrial fibrillatory activation patterns have been described as totally chaotic
and random. In 1978, the first study aiming at establishing visual differences of AF intracardiac
electrograms resulted in the classification of AF recordings into different categories based on
the discreteness of the electrograms and the baseline perturbations [9]. An important issue with
such an approach is that the classification is highly subjective on operators judgement. However,
this graduation of the fibrillatory waveforms pointed out an important aspect of AF recordings:
they can be characterized in terms of temporal regularity and repeatability. This avant-garde
perception of AF activity has motivated the scientific community to develop signal processing
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algorithms to quantify the complexity of temporal or spectral characteristics of AF dynamics in
terms of organization.
As such, multiple approaches have been proposed to quantify AF organization either based
on time-domain analysis, frequency-domain analysis or non-linear dynamical systems theory.
All these methods shared one common goal: the development of organization indices which are
interpretable from an electrophysiological viewpoint. For instance, the most commonly used
index in clinical practice is computed from intracardiac electrograms as the average time differ-
ence between consecutive atrial activation wavefronts and is named the AF cycle length (AFCL).
Clinical studies have established a fine correspondence between the intracardiac AFCL and de-
polarization properties of atrial tissues [10–12]. Furthermore, indices computed from frequency-
domain approaches constitute a logical alternative to time-domain methods, in particular if the
goal is to characterize the repeatability of AF activation patterns. As such, the most widely used
method is to locate the peak of highest amplitude in the power spectral density (PSD) of an
atrial signal. This frequency, the so-named dominant frequency (DF), can be computed either
from an atrial signal recorded from the surface electrocardiogram (ECG) or endocardially. This
measure has been used as an organization index in clinical studies in order to quantify the atrial
electrical remodelling [13–15], and to predict the response to several therapies [16–20]. Another
spectrum-based index estimated from the study of the harmonic structure of AF signals is the
organization index (OI) which is computed as the ratio between the power under the harmonic
peaks to the total power of intracardiac signals [21]. Although no physiological meaning of the
OI was provided by the authors, they have used this index in order to optimize the success of
electrical AF cardioversion [21] 1.
Because of the variety of signal processing indices proposed in the literature, the term AF
organization has become ambiguous and hence no consensus on a precise definition has been
established. As a consequence, comparing results from different studies is a difficult task. One
might argue therefore that measures of AF organization may instead be developed based on their
clinical application and interpretation from an electrophysiological viewpoint.
Challenges in predicting catheter ablation outcome of atrial fibrillation
The prediction of the procedural outcome of catheter ablation is an important information for
the physician, in particular for patients with long-standing persistent AF for which the success
rate in terminating AF is lower compared to non-sustained AF. Furthermore, for AF sustained
for more than one year, the duration of the stepwise ablation procedure is considerably longer
and extensive ablation of the atria is necessary for terminating the arrhythmia. The availability of
a prediction tool using ECG signals would possibly lead to the establishment of upstream ther-
apies for patients with long-standing persistent AF. As such, patients comfort would be greatly
enhanced and the ablation procedural time could be reduced.
Predicting AF catheter ablation outcome from ECG signals has the main advantage that it can
be performed before the procedure, without the need of inserting any catheter within the atria.
The idea is to identify in patients with long-standing persistent AF a broad pathophysiologi-
cal behaviour of the AF dynamics using novel organization indices. Importantly, these indices
estimated on ECG signals should be interpretable from an electrophysiological viewpoint, and
therefore should correspond to a certain degree with intracardiac measurements. However, from
a signal processing viewpoint, several constraints should be taken into account. First, the signal
processing methods should not be computationally expensive and ideally should run in real-time.
As such, the prognosis of the catheter ablation outcome could be established from recordings ac-
quired on embedded devices. Second, the minimal recording duration necessary to get stable and
statistically robust organization indices should be established.
1. An electrical cardioversion consists in performing an electric shock which will eventually reset the atrial activity
towards a normal rhythm.
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1.2 Objectives
The goal of the present thesis is to investigate the performance of innovative organization
indices derived from the surface ECG in predicting the outcome of first-time catheter ablation in
patients with long-standing persistent AF. As such, a logical first step was to define the ablation
and the baseline (prior to ablation) data acquisition protocols. From a clinical aspect, care was
taken in establishing a detailed record of the patient population.
The standard surface ECG was specifically designed to follow the depolarization and repo-
larization of the ventricles, which considerably compromise the estimation of the spatial infor-
mation of the atrial activity. Thus, we aimed at adapting the placement of at least one ECG lead
such that additional electrical information from the atria was provided. Moreover, a correspon-
dence between the activity recorded from the surface ECG and that from intracardiac segments
must be established, providing us a spatial interpretation of the measures of organization derived
from ECG signals.
Signals acquired within the atria are a direct measurement of the local activity and a surrogate
of the level of atrial remodelling. Therefore, before ablation, multiple catheters were inserted
within both atria and recordings were acquired sequentially at several atrial segments. We aimed
at performing an intracardiac DF analysis in order to characterize the frequency of the activation
waveforms within both atria. Moreover, the intracardiac AFCL reflects the average regularity of
the local AF dynamic and is not suitable for assessing the temporal variations in the fibrillatory
activation wavefronts. We intend to define intracardiac organization indices which quantify the
temporal variations of the atrial activation wavefront around the mean AFCL.
In this thesis, for the derivation of organization indices from the surface ECG, we hypoth-
esized that the quantification of the harmonic structure of AF signals might bring more insight
into the AF complexity rather than characterizing the AF dynamic with one component such as
the DF. We aimed at deriving organization indices from time-invariant and time-varying methods
and compare their performance for predicting the acute outcome of catheter ablation.
In the context of predicting the outcome AF catheter ablation, defining organization indices
from baseline ECG signals should be accomplished with the aim of answering the following
questions. Are the organization indices reflecting specific characteristics of the AF dynamics?
Are the organization indices useful for discriminating patients in whom AF catheter ablation
terminates AF from patients in whom AF persisted? What is the impact of epoch durations on
the performance of the organization indices for predicting the acute procedural outcome of AF
catheter ablation?
To summarize, the main objective of this dissertation are:
• to provide a clinical study of patients with long-standing persistent AF in the context of
AF catheter ablation,
• to improve the recording of the atrial activity using a modified surface ECG lead place-
ment,
• to establish a correspondence between the AF activity recorded endocardially with that
from the surface ECG,
• to quantify the variability of atrial activation intervals,
• to define novel organization indices from ECG signals to predict the outcome of catheter
ablation,
• to assess the impact of the epoch durations on the ECG organization indices in discrimi-
nating patients with AF termination from those without termination,
• to assess the predictive performance values of these measures of organization.
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The ultimate goal of this thesis is to define organization indices from the surface ECG that could
be used as an upstream tool for predicting the outcome of catheter ablation in patients with long-
standing persistent AF.
This work has been carried out in the framework of a collaboration between the Applied
Signal Processing Group 2 (ASPG) and the cardiology department at the Centre Hospitalier Uni-
versitaire Vaudois 3 (CHUV).
1.3 Organization
The dissertation is divided into four parts. The first two parts are organized as follows:
I Introduction to cardiac electrophysiology, electrography, atrial fibrillation and catheter
ablation. In Chapter 2, after a review of the anatomy of the cardiovascular system and a
description of the initiation and propagation of electrical impulses across the heart, the
different conventional electrocardiographic measures (surface ECG and intracardiac) are
also presented. Then, Chapter 3 is devoted to the main clinical aspects of AF, and to the
presentation of the alleged pathophysiological mechanisms by which cardiac conditions
favor AF. Chapter 4 briefly introduces the technologies and tools necessary for performing
AF catheter ablation. The current ablation strategies performed for eliminating AF triggers
and for modifying the substrate maintaining AF are also presented.
II Patients characteristics and data acquisition. The second part (Chapter 5) is dedicated
to the presentation of the patient population clinical characteristics used in the present
dissertation. Also, the various technologies available during the ablation procedure for the
ECG and intracardiac signals acquisitions are described. Additionally, a description of the
baseline endocardial signal acquisition and ablation protocol defined during this thesis is
provided. Finally, the databases, which were constructed off-line, are briefly expounded.
Parts III and IV are devoted to the development of novel organization indices from ECG and
intracardiac signals respectively. Figure 1.1 illustrates the organization of these parts. In this
schematic view, the node with shapes and colors denote a part of the dissertation, a thesis
chapter, and a section of a chapter.
III ECG signal processing. This part is divided into two chapters. Chapter 6 presents orga-
nization indices derived from time-invariant spectral approaches and harmonic analysis of
ECG signals. The performance of these indices to correctly and robustly identify patients
in whom catheter ablation was successful in terminating AF is investigated through an ex-
haustive statistical analysis. Then, Chapter 7, presents the adaptive harmonic frequency
tracking algorithm from which novel organization indices were estimated. For compari-
son purposes, the prediction performance of the adaptive derived organization indices was
assessed with the same statistical analysis as in Chapter 6.
IV Intracardiac signal processing. As illustrated in Figure 1.1, this part is divided into
two chapters. Chapter 8 is devoted to the spectral analysis of intracardiac signals using
a classical time-invariant spectral estimation of the DF as well as a time-varying scheme
for assessing the temporal evolution of the frequency content of atrial signals. In this
chapter, two types of study are presented. The first one, aims at evaluating the intracardiac
contribution of several atrial segments to ECG chest leads. While the second study is aimed
at studying the distribution of the DFs assessed in several atrial segments prior to ablation.
Then, Chapter 9 presents a novel method for characterizing the temporal variability of
intracardiac atrial activation wavefronts around the mean AFCL before ablation.
2. http://aspg.epfl.ch/
3. http://www.cardiologie.chuv.ch/
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Finally, Chapter 10 summarizes the results achieved during this thesis and provides a global
conclusion. Possible future directions of research are also covered.
Three appendices are included in this dissertation. Appendix A provides various medical
definitions and a mathematical background on the concept of instantaneous frequency, the Hilbert
transform, the binary logistic regression, and the receiver operating characteristic curves analysis.
Appendix B presents the technical details on the catheters as well as the recording system used
during the ablation procedure. Appendix C presents the ventricular cancellation method used on
the ECG signals.
ECG Signal Processing
Part III
Ventricular Activity Cancellation
Appendix C
Time-invariant Analysis
Chapter 6
Spectral
Section 6.1
Time-varying Analysis
Chapter 7
Harmonic Frequency Tracking
Section 7.2
DF Analysis
Chapter 8
Time-invariant
Section 8.1.1
Correlation
Section 8.2.1
Time-varying
Section 8.1.2
Variability of Atrial
Activation Intervals
Chapter 9
Intracardiac Signal Processing
Part IV
Figure 1.1: Organization of Parts III and IV of the dissertation. The shapes and colors of the
nodes are defined as such. : thesis part. : thesis chapter. : section of a chapter.
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1.4 Original contributions
The main contribution 4 of this work are:
• Electrophysiological study
– Clinical study of long-standing persistent AF catheter ablation.
– Use of a modified 12-lead ECG placement.
• Signal processing and measures of organization estimated on recordings prior to ab-
lation
– Surface ECG
∗ Characterization of the AF instantaneous frequency and phase relationship between
the AF fundamental component and its first harmonic using an adaptive harmonic
frequency tracking algorithm.
∗ Assessment of the impact of the epoch durations on the performance of the organiza-
tion indices for predicting the procedural outcome of catheter ablation.
∗ Exhaustive statistical analysis on the predictive performance of ECG organization
indices.
∗ Comparison between organization indices derived from time-invariant and time-varying
signal processing schemes.
– Intracardiac
∗ Bi-atrial frequency mapping.
∗ Evaluation of intracardiac contribution to ECG fibrillation waves.
∗ Correspondence between the intracardiac activity and the ECG outputs of the adaptive
frequency tracking algorithm.
∗ Characterization of the temporal variability of atrial activation wavefronts.
4. See also the list of publications at the end of the manuscript (page 175).
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This chapter reviews the anatomy of the cardiovascular system and describes the initiation
and propagation of electrical impulses across the heart (Section 2.1). In the second part of this
chapter, the different conventional electrocardiographic measures are explained (Section 2.2).
2.1 Cardiac electrophysiology
2.1.1 The anatomy of the heart and of the cardiovascular system
The heart is a muscular organ of the size of a fist located in the middle of the chest above
the diaphragm, between the lungs and behind the sternum. The heart weights between 200 to
425 grams and its walls are composed of cardiac muscle, called myocardium. It is surrounded
by a double-layered membrane called the pericardium.
The heart receives venous blood at a low pressure, then increases it to a higher pressure by
contracting its cardiac chambers, and finally ejects the blood into the arterial blood vessels [22].
Its anatomy (Figure 2.1) consists of two pumps working in parallel. Each pump is made of
two chambers: the atrium (where the blood enters) and the ventricle (where the blood exits the
heart). Each side is responsible for pumping synchronously different circulatory networks. The
non-oxygenated blood (i.e., coming from the systemic circulation, blue arrows in Figure 2.1)
enters the right atrium through the superior and inferior vena cava. The blood flows from the
right atrium into the right ventricle through the tricuspid valve. The blood is then expulsed into
the pulmonary artery through the pulmonary valve. The pulmonary artery then branches into
two pulmonary arteries (left and right), which deliver the blood to the corresponding lung. The
oxygenated blood (red arrows in Figure 2.1) returns from the lungs and enters the left atrium via
four pulmonary veins. The blood flows from the left atrium into the left ventricle through the
mitral valve and is ejected from the left ventricle across the aortic valve into the aorta.
2.1.2 The cardiac cycle
In order to understand how the cardiac function is regulated, one must know the sequence of
mechanical events during a complete cardiac cycle and how these mechanical events relate to the
electrical activity of the heart.
The successive mechanical events characterizing the contractile function of the heart during
the cardiac cycle can be divided into two general events: diastole (filling) and systole (ejection).
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Non-oxygenated blood 
Oxygenated blood 
Figure 2.1: Anatomy of the heart and associated vessels. The blue arrows denote the non-
oxygenated blood. The red arrows denote the oxygenated blood. Image adapted from: http:
//www.texasheartinstitute.org.
The diastole refers to the resting time in the cardiac cycle, i.e., the period of time when the
ventricles are undergoing relaxation and filling with atrial blood (Figure 2.2).
Ventricular filling is primarily passive, although atrial contraction has a variable effect on the
final extent of ventricular filling (end-diastolic volume). The systole refers to the ventricular con-
traction and ejection and is initiated by the electrical depolarization of the ventricles. Ventricular
ejection begins when ventricular pressure exceeds the pressure within the outflow tract (aorta or
pulmonary artery) and continues until ventricular relaxation causes the ventricular pressure to
fall below the aortic and pulmonary artery pressures closing the aortic and/or pulmonic valves.
The volume of blood remaining within the ventricle at the end of the ejection is the end-systolic
volume. The cardiac cycle is further divided into seven phases: atrial systole, isovolumetric
contraction, rapid ejection, reduced ejection, isovolumetric relaxation, rapid filling, and reduced
filling [22].
Non-oxygenated blood 
Oxygenated blood 
Figure 2.2: The cardiac cycle which is primarily divided into two phases: diastole (panel A,
filling of the ventricles) and systole (panel B, ejection from the ventricles). Image adapted from:
http://www.texasheartinstitute.org.
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2.1.3 Cardiac electrical activity
Cardiac muscle cells
The cardiac tissue can be illustrated as a dense array of cells arranged into bundles. These
cells are called the cardiac myocytes. Their primary function is to contract. The contractions
are initiated by electrical changes. This section explains: (1) the electrical activity of individual
myocytes, and (2) how a coordinated contraction of the heart is initiated.
Cell membrane potentials
Cardiac potentials can be measured by means of microelectrodes placed into the cell. These
microelectrodes allow to measure the electric potential in millivolts (mV) inside the cell relative
to its outside. The transmembrane potential Vm is defined by the difference in voltage between
the interior and exterior of a cell. The resting membrane potential is primarily determined by
the concentrations of positively and negatively charged ions across the cell membrane. At rest,
cardiac cells are electrically polarized (i.e., their insides are negatively charged with respect to
their outsides). In the resting state, the membrane potential of a myocardiac cell is around −80
to −90 mV (Figure 2.3).
The cell membrane is a thin film of lipid and protein molecules held together by non-covalent
interactions [23]. The lipid molecules are arranged in a continuous double layer of about 5 nm
thick. Protein molecules embedded in this lipid bilayer form ionic channels allowing specific
ions to cross the membrane. Of the many different ions present inside and outside of the cells,
the most important in determining the membrane potentials are sodium (Na+), potassium (K+),
chloride (Cl−), and calcium (Ca++). Ions channels have both opened (activated) and closed (in-
activated) states that are regulated either by membrane voltage or by receptor-coupled signal
transduction mechanism [22]. The electrical polarity is maintained by transmembrane pumps
that ensure the appropriate distribution of ions to keep the insides of the cardiac cells relatively
electronegative compared to the extracellular space. Cardiac cells can reverse their internal neg-
ativity in a process called depolarization. This happens when a normal depolarization current
spreads from one cardiac cell to another during electrical activation of the heart. After depolar-
ization is complete, the cardiac cells are able to restore their resting polarity through a process
called repolarization. The electrical cycle from a single cell of depolarization and repolarization
is called an action potential. By convention, the action potential has five phases numbered from
0 to 4.
The two general types of cardiac action potentials include nonpacemaker and pacemaker ac-
tion potentials. Nonpacemaker action potentials are triggered by depolarization currents from
neighboring cells, whereas pacemaker cells are capable of spontaneous action potential genera-
tion.
Nonpacemaker action potentials
Nonpacemaker action potentials are typically found in cells such as atrial and ventricular
myocytes and Purkinje cells. Figure 2.3 illustrates the phases of a nonpacemaker action potential.
– Phase 0. Phase 0 is the rapid depolarization phase caused by a transient increase of Na+
ions into the cell (INA) resulting in a shifting of the membrane potential away from the
potassium equilibrium potential and closer to the sodium equilibrium potential.
– Phase 1. Phase 1 represents the initial fast repolarization caused by the inactivation of the
fast Na+ channel and the opening of a specific type of K+ channel (transient outward, Ito1).
– Phase 2. Phase 2 is the “plateau” phase due to a delay in the repolarization. This delay is
sustained by a balance between inward movement of Ca++ ions (Ica, through L-type cal-
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Figure 2.3: The five phases of the nonpacemaker action potential. For each phase, the types
of ion channels (blue) and the currents (black) are indicated in the corresponding text boxes.
The sharp rise in voltage (phase 0) is primarily produced by a transient increase in sodium (Na+)
conductance. The two decays (phases 1 and 3) correspond to the sodium channel inactivation and
the repolarizing eﬄux of potassium (K+) ions. The plateau (phase 2) is principally generated by
inward calcium channels (Ca++). Figure adapted from Wikipedia (cc by-sa).
cium channels) and outward movement of K+ ions (IKS , through the slow delayed rectifier
potassium channels).
– Phase 3. Phase 3 is the rapid repolarization process. During this phase, the L-type calcium
channels close while the slow delayed rectifier potassium channels (IKs) are still open.
This ensures a net outward current, corresponding to a negative change in the membrane
potential, thus allowing more types of potassium channels to open (IKr and IK1). This net
outward current causes the cell to repolarize.
The delayed rectifier K+ channels close when the membrane potential is restored to about
−80 to −85 mV , while the inward rectifier K+ channels (IK1) remain conductive throughout
phase 4, contributing to set the resting membrane potential [24].
– Phase 4. Phase 4 is the resting membrane potential described previously. When the non-
pacemaker cells are rapidly depolarized from the resting potential of −90 mV to a threshold
voltage of about −40 mV (owing to an external stimulus, typically an action potential con-
ducted by an adjacent cell), phase 0 is initiated.
During phases 0, 1, 2, and part of phase 3, the cell is refractory (i.e., unexcitable) to the
initiation of a new action potential, which defines the effective refractory period (ERP). The ERP
limits the frequency of action potentials (and therefore contractions) that the heart can generate
and thus, acts as a protective mechanism. This enables the heart to have adequate time to fill and
eject blood. The ERP is followed by the relative refractory period during which high intensity
stimuli are required to elicit action potentials. Because not all the sodium channels have fully
recovered at this time, the action potentials generated during this phase have a decreased phase
0 slope and lower amplitude.
Atrial cells have action potentials similar in many aspects to the ventricular action potentials.
The most distinguishable feature of the atrial action potential is that it has a more triangular
appearance than the ventricular one [25]. This feature seems to be due to a prominent phase 1. In
atrial cells, phases 1, 2, and 3 tend to run together, producing a triangular shape, with a plateau
not always apparent.
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Pacemaker action potentials
Pacemaker cells have no true resting potential, but instead generate regular, spontaneous
action potentials. These types of cells possess the property of automaticity, that is, they have the
ability to spontaneously depolarize. The depolarization current of the action potential is carried
primarily by relatively slow, inward Ca++ currents (instead of fast Na+ currents).
Cells within the sinoatrial (SA) node, located in the right atrium at the junction of the supe-
rior vena cava (crista terminalis), constitute the primary pacemaker site within the heart. Other
pacemaker cells exist within the atrioventricular (AV) node (located at the boundary between
the atria and ventricles) and the ventricular conduction system, but their firing rates are driven
by the higher rate of the SA node. This is due to a mechanism called overdrive suppression in
which the intrinsic pacemaker activity of the secondary pacemakers is suppressed. Through this
mechanism, the secondary pacemaker becomes hyperpolarized when driven at a rate above its
intrinsic rate. In this case, a secondary site can take over to the pacemaker of the heart. When
this phenomenon occurs, the new pacemaker site is called an ectopic foci.
SA nodal action potential is divided into three phases (illustrated in Figure 2.4):
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Figure 2.4: The three phases of the SA nodal action potential. For each phase, the types of ion
channels (blue) and the currents (black) are indicated in the corresponding text boxes. Phase 0
(depolarization) is due to an increase in calcium (Ca++) conductance. Phase 3 (repolarization)
results from an increase in potassium (K+) conductance. Phase 4 undergoes a spontaneous depo-
larization.
– Phase 0. Phase 0 corresponds to the upstroke of the action potential. When the membrane
is depolarized to a threshold value of about −40 mV , specific slow calcium channels open,
causing a slow inward movement of Ca++ ions. For pacemaker cells, the slope of phase 0,
which corresponds to the rate of depolarization, is much slower than that of nonpacemaker
cells.
– Phase 3. Phase 3 corresponds to the repolarization. The depolarization in phase 0 causes
the potassium channels to open, repolarizing the cell toward the equilibrium potential for
K+ ions. At the same time, the slow inward Ca++ channels that opened during phase 0
become inactivated, which also contributes to the repolarization process. When the mem-
brane potential reaches −65 mV , phase 3 ends.
– Phase 4. Phase 4 undergoes a spontaneous depolarization from −65 mV to a threshold
voltage of about −40 mV owing in part to special pacemaker currents (also called “funny”
currents, I f ). As the depolarization reaches the threshold voltage, the slow calcium chan-
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nels begin to open, causing an increase in calcium conductance and phase 0 is initiated.
The intrinsic rate of the SA node is the highest at rest (60 to 100 beats per minute - bpm),
followed by the AV node (40 to 50 bpm), then the ventricular muscle (20 to 40 bpm). The heart
rate, however, can vary between low resting values of about 60 bpm to over 200 bpm during
exercise. These rate variations are controlled by autonomic nerves acting directly on the rate
of the SA node. Pacemaker activity is regulated by sympathetic and parasympathetic (vagal)
nerves as well as circulating hormones. At rest, SA nodal activity is principally influenced by
vagal activity which significantly reduces the intrinsic SA nodal firing rate to 60 to 80 bpm.
Autonomic nerves increase SA nodal firing rate by both decreasing vagal tone and increasing
sympathetic activity.
The firing rate of pacemaker cells can be altered (i.e., the rate will increase or decrease) by
autonomic influences in the following manners (Figure 2.5):
1. Modification of the slope in phase 4.
2. Altering the threshold for triggering phase 0.
3. Altering the degree of hyperpolarization at the end of phase 3.
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Figure 2.5: Effects of sympathetic and vagal stimulation on the SA nodal activity. Sympathetic
stimulation increases the firing rate (the slope of phase 4 increases and the threshold for the
action potential decreases). Vagal stimulation decreases the firing rate (the slope of phase 4
decreases and the threshold for the action potential increases). During vagal stimulation, the cell
is hyperpolarized. Figure adapted from [22].
The electrical conduction system of the heart
Cardiac cells are connected together by low-resistance gap junctions. When one cell depolar-
izes, depolarizing currents can pass through the junctions and depolarize adjacent cells, resulting
in a cell-to-cell propagation of the action potential. The action potentials generated by the SA
node spread throughout the atria primarily through cell-to-cell conduction. Action potentials in
the atrial muscle have a conduction velocity of about 0.5 m/sec, which is similar to that of the
ventricular muscle.
Non-conducting tissue separates the atria from the ventricles. Normally, action potentials
have only one pathway available to enter the ventricles, a specialized region of cells called the
AV node. The AV node is located at the junction between the interatrial septum and the ventric-
ular one, between the origin of the coronary sinus and the septal leaflet of the tricuspid valve
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Figure 2.6: The electrical conduction system within the heart. Conduction velocities of different
regions are noted in parenthesis. Image from [22].
(Figure 2.6. The AV node serves two important features. The first is to relay the wave of de-
polarization from the atria to the ventricles. A skeleton of connective tissue associated with the
valves separates the atria from the ventricles, and the AV node is normally the only conductive
link between the atria and the ventricles. The second function of the AV node is to delay the
spread of excitation from the atria to the ventricles. The impulse conduction velocity is slowed
down to about 0.05 m/sec (one-tenth the velocity found in atrial or ventricular myocytes). This
conduction delay is important. First, it allows sufficient time for complete atrial depolarization,
contraction, and emptying of atrial blood into the ventricles prior to ventricular depolarization
and contraction. Second, the low conduction velocity limits the frequency of impulses travelling
through the AV node and activating the ventricle. This is important during atrial arrhythmias
(such as atrial fibrillation or flutter, see Chapters 3 and 5 respectively), in which the atria rate
is excessively high. If these abnormal and rapid contractions propagate to the ventricles, it will
lead to severe tachycardia and reduced cardiac output caused by inadequate time for ventricular
filling.
Action potentials leaving the AV node enter the base of the ventricle at the bundle of His
and then follow the left and right bundle branches along the interventricular septum (Figure 2.6).
These specialized bundle branch fibers conduct the action potential at a high velocity (about 2
m/sec). These branches then divide into an extensive network of Purkinje fibers that conduct the
impulse at high velocity through the ventricles (about 4 m/sec). These fibers are interconnected
among the contractile cells of the ventricles and serve to quickly spread the wave of excitation
throughout the ventricles. The rapidly conducting Purkinje fibers cause the ventricular cardiomy-
ocytes to contract almost simultaneously.
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2.2 Electrocardiography
2.2.1 Electrocardiogram: the standard 12-lead ECG
An electrocardiogram (ECG) is the most commonly used tool in clinical practice for record-
ing the electrical activity of the heart. It is especially useful in diagnosing abnormal rhythms,
variations in electrical conduction, and myocardial ischemia and infarction. The first human
ECG was measured in 1887 by Augustus Walter. The essential contribution to ECG-recording
technology still in use nowadays has been developed by Willem Einthoven in 1908 by using a
string galvanometer which greatly increased the sensitivity [26].
The ECG records the electrical activity of the heart by attaching to the skin an array of elec-
trodes at specific locations on the body surface. The convention requires that electrodes are
placed on each arm and leg, and additional electrodes at defined locations on the chest. The dif-
ference between two electrodes voltage is defined as a lead. Typically, the ECG includes unipolar
and bipolar leads. A unipolar lead has a single positive electrode and the voltage variation is mea-
sured in relation to a reference electrode commonly called the central terminal. A bipolar lead is
composed of two electrodes (positive and negative) and reflects the voltage difference between
these two electrodes. Typically, the ECG magnitude ranges from a few mV to 1 V .
In practice different standardized placement of recording electrodes exist. The most widely
used in clinical practice is, however, the standard 12-lead ECG.
The standard 12-lead ECG is composed of three different leads: the bipolar limb leads, the
augmented unipolar limb leads, and the unipolar precordial chest leads.
ECG limb leads
Bipolar limb leads Figure 2.7 shows the three bipolar limb leads, denoted I, II, and III. Lead
I has the positive electrode on the left arm and the negative electrode on the right arm. In this
way, the potential difference across the chest between the two arms is measured. Lead II has the
positive electrode on the left leg and the negative electrode on the right arm. Lead III has the
positive electrode on the left leg and the negative electrode on the left arm. By noting VLA, VRA
and VLL as the voltage recorded on the left arm, the right arm and the left leg respectively, one
can derive the following combinations:
I = VLA − VRA
II = VLL − VRA
III = VLL − VLA
The three limb leads roughly form an equilateral triangle with the heart at its center, known
as the Einthoven’s triangle. It is interesting to note that only two of these three leads are indepen-
dent. Indeed, according to Kirchhoff’s law, these lead voltages have the following relationship:
II = I + III
Augmented unipolar limb leads The augmented unipolar limb leads are derived from the
three limb leads. Each of these augmented leads has a single positive limb electrode which is
referred against a combination of the two other limb electrodes. These augmented limb leads are
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Figure 2.7: Standardized placement of the bipolar limb leads I, II, and III and the location of
the positive and negative recording electrodes.
defined as the voltage difference between one limb electrode and the average of the remaining
two limb electrodes:
aVR = VRA − (VLA + VLL)/2
aVL = VLA − (VRA + VLL)/2
aVF = VLL − (VLA + VRA)/2
Therefore, aVL has the positive electrode located on the left arm, aVR on the right arm and
aVF on the left leg (the "F" stands for "foot").
These six limb leads are the base of the conventional axial reference system as shown in
Figure 2.8. The positive electrode for lead I is defined as being at zero degrees relative to the
heart, forming the horizontal axis. Similarly, relative to the heart, the positive electrode for lead
II is located at +60◦ and the positive electrode for lead III is at +120◦. By definition, the lead
aVL is at −30◦ relative to the horizontal axis (e.g. lead I); aVR is at −150◦, and aVF is at +90◦.
These six limb leads record the electrical activity of the heart along a single plane, namely the
frontal plane relative to the heart. The axial reference system is used to determine the direction of
an electrical vector. For example, if a wave of depolarization is spreading from right to left along
the horizontal axis, lead I shows the maximum positive amplitude. Likewise, if the depolarization
direction is heading towards +90◦, then aVF shows the maximum positive deflection.
ECG precordial chest leads
The six precordial chest leads are unipolar recordings obtained by electrodes placed on the
surface of the chest over the heart to record electrical activity in a horizontal plane perpendicular
to the frontal place (Figure 2.9, panel A). The six leads are labelled V1, . . . ,V6. V1 is located to
the right of the sternum over the fourth intercostal space. V2 is located to the left of the sternum
over the fourth intercostal space. V3 is located midway between V2 and V4, while V4 is located
on the midclavicular line, over the fifth intercostal space. V5 is located at the same level as V4 but
on the anterior axillary line. Finally, V6 is located laterally on the midaxillary line at the same
level as V4 and V5.
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Figure 2.8: The axial reference system giving the location and direction for all six limb leads.
Posterior 
Left Right 
Anterior 
0º V6 
30º 
V5 
60º 
V4 
75º 
V3 
V1 V2 
Fifth ICS 
Anterior axillary 
line 
Midclavicular line 
Fourth ICS 
Midaxillary 
line 
A 
B 
Figure 2.9: ECG chest leads positions and vectors. Panel A: electrodes position for the precor-
dial chest leads within the horizontal place. Panel B: directions of the precordial leads on the
horizontal plane. ICS: intercostal space.
2.2 Electrocardiography 21
With this electrode placement, leads V1 and V2 reflect the activity of the right ventricular free
wall. Leads V3 and V4 reflect the activity of the left ventricular anterior wall, while lead V5 and
V6 reflect the lateral wall of the left ventricle. Panel B on Figure 2.9 illustrates the lead vectors
for the six unipolar precordial chest leads along the horizontal plane. As it can be observed,
only the left anterior part of the heart (mostly representing the ventricles) is reflected with this
electrodes positioning.
The normal electrocardiogram
We will now describe some important ECG characteristics along with the wave-naming con-
vention and the relations between the different ECG complexes and the heart activation.
As cardiac cells depolarize and repolarize (Section 2.1.3), electrical currents spread through-
out the body because the tissues surrounding the heart are able to conduct electrical currents
generated by the heart. The repeating waves of the ECG represent the sequence of depolarization
and repolarization of the atria and ventricles (Figure 2.10). The ECG does not measure absolute
voltages, but voltage changes from a baseline (isoelectric) voltage. The duration of a wave is
defined by the two time instants at which the wave either deviates significantly from the baseline
or crosses it. A normal 12-lead ECG (in sinus rhythm) is shown in Figure 2.11.
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Figure 2.10: ECG wave definition of the cardiac cycle. Image adapted from [27].
By convention, the first wave of the ECG is the P wave which represents the wave of de-
polarization that spreads from the SA node across the atria. Once the impulse leaves the SA
node, atrial activation spreads in several directions following a specific pattern determined by
the complex anatomical and functional properties of the atrial musculature. The propagation is
rapid and moves anteriorly toward the lower portion of the right atrium. It also spreads across
the anterior and posterior surfaces of the atria toward the left atrium. At the same time, activation
spreads through the interatrial septum, entering high on the right side and moving toward the
interventricular septum. Although the right atrium is first activated, activation occurs simultane-
ously in both atria. The duration of the P wave is usually between 80 to 100 msec. Normal atrial
activation projects positive as an upright P waves in leads I, II, aVL, and aVF and negative one
in lead aVR (Figure 2.11). In the precordial leads, P wave patterns correspond to the direction
of atrial activation wavefronts in the horizontal plane. The early activation in the P wave is over
the right atrium and is oriented anteriorly and later, as activation moves toward the left atrium,
it shifts posteriorly. Thus, the P wave in the right precordial leads (mostly V1, and occasionally
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V2) is biphasic, with an initial positive deflection followed by a negative one. In the lateral leads,
the P wave is upright and reflects right-to-left spread of the activation wavefronts. The amplitude
in the limb leads is normally less than 0.25 mV and the terminal negative deflection in the right
precordial leads is normally less than 0.1 mV in depth.
Atrial depolarization is followed by an atrial repolarization wave that is rarely visible on the
surface ECG because of its very low amplitude (usually less than 100 µV) which also occurs
during ventricular depolarization. The brief isoelectric period after the P wave represents the
time in which the atrial cells are depolarized and the impulse is travelling within the AV node,
where the conduction velocity is greatly reduced.
The QRS complex represents the ventricular repolarization and its duration is normally be-
tween 0.06 to 0.11 seconds. The period of time from the onset of the P wave to the beginning of
the QRS complex, the P-R interval, normally ranges from 0.12 to 0.20 seconds. This interval
starts with the onset of atrial depolarization and ends with the onset of ventricular depolarization.
It is during this period that occur the activation of the AV node, the Bundle of His and the bundle
branches.
The isoelectric period (ST segment) following the QRS is the period at which the entire
ventricles are depolarized and roughly corresponds to the plateau phase of the ventricular action
potential (Figure 2.10). The T wave represents ventricular repolarization (phase 3 of the action
potential) and lasts longer than depolarization. During the Q-T interval, both ventricular depo-
larization and repolarization occur and roughly estimates the duration of the ventricular action
potential. On some ECGs, a small wave follows the T wave, named the U wave, may be visible
and is thought to represent the late repolarization of ventricular segments [27].
Figure 2.11: Normal electrocardiogram. The vertical lines of the grid represent time, with line
spaced at 40 msec interval. Horizontal lines represent voltage amplitude, with lines spaced at 0.1
mV intervals. Figure from http://ecg.utah.edu/lesson/3
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2.2.2 Intracardiac electrograms
The recording of cardiac potentials from electrodes directly in contact with the heart is called
an intracardiac electrogram (EGM). The electrode is an electrical conductor which is used to
make contact with the heart and convert ionic currents (ions passing trough transmembrane
channels) into electrical currents that can be detected by electronic devices. Intracardiac EGMs
record therefore the local electrical activity of the heart, that is, the cardiac tissue surrounding
the electrode in contact. All electrical potentials measured by any device are actually measuring
difference in potentials between two electrodes. By convention, all clinical EGMs are differential
recordings from one source connected to the anodal (positive) input of the recording amplifier
and a second source connected to the cathodal (negative) input. Unipolar EGMs represent the
potential difference between the electrode in contact with the heart (also called the exploring
electrode) and a reference electrode distant from the heart (referred as an indifferent electrode
and in theory placed at and infinite distance). In practice, the Wilson central terminal is used
to approximate the indifferent electrode [26]. Bipolar EGMs represent the potential difference
between two electrodes and are calculated as the algebraic difference between the two unipolar
EGMs at the two sites (using the same reference).
The following characteristics of unipolar and bipolar EGMs are separately mentioned and
summarized in Table 2.1 at page 26:
– Spatial resolution: ability to locate the discrete area of excited tissue generating the recorded
potentials [28].
– Temporal resolution: ability to identify the local activation time which coincides best with
the arrival of the depolarization wavefront.
– Directionality: ability to provide information regarding the direction and the origin of
wavefronts.
Unipolar EGM
Spatial resolution Unipolar EGMs record the activity occurring between the exploring elec-
trode and the reference electrode and, therefore, contain substantial far-field signal generated by
the depolarization of remote tissue. Typically, the far-field activity is of much higher amplitude
than the local signal occurring at the exploring electrode, and therefore, distant activity can be
difficult to separate from local activity.
Unipolar EGMs have also poor signal-to-noise ratio. Filtering may improve the signal quality
by eliminating noise, but it may also alter the signal.
Unipolar EGMs reflect the potential generated by the tissue in direct contact with the explor-
ing electrode as well as far field activity.
Temporal resolution In unipolar recording, the local activation time is positioned at the point
of maximum downslope (i.e., maximum negative dV/dt), which corresponds to the maximum
sodium channel conductance [5]. It has been shown that using this fiducial point, the error in
determining the local activation time is less than 1 millisecond [29].
Directionality The morphology of unipolar recordings indicates the direction of wavefront
propagation (and therefore its origin). Figure 2.12 illustrates the case when a wavefront originates
outside of the tissue in contact with the electrode (top plot), reaches the electrode (middle plot),
and then moves away from the electrode (bottom plot). When the depolarization wavefront is
moving towards the recording electrode, a positive deflection is produced (Figure 2.12, top plot).
When the depolarization wavefront is moving away from the recording electrode, a negative
deflection is produced (Figure 2.12, bottom plot).
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Figure 2.12: Hypothetical morphology of a unipolar recording. A unipolar EGM is recorded
from the distal electrode (red). When the depolarization wavefront originates from outside of the
tissue in contact with the recording electrode (top plot), a positive deflection is produced. When
the depolarization wavefront moves away, a negative deflection is produced. Figure adapted
from [28].
Bipolar EGM
Spatial resolution Bipolar EGMs, by virtue of subtraction of closely spaced electrodes, elim-
inate noise and far-field activity, hence improving the signal-to-noise ratio. As a byproduct, high
frequency components are more accurately seen. Indeed, when the distance from a signal or
noise source to the electrodes is larger than the distance between the two electrodes, the noise is
recorded quasi-identically by the two electrodes, and efficiently eliminated by subtraction. More-
over, as the distance from the recording site increases, amplitude and frequency of the recorded
signal decrease depending on the inter-electrode distance.
Bipolar EGMs reflect the local electrical activity produced by the area of tissue in contact
with and between the two electrodes. As the distance between the two electrodes of bipolar
recording decreases, the spatial resolution increases.
Temporal resolution For bipolar EGMs, the detection of local activation times is more prob-
lematic due to the generation of the bipolar recordings. Multiple methods were proposed [28].
Most commonly, the absolute maximum electrogram amplitude is chosen, which correlates with
the local activation time that corresponds to the maximal negative downslope (dV/dt) of the
unipolar recording as shown in Figure 2.13. However, in the case of complex fractionated EGMs,
this fiducial point cannot be reliably used for determining the local activation time.
Directionality The orientation of the bipolar recording axis with respect to the direction of
propagation of the activation wavefront has a direct influence on the morphology and amplitude
of bipolar EGMs [29]. When the depolarization wavefront is propagating in the direction exactly
perpendicular to the bipolar recording axis, no difference in potential between the recording
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Figure 2.13: Local activation time in unipolar and bipolar EGMs. In unipolar EGMs, the local
activation time is located at the maximum negative downslope (dV/dt). In bipolar EGMs, the lo-
cal activation time is most commonly estimated by the maximum absolute peak. In this particular
example, only one unipolar derivation is shown.
electrodes is produced, and hence no resulting signal is recorded. As opposed to unipolar EGMs,
the direction of wavefront propagation cannot be reliably inferred from the morphology of the
bipolar signal, although a change in morphology can be a useful finding [29].
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Unipolar Bipolar
Spatial resolution + Good spatial resolution + Reflect the local electrical
activity
– Contain far-field activity + Far-field activity is re-
moved
– Poor signal-to-noise ratio + High frequency compo-
nents more accurately
seen
– Loss of spatial resolution
depending on electrode
distance
Temporal resolution + Precise measure for esti-
mating the local activa-
tion time
+ Good for visual or man-
ual assessment of local
activation time
– Visually difficult to assess
the local activation time
– Less precise for estimat-
ing the local activation
time
Directionality +/– Morphology indicates the
direction of wavefront
propagation
+/– Morphology dependent
on wavefront direction
Table 2.1: Summary of unipolar and bipolar EGMs properties.
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Atrial fibrillation (AF) is the most commonly encountered cardiac arrhythmia in clinical prac-
tice. Hospitalizations related to AF problems account for one third of all admissions for cardiac
arrhythmia. AF alters the mechanical function of the left atrium leading to blood stasis and
thrombus formation causing an increasing number of complications and deaths. The available
data from epidemiological studies suggest that, independently of other known predictors of mor-
tality, AF is the cause for doubling death rates [30]. It is estimated that 20% of all strokes are
caused by AF and that AF-related events are more severe than strokes of other origin [4]. AF is
complicated by hemodynamic impairment (loss of atrial contractile function, irregular and fast
ventricular rate). These conditions may lead to a decrease in quality of life for affected patients.
In the context of the Global Burden of Disease 2010 Study, using data from 184 publications
it was concluded that worldwide in 2010, 33.5 millions of individuals suffered from AF, with 5
millions new cases occurring each year and that over the last two decades both the prevalence and
incidence of AF have increased meaningfully [1]. As life expectancy increases, AF prevalence
is estimated to double in the next fifty years.
In this chapter, we will first cover the clinical definition of AF (Section 3.1) and important
clinical aspects related to AF will be introduced (Section 3.2). In Section 3.3, the different stages
of the disease will be covered. Section 3.4 presents the most common symptoms of AF. Then,
Section 3.5 presents the pathophysiological mechanisms by which cardiac conditions favor AF.
Finally, the management of AF will be briefly presented in Section 3.6.
3.1 Definition
AF is a supraventricular arrhythmia characterized by rapid and irregular atrial activation lead-
ing to a consequent deterioration of atrial mechanical functions. On the ECG, AF is distinguish-
able by the replacement of the P wave with rapid oscillations called atrial fibrillatory waves
(f-waves). A 12-lead ECG with AF is shown in Figure 3.1. Generally, atrial fibrillatory activity
is best seen in lead V1. The rate of the f-waves is generally between 300 and 600 bpm. The
f-waves vary in amplitude, morphology and period, which may be reflective of various simulta-
neous atrial activations present at different locations and time within the atria.
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Figure 3.1: 12-lead ECG tracing of AF. Note the replacement of P waves by f-waves and the
irregular response of the ventricles. Figure from [31].
3.2 Clinical considerations
3.2.1 Epidemiology
Worldwide epidemiological data on AF suggest that this disease can be considered as an
emergent global epidemic [1]. It is important to mention that AF may be undiagnosed, and that
many patients with AF will never present to hospital [32]. The prevalence of AF increases with
age (from < 0.5% at 40 − 50 years, to 5 − 15% at 80 years) and AF incidence rates are higher
in males compared to females [4]. Lifetime risks for developing AF are ∼ 25% in subjects older
than 40 years, independently of gender [2].
AF is associated with different cardiovascular events the prevention of which is the main goal of
therapeutic strategies. Outcomes related to AF are summarized in Table 3.1.
Outcome parameters Relative changes in AF patients
Death Death rate doubled.
Stroke Stroke risk increased; AF is associ-
ated with more severe strokes.
Hospitalizations Hospitalizations related to AF ac-
count for ∼ 30% of all admission
for cardiac arrhythmias.
Quality of life Wide variation, from no effect to
major reduction.
Left ventricular function May be impaired.
Table 3.1: Clinical outcomes associated with AF. Table from [4].
3.2.2 Conditions associated with atrial fibrillation
AF is related to numerous conditions. Most of them contribute to a progressive process in the
development of the disease by favoring either the occurrence of AF "triggers" (i.e. responsible
for the initiation) and/or the formation of "substrate" for AF (i.e. responsible for its perpetuation).
Several conditions are listed below:
– Age: increases the risk of developing AF.
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– Hypertension: found in most of AF patients. It is an independent predictor of AF and
contributes to its progression.
– Thyroid dysfunction: in particular hyperthyroidism is associated with AF and may be the
only cause for its development.
– Obesity: found in more than a quarter of AF patients [4].
– Sleep apnea: may be a pathophysiological factor for AF (especially in association with
hypertension or diabetes).
Other conditions are also coronary artery disease, valvular heart disease, obstructive lung
disease, symptomatic heart failure, cardiomyopathies, diabetes and chronic renal diseases [4].
3.3 Types of atrial fibrillation
Various classifications of AF have been used, making the comparison between studies or
therapy effectiveness difficult. In clinical practice, a classification is useful for the management
of AF patients. Typically, it is important to characterize the arrhythmia at a given moment based
on the clinical presentation and duration of the arrhythmia. In this manuscript, the recent classi-
fication published by the Task Force for the Management of Atrial Fibrillation of the European
Society of Cardiology [4] has been chosen. The types of AF are as follows (also illustrated in
Figure 3.2):
1. First diagnosed AF: a patient presents an AF for the first time, independently of the
severity of AF-related symptoms.
2. Paroxysmal AF: the arrhythmia self-terminates, usually within 48 hours.
3. Persistent AF: the arrhythmia becomes sustained for a duration longer than 7 days or
requires termination by cardioversion (see the AF management Section 3.6).
4. Long-standing persistent AF: the arrhythmia becomes sustained for a duration greater
than one year.
5. Permanent AF: when the presence of the arrhythmia is accepted by the physician and the
patient. In this category, the cardioversion has failed (see the AF management Section 3.6).
If a rhythm control strategy is chosen, the arrhythmia is reclassified in long-standing per-
sistent.
3.4 Symptoms
Patients can experience periods of both symptomatic and asymptomatic AF. Most commonly,
AF can be recognized by a sensation of palpitations. In patients in whom the arrhythmia has
become permanent, palpitations may decrease with time. Other symptoms of AF are chest pain,
dyspnea (e.g. a respiratory distress), or dizziness.
3.5 Pathophysiological mechanisms of atrial fibrillation
It is important to separate the underlying AF mechanisms into two main components: ar-
rhythmia triggers and arrhythmia perpetrators. The onset and maintenance of the arrhythmia
require both triggers for its initiation and substrates for its maintenance. These mechanisms are,
however, not mutually exclusive and are likely to be present simultaneously at various times [4].
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Figure 3.2: Types of atrial fibrillation. Figure adapted from [4].
3.5.1 Initiation
Focal mechanisms
Many studies have suggested that in most cases AF begins with a rapid focal activity in
the pulmonary veins (PVs), and less commonly in the superior vena cava, the coronary sinus
(CS), or the left atrial posterior wall [5, 31]. Figure 3.3 shows a posterior view of the atria,
and the corresponding locations of the common triggers. The identification of these triggers is
of major clinical importance because any treatment that may eliminate them may be successful
in terminating AF. Haisseguerre et al. have shown in 1998 that the ablation of focal triggers
around the PVs could terminate paroxysmal AF [33]. It is now well established and accepted by
the medical community that the PVs are a crucial source of triggers in the initiation of AF. The
underlying mechanism responsible of focal firing remains unclear yet.
3.5.2 Maintenance
Once initiated, an AF episode may be brief and may end spontaneously. Maintenance of AF
is ensured by various factors. On one hand, focal triggers which initiated AF may persist, acting
as drivers for the maintenance of AF. On the other hand, AF can persist even in the absence of
triggers. In this case, AF maintenance results from additional factors including various amount of
electrical and structural remodeling characterized by shortening of atrial refractoriness and atrial
dilation. These factors are presumably responsible for favoring the development of a common
pathway for AF throughout the atria [5]. This mechanism is known as the "multiple wavelet
hypothesis".
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Figure 3.3: Common locations of focal triggers responsible for initiating AF. The four pulmonary
veins (PVs, in red) are the most common source of foci. The four PVs are: left superior PV
(LSPV), left inferior PV (LIPV), right superior PV (RSPV), right inferior PV (RIPV). Other
sites of AF sources (blue) are the coronary sinus (CS), the superior vena cava (SVC), and the left
posterior free wall. Figure adapted from [34].
Multiple wavelet hypothesis
For many years, the multiple wavelet hypothesis for AF maintenance was widely accepted
as the dominant AF mechanism. The hypothesis was advanced by Moe et al., who proposed a
model in which AF is sustained by multiple randomly wandering wavelets colliding with each
other [35]. These wavelets occur simultaneously throughout the left and right atria and con-
tinuously undergo either self-extinction or self-perpetuation (e.g. wavebreaks) into "daughter"
wavelets. Figure 3.4 shows a schematic drawing of the large and small reentrant wavelets.
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Figure 3.4: Schematic drawing of the large and small reentrant multiple wavelets favouring AF
initiation and maintenance. Figure adapted from [34].
Typically, these circuits have a variable and short cycle length. AF requires the presence of
at least four to six independent wavelets to perpetuate [5]. In this model, the number of wavelets
depends at any time on the excitable mass, atrial conduction velocity and refractory period in
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different parts of the atria. The presence of anatomical obstacles (such as the PVs) also favours
the creation of daughter wavelets. The number of wavelets increases with a larger atrial mass,
shorter refractory period and delayed conduction. It is more likely that AF is sustained when the
number of wandering wavelets increases. The multiple wavelet hypothesis has been subsequently
confirmed by experimental work [36, 37].
Mother circuit
Some authors have shown in isolated sheep hearts that, in the presence of an appropriate
heterogeneous AF substrate, a focal trigger usually localized in one PV can result in a single
meandering functional reentrant AF driver (rotor) [38]. This model is illustrated in Figure 3.5
which shows the presence of a single source of stable reentrant activity, i.e., the mother circuit,
with high frequency wavefronts emanating from a focal trigger located within the left superior
PV (LSPV). When conditions of heterogeneity are adequate, the wavefronts break and initiate
two counter-clocking vortices. Alternatively, only one of the vortices remains (drawn in red plain
line), and is responsible for maintaining AF.
Posterior view 
Left atrium Right atrium 
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Figure 3.5: Schematic drawing of the mother circuit mechanism. High frequency wavefronts
emanate from a focal trigger located within the LSPV. When conditions of heterogeneity are
adequate, the wavefronts break and initiate two counter-clockwise vortices. Alternatively, only
one of the vortices remains (drawn in red plain line) and is responsible for maintaining AF. Figure
adapted from [34, 38].
The waves emerging from the rotor may undergo spatial fragmentation upon anatomical ob-
stacles (such as PVs or scars), leading to the formation of multiple wavelets spreading out in
multiple directions at varying conduction velocity (fibrillatory conduction). The dominant rotors
responsible for driving AF generally originate and anchor within the left atrium (LA), while the
right atrium (RA) is being activated passively [39].
3.5.3 Atrial remodeling and atrial fibrillation
The atria may display some electrical and structural remodeling over time that may, in turn,
favor the maintenance of AF. More specifically, modifications primarily affecting excitability and
action potentials characteristics are termed electrical remodeling, while the changes in atrial vol-
ume and tissue structure are referred to as structural remodeling. The hemodynamic impairment
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such as loss of atrial contractile function is referred as contractile remodeling. Experimental stud-
ies have shown that electrical and structural remodeling play a major role in the initiation and
maintenance of AF. These modifications in atrial structure and conduction have provided a pos-
sible explanation for the progressive and self-perpetuating nature of AF ("AF begets AF" [12]).
Figure 3.6 illustrates the different types of remodeling and their interactions [13]. Each of these
remodelings affects the atrial function and structure at different stages of the disease. The elec-
trical remodeling develops within the first days of AF and results from high frequency atrial
activations, decreasing rapidly the atrial ERP. It has been observed in clinical practice that the
time course for persistent AF development is slower than that of the electrical remodeling. In-
deed, the structural remodeling takes weeks to months after AF onset. This observation suggests
that in the development of sustained AF (such as long-standing or permanent AF), the structural
remodeling is important.
Action potential duration ↓ 
Electrical 
Contractile Structural 
AF 
Circuit Size Ca++ channels 
Stretch 
Contractility ↓ 
Dilation 
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Anisotropy 
Figure 3.6: Three proposed positive feedback-loops associated with remodelings: electrical, con-
tractile and structural. The primary cause for electrical and contractile remodeling is considered
to be the down regulation of Ca++ channels function. The structural remodeling of the atria is
due to its dilation. Atrial regions with advanced fibrosis can be the harbinger for local sources
of AF. The resulting electro-anatomical substrate of AF consists of dilated atria and increased
tissue heterogeneity. Figure adapted from [13].
3.6 Management
The clinical management of patients with AF is aimed at:
– Preventing thromboembolism. For each patient, the evaluation of stroke risk determines
the need for anticoagulation. Numerous studies have shown that in the presence of risk
factors, patients with paroxysmal AF appear to have an equivalent stroke risk to those with
persistent or permanent AF [4].
– Rate control. AF is characterized by a rapid heart rate that may decrease the cardiac out-
put. During AF, rate control is important to prevent haemodynamic distress in AF patients.
The main goal of a rate control therapy is to target a ventricular rate between 60 to 80 bpm
at rest and 90 to 115 bpm during exercise. The criteria for rate control vary with patient
age. However, an adequate ventricular rate control therapy should target a decrease in
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symptoms and improve haemodynamics.
– Rhythm control. Rhythm control is aimed at restoring and maintaining the sinus rhythm.
The restoration of the heart normal rhythm is called a cardioversion .
These three objectives are not mutually exclusive; they can be pursued in parallel. For each
patient, the clinician shall establish an overall strategy considering several factors such as the
patient’s age, the type and duration of AF, the severity of symptoms, the associated cardiovascular
disease or medical conditions, short or long-term treatment goals, and therapeutic options (e.g.
pharmacological or non pharmacological approach).
3.6.1 Pharmacological therapies
Rate control
During AF, the conduction characteristics and refractoriness of the AV node as well as the
sympathetic and parasympatetic tones are the main determinants of the ventricular rate. More-
over, the functional refractory period of the AV node is inversely correlated with the ventricular
rate [31]. Drugs prolonging the AV node refractory period are generally effective for rate control.
The most commonly prescribed drugs are beta-blockers, non-dihydropyridine calcium channel
antagonists, digoxin, digitalis, and amiodarone. When a pharmacological approach fails to re-
duce the heart rate, a non pharmacological strategy should be considered (such as an AV node
ablation after pacemaker implantation [4]).
Rhythm control
Pharmacological cardioversion of AF may be initiated by the administration of antiarrhyth-
mic drugs such as flecainide, propafenone, sotalol, amiodarone or ibutilide [4]. When the phar-
macological cardioversion fails to terminate AF, a non pharmacological approach may be con-
sidered (such as a direct-current cardioversion, Section 3.6.2, or a catheter ablation ablation,
Section 3.6.2 and Chapter 4)
Rhythm versus rate control
For patients in whom AF related symptoms are considered tolerable (typically the elderly),
a rate control strategy may be appropriate. Two major prospective studies (Atrial Fibrillation
Follow-up Investigation of Rhythm Management - AFFIRM - and Rate Control vs Electrical
cardioversion - RACE) that compared rate control and rhythm control therapies, have shown that,
regardless of the selected strategy, embolic events occur with equal frequency after interruption
of anticoagulation [40, 41].
The clinical management of symptomatic AF may differ from one patient to another. For
symptomatic patients with AF lasting several weeks, the initial therapy should be rate control
and anticoagulation. When rate control does not provide sufficient symptom relief, restoration
of sinus rhythm may become a long-term goal, that may be achieved with non pharmacological
approaches.
3.6.2 Non pharmacological therapies
Direct-current cardioversion of atrial fibrillation
Direct-current cardioversion (DCC) is a non pharmacological method for restoring sinus
rhythm in AF patients and is generally preferred to a pharmacological approach because of
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greater efficacy. As cardioversion is associated with an increased risk of thromboembolism,
anticoagulation must be initiated several weeks before.
DCC consists in delivering an electrical shock in synchronization with the ventricular ac-
tivation. Indeed, it is important to ensure that the electrical shock does not occur during the
vulnerable phase of the cardiac cycle (i.e., the T-wave) [42]. Most commonly, the current is
delivered through special external chest electrodes (or paddles) which are located on either side
of the heart or in an antero-posterior configuration. In both configurations, the electrical cur-
rent delivered between the patches spreads through the heart. Traditionally, the energy output is
successively increased in increments of 100 J to a maximum of 400 J [31].
Because the shock is uncomfortable, DCC is performed under general anaesthesia. Recur-
rences after cardioversion can be divided into three phases: a) immediate (seconds to minutes
after DCC); b) early (five days after DCC); c) late. Importantly, factors that predispose to AF
recurrence are age, AF duration, number of previous DCCs, and a dilated left atrium.
Surgical ablation
In the 1980s, several studies have identified important factors involved in the termination of
AF surgically. The main hypothesis for the surgical approach is that reentry underlies the de-
velopment and maintenance of AF and, that atrial incisions at critical locations would produce
barriers to the conduction of AF [43]. Following this assumption, the surgical procedure de-
veloped was called maze [44]. Since its introduction, the procedure has gone through different
iterations. Results appeared quite effective (over fifteen years of follow-up success rates from
75 − 95% have been reported) but decreased in the most recent studies using long-term ECG
recordings [4]. The maze procedure is complex mainly because of the need for cardiopulmonary
bypass and requires extensive lesions precluding the atrial function.
Catheter ablation
Radiofrequency catheter ablations techniques were developed for terminating AF in the 90′s
following the maze procedure by performing linear lesions from the atrial endocardium, i.e.,
inside the atria [45]. Currently, AF catheter ablation is the cornerstone of non pharmacological
AF therapy. Radiofrequency catheter ablation of AF is covered in more details in Chapter 4.
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Catheter Ablation of
Atrial Fibrillation 4
Since the late 90′s, treatment of AF by catheter ablation has evolved from an experimental
procedure to one that is nowadays widely performed in a large number of medical centres world-
wide. It has become the cornerstone of non pharmacological AF therapy.
As shown in the previous chapter, the development of AF requires both a trigger for its ini-
tiation and a substrate for its perpetuation (Section 3.5 page 29). Catheter ablation is aimed at
eliminating the trigger(s) and/or altering the arrhythmogenic substrate. Importantly, various ab-
lation strategies have been deployed in order to terminate AF in different patient populations.
However, the optimal ablative strategy remains to be established.
In this chapter, we will first cover the technologies and tools necessary for performing AF
catheter ablation (Section 4.1). Then, in Section 4.2, the ablation strategy for eliminating AF
triggers is explained whereas the last two Sections (4.3 and 4.4) focus on different approaches
for modifying the substrate maintaining AF.
4.1 Technologies and tools
4.1.1 Left atrial access
Catheter ablation is considered as a minimally invasive procedure as no major incision is
necessary. Catheters are inserted within the heart using blood vessels, typically the left and/or
right femoral veins as illustrated in Figure 4.1. The catheters are then advanced into the right
atrium via the inferior vena cava. Drivers of AF are thought to be mainly localized within the
left atrium (Section 3.5), which is separated from the right atrium by an interatrial septum. In
order to access the left atrium, a transseptal puncture must be performed. Figure 4.1 illustrates
the situation when a mapping and ablation catheters have been introduced within the left atrium.
4.1.2 Energy sources
The most dominant energy source used for catheter ablation is by far the radiofrequency en-
ergy (RF) which is electrically conducted. A unipolar alternating current (typically 500 kHz) is
delivered from the ablation catheter tip to a dispersive indifferent electrode (or patch) applied on
the patient’s skin. RF current heats up the cardiac tissue to produce variable amount of myocar-
dial oedema an necrosis. The assumption of successful AF ablation is the creation of lesions that
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Figure 4.1: Catheters are inserted within the heart using the right femoral vein and enter the right
atrium through the inferior vena cava. A transseptal puncture is performed in order to introduce
the catheter within the left atrium. Figure adapted from [46].
block the propagation of AF wavefronts.
When the contact between the electrode and the tissue is constant, only a fraction of the
power is effectively applied to the cardiac tissue. The rest is dissipated in the blood pool because
the electrode has better conductance with blood than tissue. Also, the blood is a better conductor
and has significantly lower impedance than the tissue. Therefore, much more power will be
delivered to the blood. When the surface is excessively heated, coagulum or steam popping can
form which may tear apart the tissue. In order to increase the efficiency of RF delivery to the
tissue, a cooling system of the ablation catheter has been developed. There are two types of
irrigated catheters:
1. Internal closed-loop: a saline fluid continuously circulates within the electrode, internally
cooling the electrode.
2. External open-loop: the electrode cooling is performed by flushing a saline fluid through
multiple irrigation holes located around the distal electrode. This method provides both
internal and external cooling.
With an irrigated ablation catheter, higher amounts of RF energy for a longer duration can be
delivered creating larger and deeper myocardial lesions. Open irrigation appears to be more
effective than closed-loop irrigation.
4.1.3 Electroanatomical mapping system
Mapping and ablation require accurate navigation within the atria. The CARTO R© 3 System 1
is aimed both at reconstructing a 3D shell of any cardiac structures, including the atria, and at
visualizing on a real-time basis all catheters simultaneously. Also, it allows to tag specific sites
of interest for future diagnostic manoeuvres and ablations.
1. http://www.biosensewebster.com/carto3.php
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4.2 Pulmonary veins isolation
In Section 3.5.1, we have seen that paroxysmal AF is commonly initiated by a rapid focal
activity coming from the PVs. Haissaguerre et al. was the first to introduce an ablation procedure
in which the PVs were electrically isolated [33]. This technique was segmental and involved the
sequential identification and ablation of the earliest sites of activation of each PV. To achieve this
goal, a circumferential mapping catheter (similar to the one shown in Figure 4.1) was positioned
within the PV ostium. Another ablation strategy was subsequently developed by Pappone et al.,
in which each PV was totally encircled with RF lesions [47, 48].
4.2.1 Endpoints of pulmonary veins isolation
The main endpoint of the PV isolation (PVI) procedure is the complete electrical isola-
tion/disconnection of all four PVs.
4.2.2 Outcome of pulmonary veins isolation
Successful PVI does not ensure permanent disconnection. In patients with paroxysmal AF,
it has been reported that in the first 3 months post-PVI, 70% of the patients were AF free [5]. In
patients with non-paroxysmal AF, however, the success dropped to 30% [5]. Once AF becomes
sustained, it is more likely that PVI alone is not sufficient for terminating the arrhythmia, and
that some additional ablation strategy should be considered. The lower success of PVI ablation in
non-paroxysmal AF suggests that once AF has become sustained, the PVs play a less critical role
in maintaining AF and that some level of structural remodelling enables the atria to perpetuate
the AF independently of the triggers, i.e., the PVs.
4.3 Linear atrial ablation
In patients with non-paroxysmal AF, when PVI alone is performed, the recurrence rate is
higher than in patients with paroxysmal AF, suggesting that a residual substrate is responsible
for maintaining AF. Alternative ablation strategies have been attempted in non-paroxysmal AF.
One of these strategies is to perform linear lesions in the atria similar to those produced during
the maze procedure (Section 3.6.2).
The main linear ablations involve the LA roof line, LA mitral isthmus line, and/or RA cavotri-
cuspid line and are illustrated in Figure 4.2.
Left atrial roof line
The LA roof line (shown in green in Figure 4.2) connects the postero-superior lesions (red
dashed lines) of the left and right upper PVs. Although the exact mechanism by which the LA
roof is involved in AF maintenance remains unclear, clinical evidences have established a clear
implication of this LA region in the AF substrate [5].
Left atrial mitral isthmus line
The LA mitral isthmus line (shown in blue in Figure 4.2) is made of a complete line of
conduction block that transects the lateral part of the LA starting from the infero-lateral antrum
of the LIPV to the mitral isthmus. The LA mitral isthmus ablation line (in adjunction to other AF
ablation strategies) eliminates perimitral reentry and is associated with an increased organization
in AF after its completion [6].
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Figure 4.2: Linear atrial ablation may involve the LA roof line (green), LA mitral isthmus line
(blue), and/or the RA cavotricuspid line (pink). Panel A shows an anterior view of the atria and
panel B a posterior view. IVC: inferior vena cava.
Right atrial cavotricuspid isthmus line
The RA cavotricuspid isthmus line (shown in pink in Figure 4.2) connects the inferior vena
cava and the tricuspid annulus.
4.3.1 Endpoints of linear atrial ablation
The electrophysiological endpoint of linear ablation is the effectiveness of bidirectional con-
duction block across each line. To prove the effectiveness of linear ablation, differential pacing
is performed on either sides of the lines [5].
4.3.2 Outcome of linear atrial ablation
Many studies have shown the benefit of linear atrial ablation [6, 49, 50]. Prospective clinical
studies have shown that in patients with non-paroxysmal AF, linear ablation of the mitral isthmus
or linear ablation of the LA roof were associated with an improved clinical outcome compared
to PVI alone [49]. In patients with long-standing persistent AF, Haissaguerre et al. have shown
that linear lesions following PVI produced a significant prolongation of AF cycle length, which
is indicative of the role played by these structures in maintaining AF and its substrate [6, 50].
Importantly, other studies have shown that incomplete block across linear ablation lines were
the most predictive factor for AF recurrence [51, 52]. It is therefore crucial to assess the effec-
tiveness of bidirectional conduction block across each ablation line.
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4.4 Complex fractionated atrial electrograms ablation
Nademanee et al. proposed to target sites with high continuous frequency activities described
as complex fractionated atrial electrograms (CFAEs) defined as [53]:
1. Atrial EGMs that are fractionated and composed of ≥ two deflections, and/or have a per-
turbation of the baseline with continuous deflections of prolonged activation complex over
a 10 sec recording epoch.
2. Atrial EGMs with a very short cycle length (≤ 120 ms) averaged over a 10 sec recording
epoch.
Typically, CFAEs are of low-voltage with multiple potential signals between 0.06 and 0.25 mV [34].
During the ablation procedure, their visual identification by the operator can be challenging and
is highly subjective.
CFAEs are believed to be involved in AF maintenance as fractionated and continuous activity
may be indicative of the presence of wave collision, and/or pivot points where the wavelets
turn around [5]. CFAEs areas may locally represent a reentry circuit, or a collision of different
wavelets. Also, a short cycle length may be indicative of the presence of AF drivers or rotors [38].
In their seminal study, Nademanee et al. suggested that any atrial site displaying CFAEs
activity can be targeted for ablation and that once CFAEs are eliminated AF can no longer be
maintained [53]. While PVI aims at removing the AF triggers, CFAEs ablation aims at removing
the AF substrate.
4.4.1 Endpoints of complex fractionated atrial electrograms ablation
The primary endpoints of CFAEs ablation are either complete elimination of areas with
CFAEs, and/or AF termination.
4.4.2 Outcome of complex fractionated atrial electrograms ablation
In long-standing persistent AF, CFAEs ablation throughout the atria can restore sinus rhythm [53].
Recently, the ablation of CFAEs with given characteristics was of benefit in terms of organization
over PVI [54], including RA CFAEs when the RA AF cycle length became shorter than that of
the LA [49]. CFAEs ablation, however, results in extensive atrial lesions that may preclude any
recovery of atrial contractile function despite sinus rhythm restoration.
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The first step in this thesis was to elaborate a detailed medical study design. This chapter aims
at presenting the various settings used during each ablation procedure. First, the characteristics of
the patient population (Section 5.1) are presented. In the second part, one can find all information
regarding the various tools used for the acquisition of ECG and intracardiac signals (i.e., also
known as the electrophysiological study, Section 5.2). This section also covers the acquisition
and ablation protocols which were meticulously followed during each procedure. Finally, the
different databases, which were constructed off-line, are described in Section 5.3.
5.1 Patient population
Overall, 33 consecutive patients of a mean age of 61 ± 7 years made the study population.
They suffered on average from AF for 6 ± 4 years that was sustained for 19 ± 11 months before
ablation, and resistant to pharmacological and electrical cardioversion. Among the population,
the left atrium was extremely dilated as the average volume was 173.81 ± 43.59 ml for a normal
value of approximately 70 ml. Table 5.1 at page 51 reports the other clinical characteristics of the
study population. Medical definitions of the clinical characteristics are provided in Section A.1
of Appendix A. Numerical data are expressed as mean ± standard deviation.
5.2 Electrophysiological study
All patients had effective oral anticoagulation for > 1 month before the intervention. All
antiarrhythmic drugs, with the exception of amiodarone and beta-blockers, were discontinued for
≥ five half-lives before the procedure. The procedure was performed under general anesthesia.
5.2.1 Surface ECG
In order to improve the recording of the antero-posterior activity of the atria [55], chest lead
V6 was placed in the back of each patient, and denoted V6b as illustrated in Figure 5.1. More
specifically, the dorsal site for each patient was placed facing the left atrial silhouette using X-
Ray.
In the testing phase, an extra unipolar chest lead derivation was used. The signal shown in
panel A of Figure 5.2 was of too poor quality for further analysis of its frequency content due
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Figure 5.1: Modified ECG chest leads positions and vectors. The electrode V6 was placed in
the back of each patient and denoted V6b in order to improve the recording of antero-posterior
activity. Panel A: electrodes position for the precordial chest leads within the horizontal plane.
Panel B: directions of the precordial leads on the horizontal plane. ICS: intercostal space.
to high frequency noise. Several cables and notch filters were unsuccessfully used. Therefore,
chest lead V6 was moved to the patient’s back as the regular ECG cables and electrophysiology
system offered a better shielding. Panel B of Figure 5.2 shows a snapshot of the resulting ECG
signal whose quality was much improved with respect to the first attempt.
5.2.2 Intracardiac electrograms
The following catheters were introduced via the right and/or left femoral veins:
1. A 3.5 mm cooled-tip catheter for mapping and ablation (Navistar, Biosense Webster). In
this manuscript, this catheter is denoted as the MAP catheter.
2. A steerable decapolar catheter within the CS (electrodes spacing 2−8−1 mm, tip electrode
of size 1 mm, Biosense Webster). In this manuscript, this catheter is denoted as the CS-cath
catheter.
3. A circumferential duodecapolar Lasso catheter within the LA (electrodes spacing 2−6−2
mm, Biosense Webster).
4. A quadripolar catheter into the RA appendage (RAA) (electrodes spacing 5 − 5 − 5 mm,
tip electrode of size 4 mm, St Jude). In this manuscript, this catheter is denoted as the HRA
catheter.
More technical details of the catheters are provided in section B.1 of the appendix B.
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Figure 5.2: Signal quality for different back electrode placements. Panel A: first attempt with the
back electrode using an extra unipolar derivation. Panel B: second attempt with V6 placed in the
back.
5.2.3 Study protocol
The general overview of the study protocol is illustrated in Figure 5.3. The first step consisted
in reconstructing a precise 3D model of the LA using the CARTO R© 3 system. During the
second step, baseline data were systematically acquired (Section 5.2.3). Finally, the ablation was
performed following a specific protocol (Section 5.2.3).
3D reconstruction of the LA
Baseline endocardial signal
acquisition (Figure 5.4)
Ablation protocol (Figure 5.5)
Figure 5.3: General overview of the study protocol.
Baseline endocardial signal acquisition
Once the 3D volume had been reconstructed with the CARTO R© 3 system, the Lasso was
placed consecutively in a stable position at thirteen different locations within the LA for a mini-
mum duration of 20 seconds. The locations are the following which are illustrated in Figure 5.4:
– The ostium of the four PVs.
– The base of the LAA.
– The anterior and posterior parts of the roof.
– The middle and inferior parts of the posterior wall.
– The mitral isthmus.
– The superior, middle and inferior parts of the septum.
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Figure 5.4: Baseline mapping of the left atrium. The Lasso is placed consecutively in a stable
position at different locations within the LA for a minimum duration of 20 seconds. Panel A
shows an anterior view of the atria and panel B a posterior view.
Ablation protocol
As described in Section 3.5.3, in long-standing persistent AF significant electrical and struc-
tural remodeling of the atria was observed providing a diffuse substrate for AF perpetuation [12].
The ablation strategy must therefore target the different substrate responsible for initiating and
maintaining AF. Some groups have reported the benefit of using a stepwise approach in long-
standing persistent AF [6, 8, 49, 50]. Haïssaguerre et. al. have shown the incremental benefit
of linear ablation of long-standing persistent AF over PVI [50]. In another study, they reported
termination of persistent AF in 87% of patients by stepwise catheter ablation consisting of PVI,
CFAEs and linear ablation of the roof and mitral isthmus [6].
During this study, the stepwise radiofrequency catheter ablation (step-CA), illustrated in Fig-
ure 5.5, was performed within the LA as follows:
1. PVI: all PVs were electrically disconnected in this specific order: LSPV, LIPV, RSPV and
RIPV. Following each isolation, the Lasso was placed within the LAA in a stable position
to provide a recording for a minimum duration of 20 seconds.
2. CFAEs: CFAEs were visually identified as such by the ablating physician. CFAEs were
ablated sequentially in a specific order in the following regions of the LA:
– The posterior wall. The ablation started in the inferior part along the CS, then it pro-
gressively moved upwards by first defragmenting the middle part and finishing at the
superior region near the posterior area of the roof.
– The anterior wall (defined as the separation between the septum and the base of the
LAA).
– The septum.
– The lateral wall (defined as the left lateral region of the LA).
– The base of the LAA.
3. Linear: two ablation lines were performed within the LA, first on the roof, and then at the
mitral isthmus (see Figure 4.2 at page 40).
The ablation protocol was approved by the Human Research Ethics Committee of the Lau-
sanne University Hospital and all patients provided informed consent.
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Figure 5.5: Stepwise radiofrequency catheter ablation (step-CA) protocol starting with PVI, fol-
lowed by CFAEs ablation and LA linear ablation (roof and mitral isthmus). If AF was non
terminated within the LA, a cardioversion (DCC) was performed. At the end of step-CA, the ef-
fectiveness of PVI and bidirectional conduction block across the lines was verified and completed
when needed.
Procedural endpoint
The study endpoint was reached when AF was terminated into SR or atrial tachycardia (AT).
AT is defined as a regular atrial rhythm at a constant rate more than 100 bpm [5]. The term AT
encompasses several types of tachycardia that originate within the atria. Mechanisms include
abnormal automaticity, triggered activity (focal AT), or micro/macroreentry. Focal AT is initi-
ated and maintained by a focus from which its activation spreads out centrifugally. In contrast,
macroreentrant AT occurs around an anatomical obstacle. This type of AT includes the atrial
flutter. Atrial flutter refers to a pattern of very organized and rapid atrial activation with a rate
of 240 bpm or more and is frequently observed after catheter ablation of AF. When AF was ter-
minated in atrial flutter, the tachycardia was mapped by identifying the earliest site of activation
and was ablated.
Non terminated AF cases were cardioverted electrically. At the end of step-CA, following AF ter-
mination or electrical cardioversion, the effectiveness of PVI and bidirectional conduction block
across the lines was checked and completed when needed. To prove the effectiveness of ablation,
differential pacing was performed on either side of the lines.
Based on the clinical outcome of the procedure, the study population was divided into two
groups:
1. Left terminated (LT, N = 22): patients in whom AF was terminated into SR or AT during
ablation within the LA.
2. Not left terminated (NLT, N = 11): patients in whom ablation within the LA failed to
terminate AF and required a cardioversion.
Among these two groups, the level of significance of the distribution of the clinical character-
istics presented in Table 5.1 was assessed using the ANOVA framework for numerical data and
the Kruskal-Wallis test for categorical data. Importantly, the average duration of sustained AF
was found to be significantly lower (16± 8 months) for the LT patients than for the NLT patients
(25 ± 14 months, p < 0.05).
Table 5.2 reports several characteristics during step-CA such as the cumulative time of abla-
tion within the LA, and the sites of AF termination within the LA. The average duration of each
ablation step is given in minutes. Numerical data are expressed as mean ± standard deviation.
The level of significance of the average duration between each group was assessed using the
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ANOVA framework. For the LT patients, 45±16 minutes of ablation were delivered to terminate
the AF, while for the NLT patients the ablation time was slightly longer (53 ± 12 minutes), al-
though non significantly. During each ablation step, the average ablation duration of both groups
was similar.
5.3 Databases
Surface ECG and endocardial EGMs were continuously monitored and recorded at 2kHz
sampling rate (AXIOM Sensis XP, Siemens, see Section B.2 of Appendix B) for off-line analy-
sis. Two databases were constructed off-line. Importantly, in both databases, recordings during
ablation were discarded.
The first database contained continuous and synchronous recordings of both ECG and EGM
signals (except when an ablation was performed). This database was named DB f ull.
The second database is a subset of DB f ull; it has been manually segmented according to the
timing of the different acquisition steps at baseline (i.e., before ablation) and during ablation (see
Section 5.2.3).
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Characteristics
All
(N = 33)
LT
(LT = 22, 67%)
NLT
(NLT = 11, 33%)
Age, (years) 61 ± 7 61 ± 8 60 ± 4
Sex, (male/female) 31/2 19/2 11/0
AF duration, (years) 6 ± 4 7 ± 5 4 ± 2
Duration of sustained AF, (months) 19 ± 11 16 ± 8 25 ± 14 ∗
BMI, (kg/m2) 30 ± 6 30 ± 6 29 ± 7
High blood pressure, n (%) 24 (73) 16 (73) 8 (73)
Valvular disease, n (%) 5 (15) 4 (18) 1 (9)
Diabetes, n (%) 6 (18) 4 (18) 2 (18)
Tobacco, n (%) 5 (15) 3 (14) 2 (18)
Hypercholesterolemia, n (%) 15 (45) 11 (50) 4 (36)
Coronary artery disease, n (%) 0 (0) 0 (0) 0 (0)
Sleep apnea syndrome, n (%) 19 (58) 13 (59) 6 (55)
Chronic kidney disease, n (%) 1 (3) 1 (5) 0 (0)
CHA2DS2 VASc score 1.5 ± 1.1 1.7 ± 1.1 1.1 ± 1
Dilated cardiomyopathy, n (%) 12 (36) 9 (41) 3 (27)
Hypertrophic cardiomyopathy, n (%) 2 (6) 2 (9) 0 (0)
Left ventricular fraction ejection, % 48.9 ± 10.9 47.1 ± 11.2 52 ± 9.6
Left atrial volume, (ml) 173.81 ± 43.59 173.14 ± 44.14 175.1 ± 44.63
Beta-blockers, n (%) 25 (76) 18 (82) 7 (64)
Calcium channel blockers, n (%) 6 (18) 5 (23) 1 (9)
Amiodarone, n (%) 7 (21) 6 (27) 1 (9)
Other antiarrhythmics, n (%) 5 (15) 2 (9) 3 (27)
Enzyme conversion inhibitor, n (%) 8 (24) 5 (23) 3 (27)
Angiotensin receptor inhibitor, n (%) 5 (15) 4 (18) 1 (9)
Number of antiarrhythmics drugs, (n) 2.2 ± 0.9 2.4 ± 0.85 1.7 ± 0.7 ∗
Statins, n (%) 5 (15) 2 (9) 3 (27)
Table 5.1: Study population clinical characteristics. The left atrial volume was measured with
the Carto R© software (Biosense Webster R©) after exclusion of the pulmonary veins. The level
of significance of the distribution of numerical data was inferred through the ANOVA frame-
work, while for categorical variables the Kruskal-Wallis test was used. Levels of significance are
indicated as such: ∗ : p < 0.05, ∗∗ : p < 0.01, † : p < 0.005 and ‡ : p < 0.001.
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Characteristics
All
(N = 33)
LT
(LT = 22)
NLT
(NLT = 11)
LA cumulative ablation time, (min) 48 ± 15 45 ± 16 53 ± 12
LSPV ablation, (min) 6 ± 3 6 ± 3 4 ± 2
LIPV ablation, (min) 4 ± 3 5 ± 3 3 ± 1
RSPV ablation, (min) 6 ± 3 7 ± 3 5 ± 2
RIPV ablation, (min) 5 ± 2 5 ± 2 5 ± 2
CFAEs ablation, (min) 25 ± 10 23 ± 10 29 ± 10
Linear ablation, (min) 8 ± 4 9 ± 4 7 ± 4
LA sites of AF-termination:
Mitral isthmus 7
Roof 4
Septum 3
Coronary sinus 3
Left atrial appendage 2
Left superior pulmonary vein 1
Right inferior pulmonary vein 1
Lateral 1
Table 5.2: Characteristics during step-CA. Average ablation durations are provided for each
ablation step as well as the cumulative ablation duration within the LA. Importantly, all ablation
durations between the two groups were non-significantly different. For the LT patients, sites of
AF-term are reported.
Part III
ECG Signal Processing

Time-invariant Analysis 6
The ECG of AF is characterized by the replacement of the P waves with f-waves made of
rapid but variable oscillations. Spectral time-invariant approaches have been widely used for
analysing the rate of the f-waves. The ECG comprises both ventricular and atrial components.
Hence, the PSD computed from a raw ECG signal is typically characterized by a peak within the
low frequency band reflecting the ventricular activity that may prevent the accurate determination
of the atrial activation PSD because of some overlap in their frequency content. The first step is to
separate the ventricular activity from the atrial one. This task is non-trivial as extracting the atrial
signal cannot be achieved using linear filters. Appendix C covers in more details the schemes
proposed in the literature for subtracting the ventricular activity from the ECG during AF. In
this thesis, we chose to use the approach developed by Lemay et al. [56], which is presented in
details in Appendix C, page 149. Their approach has the main advantage to be independent of
the duration of the ECG recordings as opposed to other techniques.
Following the extraction of the atrial signal devoid of ventricular activity, the PSD is com-
puted. The spectral peak of highest amplitude is taken as an estimate of AF frequency and is
named the dominant frequency (DF). Previous studies have shown that the DF computed from
the ECG reflects the average frequency of atrial activation during AF [16, 17, 57, 58]. This
measure has been used as an organization index in clinical studies in order to quantify the atrial
electrical remodeling [13–15], and to predict the response to several therapies [16–20].
Once the DF has been identified, its harmonics can be localized. In a perfectly periodic sig-
nal, the power is concentrated at the DF and its harmonics. Conversely, for an irregular signal,
the PSD is characterized by a broader spectrum with multiple spectral peaks. In this case, the
power concentrated at the DF and its higher harmonics represents a fraction of the entire PSD.
Harmonic analysis can therefore be used to quantify the organization of any AF signal. Everett
et al. proposed such an index computed as the ratio between the power under the harmonic peaks
to the total power of bipolar intracardiac signals [21]. Another method for characterizing the fib-
rillatory content of the ECG signals from their AF harmonic component was presented by Stridh
et al. [59] in which time-invariant bandpass filters were used to extracted the AF harmonic com-
ponents. Once the AF harmonic components were extracted, the phase difference between them
was computed. The phase difference between harmonic components is a direct indicator of their
relative timing and subsequently of their synchronization. Hence, an index quantifying the phase
difference between the DF and its higher harmonics reflects the regularity of the morphology of
the f-waves.
This chapter is aimed at 1) presenting ECG organization indices derived from time-invariant
approaches and harmonic analysis, and 2) analysing the performance of these indices to discrim-
inate patients in whom catheter ablation terminated long-standing persistent AF from patients in
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whom SR could not be restored.
This chapter is organized as follows. In Section 6.1 the methods for computing the time-
invariant based organization indices are presented. Then, in Section 6.2, the results of these
indices on the study population for predicting the procedural outcome are given. Finally, Sec-
tion 6.3 covers the discussion of the results and concludes this chapter.
6.1 Methods
6.1.1 Measures of AF organization
Dominant frequency
The frequency spectra from all ECG chest leads were computed using Welch’s method (Ham-
ming window of segment length of bN/4c, where N is the length of the input signal, and 50%
overlap between segments). The DF was estimated as the frequency of the highest peak between
3 and 20 Hz in the PSD estimate of each lead. The mean ECG DF was then calculated for
each patient over different epoch durations from chest leads V1 to V6b. Typically, a lower DF is
indicative of an organized atrial signal.
Organization index
The second measure computed from the surface ECG is similar to the organization index (OI)
introduced by Everett, et al. [21]. Originally, the OI was defined as the ratio between the power
under the harmonic peaks (over a 1 Hz band centered around the fundamental and up to the 4th
harmonic) to the total power of bipolar intracardiac signals.
In the present thesis, we developed a similar ratio that only used the fundamental and the first
harmonic as the power of higher harmonics was negligible and did not contribute significantly to
the overall power. The power spectrum was estimated using Welch’s method (segment length of
1 second, with 50% overlap).
Phase difference
The phase difference (PD) between two waveforms measures their relative timing, and is
therefore an indicator of their synchronization [59]. An approach for characterizing the com-
plexity of fibrillatory waves using phase information was proposed in [59]. More specifically,
the power spectrum was estimated using Welch’s method (segment length of 512 samples, 50%
overlap). The estimate f0 of the fundamental frequency was determined by locating the highest
peak in the interval from 3 to 12 Hz. The mth harmonic frequency fm was found by searching an
interval centered around (m+1) f0. Then, the fundamental and harmonic signal components were
extracted by (m + 1) linear, time-invariant band-pass Kaiser filters, centered around the identified
peaks [59].
In [59], the phases of the fundamental and harmonic components were recovered using a
maximum likelihood estimation. A typical method for extracting the phase information is the
discrete Hilbert transform and the associated analytic representation [60]. A definition of the
Hilbert transform is provided in Appendix A.2. It has been shown that proper estimation of
phase parameters can only be performed on narrow-band signals [61, 62]. Importantly, the vast
majority of ECG recordings display narrow-banded frequency spectra [63]. In this thesis, we
chose to extract the phase information using the Hilbert transform.
The approach for computing the PD in this chapter is closely related to the one proposed
in [59]. The PD was computed between the fundamental component (i.e., the DF) and its first
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harmonic component extracted with the linear, time-invariant bandpass filters as in [59]. The
phase of the first harmonic component was divided by 2 to ensure that both quantities were
comparable. Once the PD was computed, its slope (sPD) was locally estimated by fitting a
polynomial of degree 1 to centered sliding windows of odd length (L = 101). The sPD therefore
reflects the variations of the PD. If the shape of the oscillations does not vary over time, the PD
is constant, and therefore the sPD is null. Conversely, a change in the oscillations morphology
translates into a change in the slope. By computing the variance of the sPD, the regularity of
the oscillations between the fundamental and its first harmonic can be quantified. The resulting
index is called the time-invariant phase difference (TIPD). The closer to zero the TIPD, the higher
the coupling between the fundamental and its first harmonic. Small TIPD values are therefore
indicative of organized AF oscillations.
6.1.2 Material
Most ECG-based clinical studies are performed on durations of 10 seconds. In this chapter,
we aimed at evaluating the performance of classical ECG-based methods on longer durations.
As such, durations of 10 to 60 seconds were compared by steps of 10 seconds.
The analysis was performed on DB f ull, as this database contains continuous recordings 1. For
each patient, the signals at baseline (before any ablation) were considered. More specifically, on
average, 21 ± 10 minutes of continuous recordings were available per patient at baseline. For
each patient, the recordings were split into non-overlapping epochs of fixed durations (10 to 60
seconds by steps of 10 seconds). Then, the organization indices were computed on each epoch
and averaged over all available epochs. As such, for each patient and each epoch duration, this
led to one average value for the corresponding organization index.
Importantly, all ECG methods presented in this chapter were applied after QRST cancella-
tion. Once the ECG was devoid of ventricular activity, the atrial signals were down sampled to
50 Hz [57, 64]. Previous studies have shown that the atrial rate rarely goes above 10 Hz. There-
fore, reducing the sampling rate to 50 Hz does not only guarantee the conservation of the atrial
frequency components, but also speeds up subsequently the analysis process.
Finally, only the ECG chest leads were included in this study (i.e., from V1 to V6b, where V6b
denotes the dorsal electrode, see Section 2.2.1).
6.1.3 Statistical analysis
The statistical analysis aims at comparing the various indices between the LT and NLT groups
before the first ablation step. The distribution of the mean values at baseline of the three indices
was inferred through the analysis-of-variance (ANOVA) framework. First, the statistical signifi-
cance between the LT and NLT groups was assessed on the different epochs (from 10 to 60 sec,
by steps of 10 seconds).
In the second step, the longest available duration (i.e, 60 seconds) was selected to perform an
advanced statistical analysis. When the ANOVA p-value was significant for a given index/lead,
a binary logistic regression model was applied to the corresponding index values. The definition
of the binary logistic regression is provided in Section A.3 of Appendix A. The performance of
the binary logistic regression model was evaluated using the odds ratio and its 95% confidence
interval. Another method to evaluate the binary logistic regression model is to make use of
the receiver operating characteristic (ROC) curve analysis, in which the power of the predicted
values by the model to discriminate between a LT and a NLT patient is investigated. Section A.4
of Appendix A briefly presents the technique involved in ROC analysis. In this study, the area
under the curve (AUC) is reported as well as the Youden index (YI) with its corresponding
sensitivity, specificity and cut-off threshold value. Since the available data set is not large, and in
1. See Section 5.2.3 of Chapter 5 for the description of the study protocol
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order to assess the generalization ability of the analysis to an independent data set, a leave-one-
out cross validation was performed (LOOCV). LOOCV is a simple cross validation technique in
which the validation set is created by taking all the available samples except one (in our case the
samples are the patients). ROC characteristics, AUC values and cut-off thresholds were averaged
over all possible validation sets.
6.2 Results
6.2.1 Illustrative examples
Figure 6.1 shows an example of DF and OI measures on an LT (6.1a) and on an NLT pa-
tient (6.1b) respectively, computed on a 60 sec epoch acquired from lead V1. The PSD was
estimated after QRST cancellation. The DF (red square) for the LT patient is located at 5.08 Hz
and the first harmonic (H1, green diamond) at 10.16 Hz. In both figures, the bandwidth limits of
±1 Hz for OI computation are represented by vertical dashed lines.
For the LT patient, most of the power lies within the bandwidth limits resulting in an OI of
0.77, which is indicative of a high spectral organization and hence a rather organized AF signal.
For the NLT patient, the DF is located at 4.93 Hz and H1 at 9.86 Hz. Note the widely dis-
tributed frequency components with multiple peaks of high magnitude, some outside the band-
width limits. This wide distribution results in a low OI value of 0.35 indicative of a low spectral
organization and hence a disorganized AF signal.
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Figure 6.1: Examples of DF and OI measures on an LT patient (a) and on an NLT patient (b)
both computed on a 60 sec epoch acquired from chest lead V1. PSDs were estimated after QRST
cancellation. On both figures the DF (red square) and the first harmonic (H1, green diamond) are
shown. In both examples the PSD, estimates were normalized.
Figure 6.2 shows the time-invariant sPD (top plots) estimated from the outputs of the time-
invariant filters. For both patients, the input signals were the same AF signals as in the previous
figure.
For the LT patient (Figure 6.2a), T IPD equals 2 · 10−3 (rad/s)2. Interestingly, one can notice
three short periods (highlighted in gray, time intervals [13.7; 17.3], [30.3; 32.4], and [37.6; 42.6] sec)
during which the sPD remains close to zero. In other words, these intervals correspond to a phase
lock between the fundamental component and its first harmonic. The bottom plot shows an ex-
cerpt of the initial ECG signal on a time interval covering the last two phase locks. The original
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V1 is shown in blue (top), while the same signal devoid of ventricular activity is plotted in black
(bottom). Note the regular morphology of the atrial ECG during the phase locks, while at the
time following the last phase lock, the shape of the atrial ECG transitions into an irregular pat-
tern. Nevertheless, between the two phase locks, the morphology of the AF waveforms does not
change much as compared to the shapes during the two phase locks.
For the NLT patient (Figure 6.2b), a higher TIPD was found (T IPD = 7.4 · 10−3 (rad/s)2).
Note the erratic sPD during the whole recording duration, with larger deviations than for the LT
patient and the lack of phase lock as well. The AF waveform morphology after QRST cancella-
tion appears highly irregular without any apparent organization.
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(a) LT patient, T IPD = 2 · 10−3 (rad/s)2.
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(b) NLT patient, T IPD = 7.4 · 10−3 (rad/s)2.
Figure 6.2: Examples of the TIPD index on an LT (a) and an NLT (b) patient. On both figures
the top plot shows the time-invariant sPD, while the bottom plot displays an excerpt of the corre-
sponding input ECG signals. The blue signal corresponds to the original ECG whereas the black
signal corresponds to the ECG after QRST cancellation. The highlights in gray illustrate time
intervals during which a phase lock occurs between the DF and its first harmonic.
6.2.2 Epoch durations
Figure 6.3 shows the baseline p-values obtained when comparing LT and NLT patients for
the all three indices computed from each ECG chest lead (x-axis) and on the different epoch
durations (y-axis). White squares denote non-significant differences between groups (p = ns).
When the ANOVA test was found significant, the square was filled with gray, from light (less
significant, p < 0.05) to dark (most significant, p < 0.001).
DF analysis Figure 6.3a reports the p-values for the DF analysis. Among the six leads and
all available epochs, only V1 and V6b display significant p-values. On lead V1, the significance
level was constant on all epoch durations (p < 0.005). On the dorsal lead V6b, the statistical
significance between the two groups was higher for epoch durations < 50 sec (p < 0.001), while
for 60 sec epochs the p-value slightly decreased (p < 0.005). Chest lead V4 showed a significant
difference on the 10 sec epochs (p < 0.05). On the remaining leads (V2, V3, and V5), no signifi-
cant difference between the two groups was observed (p = ns).
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Figure 6.3: Statistical significance levels for all epoch durations (y-axis) and chest leads (x-axis)
for DF (a), OI (b) and TIPD (c). White squares denote non-significant differences between groups
(p = n.s.). When the difference was significant, the corresponding square was filled with gray,
from light (less significant, p < 0.05) gradually to dark (most significant, p < 0.001).
OI analysis Figure 6.3b shows the p-values for the OI analysis. Among all chest leads and all
epoch durations, no significant differences were found between the two groups (p = ns).
TIPD analysis Figure 6.3c shows the significance levels for the TIPD. Among all precordial
leads and all epoch durations, significant differences between groups were only found on V1 and
V6b. For the remaining leads, the p-values were non-significant (p = ns). On chest lead V1 and
on durations of 40 and 50 sec, the levels of discrimination between LT and NLT groups were
lower as compared to the remaining periods (p < 0.05 vs. p < 0.01). Finally, on the dorsal
lead V6b, the level of significance for all epoch durations was estimated to p < 0.005 (except on
40 sec duration for which p < 0.001).
6.2.3 Group comparisons on the procedural outcome
Figure 6.4 reports the distribution of DF (a), OI (b) and TIPD (c) on all chest leads for the
LT (blue) and the NLT (red) groups. Mean and median values are displayed as circle and square
respectively. The vertical lines indicate one standard deviation. ANOVA was used to determine
significant differences between the two groups. The following annotations were used for the dif-
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Lead
DF [Hz] OI TIPD [·10−3(rad/s)2]
LT NLT LT NLT LT NLT
V1
5.52 6.33 0.37 0.34 6.31 7.8
±0.72 ±0.46† ±0.07 ±0.11 ±1.56 ±0.92 ∗ ∗
(5.36) (6.28) (0.36) (0.34) (6.23) (7.72)
V2
5.45 5.49 0.32 0.33 7.19 7.62
±0.73 ±0.92 ±0.10 ±0.08 ±0.88 ±0.75
(5.42) (5.45) (0.29) (0.30) (7.11) (7.49)
V3
5.22 5.35 0.31 0.35 7.40 7.60
±0.72 ±0.66 ±0.09 ±0.09 ±0.80 ±0.64
(5.13) (5.31) (0.28) (0.32) (7.42) (7.46)
V4
5.21 5.48 0.32 0.37 7.30 7.76
±0.55 ±0.61 ±0.06 ±0.10 ±0.91 ±0.8
(5.23) (5.46) (0.32) (0.40) (7.38) (7.65)
V5
5.32 5.61 0.38 0.43 7.38 7.92
±0.64 ±0.71 ±0.10 ±0.11 ±0.95 ±0.91
(5.27) (5.51) (0.36) (0.43) (7.51) (7.90)
V6b
5.38 6.08 0.32 0.33 6.82 8.13
±0.61 ±0.36† ±0.05 ±0.09 ±1.07 ±0.90†
(5.34) (6.13) (0.32) (0.3) (6.63) (8.24)
Table 6.1: Mean ± standard deviation and median (in brackets) of the time-invariant based indices
before ablation computed on 60 sec epochs. From left to right: DF, OI and TIPD. The following
annotations were used for the different level of significance: ∗ : p < 0.05, ∗∗ : p < 0.01,
† : p < 0.005 and ‡ : p < 0.001.
ferent levels of significance: ∗ : p < 0.05, ∗∗ : p < 0.01, † : p < 0.005 and ‡ : p < 0.001. The
respective values are reported in Table 6.1.
DF analysis LT patients displayed significantly lower DF values in V1 and V6b compared to
NLT patients (5.52±0.72 vs 6.33±0.46 Hz, p < 0.005 for V1 and 5.38±0.61 Hz vs. 6.08±0.36 Hz,
p < 0.005 for V6b respectively). Interestingly, for the LT patients, DF analysis had similar
values between leads V1 and V6b (5.52 ± 0.72 Hz and 5.38 ± 0.61 Hz respectively), whereas a
gradient was observed in NLT patients with significantly higher DF values in V1 compared to V6b
(6.33 ± 0.46 Hz vs. 6.08 ± 0.36 Hz).
The binary logistic parameters estimated for leads V1 and V6b are reported in Table 6.2. On
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Figure 6.4: Distributions of the baseline DF (a), OI (b) and TIPD (c) for the LT (blue) and NLT
(red) groups computed on 60 sec epochs. The mean (circle) as well as the median (square) of each
group are shown. The vertical lines delimit the mean ± the standard deviation. The following
annotations were used for the different level of significance: ∗ : p < 0.05, ∗∗ : p < 0.01,
† : p < 0.005 and ‡ : p < 0.001.
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both leads, the odds ratio was slightly smaller than one (0.97996 for V1 and 0.96995 for V6b)
and their corresponding 95% confidence intervals were relatively small, indicative of a reliable
precision on the odds ratio ([0.96502−0.99513] for V1 and [0.94798−0.99243] for V6b). Finally,
on both leads, the respective p-values were < 0.01.
Figure 6.5 shows the ROC curves estimated for leads V1 (a) and V6b (b), while Tables 6.3a
and 6.3b report the values of the estimated AUCs and YIs (a) as well as the results of the
LOOCV (b). On both leads, the AUC was estimated at 0.84 and this value was corroborated
by the average AUC from the LOOCV (0.84 ± 0.02). On lead V1, however, the YI was slightly
inferior than that on lead V6b, suggesting that the correct classification rate was higher on the
dorsal lead compared to V1 (0.6 with 59% sensitivity and 100% specificity for V1 vs. 0.66 with
75% sensitivity and 91% specificity for V6b). Interestingly, the cut-off value for discriminating
LT patients from NLT patients was smaller for lead V1 (5.4 Hz) as compared to the cut-off on
the dorsal lead V6b (5.82 Hz) suggesting that the organization quantified on lead V1 has to be
somewhat higher than that on lead V6b for a patient to be labelled as LT. Finally, it is also worth
mentioning that the standard deviation of the average cut-off estimated from the LOOCV was
higher on V1 as compared to lead V6b (0.16 Hz vs. 0.005 Hz).
OI analysis For the OI (Figure 6.4b and middle column of Table 6.1), no significant differences
were observed between groups on any lead (p = ns). Importantly, on leads V3, V4 and V5, the
OI for the NLT patients was on average slightly larger than that for the LT patients, however non
significantly. The largest difference can be observed for lead V5, on which the average OI for the
NLT group was estimated at 0.43 ± 0.11 whereas for the LT group, the average OI lay within the
interval 0.38±0.1. These results are indicative of a higher organization in the NLT group, though
non-significant. For both groups and on most leads, the mean and median diverged considerably.
TIPD analysis LT patients displayed significantly lower TIPD values in leads V1 and V6b com-
pared to NLT patients suggestive of a higher coupling between the DF and its first harmonic
Figure 6.4c and right column of Table 6.1). More precisely, on lead V1, the average TIPD for
the LT patients was significantly lower than for the NLT ones ((6.31 ± 1.56) · 10−3 (rad/s)2 vs
(7.8±0.92) ·10−3 (rad/s)2 respectively, p < 0.001). Likewise, on the dorsal lead V6b, the average
TIPD for the LT group was significantly lower than for the NLT group ((6.82±1.07)·10−3 (rad/s)2
vs. (8.13 ± 0.9) · 10−3 (rad/s)2 respectively, p < 0.005). On the remaining leads, no significant
difference between the groups was observed (p = ns).
The binary logistic regression parameters estimated for leads V1 and V6b are reported in
Table 6.2. On both leads, the odds ratio was lower than one. On lead V1 the odds ratio was higher
than that on lead V6b (0.91513 and 0.871 respectively). Furthermore, the 95% confidence interval
was narrower on lead V1 compared to that on lead V6b, indicating that the odds ratio was more
precisely estimated on lead V1 than on lead V6b ([0.8504−0.98479] for V1 and [0.78341−0.96838]
for V6b).
Figure 6.6 displays the ROC curves estimated for leads V1 (a) and V6b (b) while Table 6.2
reports the values of the estimated AUCs and YIs (a) as well as the results of the LOOCV (b). The
AUC as well as the YI estimated on lead V1 were lower compared to lead V6b. More specifically,
the AUC on lead V1measured 0.8, while on the dorsal lead it was 0.84. The value of the YI on
lead V1 was estimated at 0.55 with 64% sensitivity and 91% specificity, while on lead V6b, the
YI was estimated at 0.63 with 90% sensitivity and 73% specificity. Interestingly, the estimated
cut-off threshold for discriminating LT from NLT patients was lower on V1 (6.73 · 10−3 (rad/s)2)
compared to V6b (8.07·10−3 (rad/s)2), suggesting that a higher level of organization was required
on V1 to increase the probability of terminating AF (the same behavior was observed previously
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for the DF). All these values were corroborated by the respective average values estimated from
the LOOCV. These results suggest a better classification performance on lead V6b than on lead
V1.
Lead Index Odds ratio 95% confidence interval p-value
V1
DF 0.97996 [0.96502 − 0.99513] 0.0098163
TIPD 0.91513 [0.8504 − 0.98479] 0.01781
V6b
DF 0.96995 [0.94798 − 0.99243] 0.0090481
TIPD 0.871 [0.78341 − 0.96838] 0.010641
Table 6.2: Binary logistic regression parameters of the time-invariant based indices/leads before
ablation computed on 60 sec epochs. The binary logistic model was estimated when the ANOVA
declared a significant difference for a pair of lead/index. The table reports the corresponding
odds-ratio, its 95% confidence interval and associated p-value.
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Figure 6.5: ROC curves (black) for the DF on lead V1 (a) and V6b (b) assessed on recordings of
60 sec duration. The corresponding AUCs and YI (pink diamond) estimated from the ROC curve
are also reported. The average LOOCV ROC curves is plotted in gray.
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Lead Index AUC
Youden index
Cut-off Value Sensitivity Specificity
V1
DF 0.84 5.40 [Hz] 0.60 0.59 1
TIPD 0.80 6.73 · 10−3 [(rad/s)2] 0.55 0.64 0.91
V6b
DF 0.84 5.82 [Hz] 0.66 0.75 0.91
TIPD 0.84 8.07 · 10−3 [(rad/s)2] 0.63 0.90 0.73
(a)
Lead Index
LOOCV
AUC Cut-off Youden index
V1
DF 0.84 ± 0.02 5.46 ± 0.16 [Hz] 0.60 ± 0.02
TIPD 0.80 ± 0.02 (6.74 ± 2.97 · 10−2) · 10−3 [(rad/s)2] 0.55 ± 0.03
V6b
DF 0.84 ± 0.02 5.82 ± 0.005 [Hz] 0.66 ± 0.03
TIPD 0.83 ± 0.02 (8.07 ± 4.05 · 10−3) · 10−3 [(rad/s)2] 0.63 ± 0.03
(b)
Table 6.3: ROC (a) and LOOCV (b) estimations for the DF and TIPD assessed on epochs of
60 sec duration. Results are reported for the leads which were declared significant through the
ANOVA framework, i.e., leads V1 and V6b. Table (a) reports the AUCs, Youden indices with
their respective sensitivities/specificities as well as the cut-off thresholds for discriminating LT
patients from NLT patients. Table (b) reports the average AUCs, Youden indices and cut-off
values assessed with LOOCV.
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Figure 6.6: ROC curves (black) for the TIPD on lead V1 (a) and V6b (b) assessed on recordings
of 60 sec duration. The corresponding AUCs and YI (pink diamond) estimated from the ROC
curve are also reported. The average LOOCV ROC curves is plotted in gray.
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6.3 Discussion
In this chapter, organization indices derived from time-invariant approaches for characteriz-
ing the frequency content (the DF) as well as the harmonic structure (the OI and TIPD) of ECG
AF signals were presented. Importantly, all measurements aiming at quantifying the amount of
organization during AF were computed on AF signals devoid of ventricular activity.
The first index presented in this chapter is the DF defined as the peak of highest amplitude
in the PSD from AF signals. This index is widely used in the literature for assessing the amount
of organization in AF signals. It has been established that the frequency content of f-waves
computed from ECG signals can be used as a surrogate of the average AF cycle length, and
subsequently of the atrial refractoriness [16, 17, 57, 58]. The atrial fibrillatory rate has been used
in clinical studies to quantify the atrial electrical remodeling [13–15], and to predict the success
following several therapies such as with antiarrhythmic drugs or electrical cardioversion [16–
18]. For instance, an increase in the fibrillatory frequency measured in lead V1 was associated
with more advanced remodeling [14, 15]. Moreover, several studies have demonstrated that a
lower fibrillatory rate was associated to AF termination by cardioversion whereas a higher AF
frequency predicted an early arrhythmia recurrence [16–18].
The second spectrum-based index analyzed in detail in the present thesis is the OI defined as
the ratio between the power under the DF and the first harmonic to the total power of the signal.
This index was originally presented by Everett et al. in order to optimize the success of AF
electrical cardioversion [21]. Although no physiological meaning was given by Everett et al., in
another study performed by Dibs et al., a significant correlation between the intracardiac OI and
the DF was observed in patients with persistent AF [65]. Others also showed that AF successfully
terminated by pharmacological cardioversion was associated with a higher intracardiac OI [66].
The third organization index presented in this chapter is directly inspired from an approach
proposed by Stridh et al. based on the extraction of AF harmonic components [59]. Using
linear, time-invariant bandpass filters, the atrial activity is divided into fundamental (i.e., the
DF) and harmonic components from which a phase relationship is extracted. As the PD between
harmonic components measures their relative timing, it is therefore an indicator of their coupling.
Quantifying the PD between harmonic components to characterize the atrial complexity is also an
indirect measure of the f-waves morphological regularity. In this chapter, we proposed a novel
approach for quantifying the variations of the PD over time. The resulting index, the TIPD,
was computed as the variance of the slope of the PD between the fundamental and harmonic
components.
6.3.1 Relevance of the epoch durations
To the best of our knowledge, no prior studies have investigated the impact of epoch durations
on organization indices derived from the ECG at baseline for predicting the procedural outcome
of catheter ablation. Typically, segments ranging between 7 to 10 seconds are used [14, 20].
ECG segments of short durations have been shown to reproducibly represent the average AF
dynamics [18], while some used epochs of one minute duration [19].
In our study, we found that the mean DF and TIPD computed on leads V1 and V6b were
the most robust for separating LT from NLT patients on all epoch durations. A significant level
was observed for the DF on lead V4, but only for an epoch duration of 10 seconds. The levels
of significance for the DF were higher as compared to the TIPD. Among all leads and epoch
durations, the OI was not predictive of the procedural outcome. Thus, the spectral organization
of harmonic components can not be assessed using a time-invariant approach regardless of the
epoch duration.
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6.3.2 Prediction of the procedural outcome before ablation
DF computed on atrial ECG has been used to predict the outcome of first-time catheter abla-
tion in patients with persistent [19] and chronic AF [20]. It has been shown that the baseline DF
on lead V1 was significantly lower in patients with AF termination than in patients without AF
termination [20, 67]. The OI, in association with the DF, was used in several studies in order to
predict the success of AF catheter ablation [68–71]. Takahashi et al. showed that the intracardiac
OI was more predictive of AF termination than the mean DF [68]. In another study, during ab-
lation of persistent AF, the mean intracardiac OI was unchanged whereas a significant decrease
in the DF was observed [69]. More recently, ablation of intracardiac segments displaying high
OIs was associated with an increase of the OI assessed remotely within the LAA [70]. Lately,
Jones et al. have used the ECG OI and DF measured at baseline to identify patients in whom
brief ablation of focal impulses and stable rotors achieved acute AF termination [71]. In their
results, the OI had a better ROC with AUC of 0.67 as compared to the DF, which yielded an
AUC of 0.38. In their study, however, the DF and OI were assessed in three pseudo-orthogonal
ECG planes 2.
In our study, we found that the average DF and TIPD were significantly lower on leads V1 and
V6b for LT patients compared to NLT patients. For both indices, the statistical analysis showed
that the classification performance was better on the dorsal lead V6b than on lead V1. However,
the significance level was higher for DF than for TIPD. For both indices, the discriminative cut-
off values were lower on lead V1 than on the dorsal lead V6b, suggesting that a higher level of
organization on lead V1 was necessary to increase the probability of terminating AF. For the OI,
no statistical significance could be observed between the groups. It even showed an opposite
trend as the organization appeared slightly higher, though non significantly, in NLT patients than
in LT patients.
6.3.3 Limitations of time-invariant approaches
Using time-invariant approaches, the number of ECG leads displaying a significant difference
between the LT and NLT groups was limited. For the DF and TIPD, only two leads (V1 and the
dorsal V6b) were predictive of procedural outcome. The OI computed on all ECG precordial
leads was unable to separate the two groups. Several arguments can be put forward in order to
explain these poor performances.
First, classical PSD analysis typically reflects the average frequency content of a signal. Mul-
tiple peaks can be seen in the frequency spectrum as the results of the temporal variations in AF
frequency. Also, linear time-invariant filters shall be restricted to well organized signals, which is
seldom in biological signals. Even in the case of well organized signals such as in the illustrative
example of the LT patient (page 59), the long period of regular morphology was not correctly
identified. Indeed, only some short excerpts of phase locks were observed.
Second, in order to explain the inability of the OI to discriminate LT and NLT patients, one
may refer to the recent study of Lee et al. [72]. In their work, the authors used simulated atrial
electrograms of varying amplitudes on which the OI was computed. Importantly, the repetition
of the atrial wavefronts was similar in each simulated electrograms, only their amplitudes were
variable. They observed that the amplitude variations of the signal greatly influenced the value
of the OI, even if the DF was correctly detected. It was established that the amplitude measure-
ments of ECG f-waves were repeatable over time within patient, but that inter-patient variability
was considerable [73]. One might therefore argue that this substantial inter-patient variability re-
2. The pseudo-orthogonal ECG space is a three dimensional space defined as such: the X axis corresponds to the
signal from lead I, the Y axis corresponds to the signal from aVF, and the Z axis corresponds to the signal from V1. The
spectral analysis was performed on the signal characterizing the phase angle [71].
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duces the potential of the OI to discriminate one group of patients from another when computed
on ECG signals.
In conclusion, time-invariant schemes are not optimal in characterizing the temporal varia-
tions of long-standing persistent AF, which is typically described as a disorganized arrhythmia
with considerable short-term rate variations. The performance of the time-invariant based organi-
zation indices in predicting the acute procedural outcome was relatively poor. The time-invariant
quantification of the spectral content of the fundamental and first harmonic components (the OI)
did not show any discrimination between the two groups of patients, while those based on the
DF and TIPD did with a limited success. In the next chapter, we propose a novel time-varying
(adaptive) approach in order to circumvent these issues.
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Time-varying Analysis 7
In the previous chapter, we showed the inaccuracy of time-invariant methods to track rapid
temporal variability of AF waveforms. Classical approaches for retrieving the frequency infor-
mation from a signal are based on the estimation of its PSD. Typically, these methods are limited
to stationary signals. The temporal information is lost as the frequency information assessed from
the power spectrum estimates the average oscillations embedded within a signal during the study
duration. When the frequency content is stable over time, no matter how long the epoch is, the
signal properties remain unchanged. However, in practical applications, this assumption is rarely
valid as most of the signal properties (amplitude, frequency and phase) vary over time. This is-
sue can be circumvented by using time-varying approaches, such as time-frequency techniques.
With these schemes, the energy at a given instant and frequency can be adequately estimated.
Time-frequency techniques were developed for characterizing short- and long-term AF fre-
quency temporal variations from ECG f-waves [74]. Separate algorithms were proposed for
short- and long-term analyses. The short-term scheme was specifically designed to investigate
spontaneous AF frequency temporal variations in recordings of about ten seconds to several min-
utes. Conversely, the long-term method was elaborated for tracking temporal variations in AF
frequency on recordings ranging from several minutes to hours. Their results revealed consider-
able temporal variations of the AF frequency.
Although time-frequency representations are aimed at analyzing the temporal evolution of
the frequency content of a signal, these techniques suffer from three major drawbacks. The first
one comes from the fact that time-frequency representations are estimated block-by-block. A
classical approach, namely the short-term Fourier transform, consists in using a sliding window
along the signal such that at each sample value a new portion of the signal is used to estimate
its frequency content. The primary purpose of this sliding window is based on the assumption
that the spectral characteristics of the signal are reasonably stationary over the duration of this
window. The more rapidly the frequencies of the signal vary over time, the shorter the window
shall be. However, as the window shortens, the frequency resolution decreases. Consequently,
the choice of the window length carries an inherent trade-off between frequency resolution and
time resolution. Secondly, it may be difficult to extract the instantaneous frequency from a time-
frequency distribution estimation, especially in the presence of random noise. In this case, the
estimation of the instantaneous frequency can be very arduous and unreliable. Additionally, in
practical situations, the component corresponding to the estimated frequency is often needed, and
in order to retrieve this component with time-frequency techniques, further non-trivial processing
is required. Lastly, the important computational costs of time-frequency approaches are often
limiting the development of applications running in real-time and on embedded devices.
These issues can be avoided by using adaptive frequency tracking algorithms. Basically, these
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algorithms are composed of two elementary parts: a time-varying filter (band-pass or notch) for
extracting the oscillations present in the input signal and an adaptive mechanism for controlling
the central frequency of this filter and subsequently for estimating the instantaneous frequency
of the extracted oscillations.
The previous chapter was focused on characterizing the harmonic structure of ECG f-waves
oscillations. Specific organization indices were presented for quantifying in an ECG AF signal
the harmonic content in the power spectrum (the OI) and to assess the PD between the funda-
mental component and its first harmonic (the TIPD). The current chapter is therefore aimed at
1) presenting a novel adaptive harmonic frequency tracking algorithm, 2) from the output of this
algorithm, deriving innovative organization indices that extend the time-invariant ones, and 3)
analyzing the performance of these indices in predicting the procedural outcome of catheter ab-
lation in patients with long-standing persistent AF.
This chapter is organized as follows. Section 7.1 illustrates in details the motivations of
developing an adaptive frequency tracking algorithm for characterizing the temporal evolution
of the harmonic components of ECG f-waves. Then, Section 7.2 presents the adaptive frequency
tracking algorithm and the derived organization indices. Section 7.3 covers the results of these
organization indices in predicting the outcome of catheter ablation in patients with long-standing
persistent AF. Finally, Section 7.4 covers the discussion on the results and concludes this chapter.
7.1 Motivations
In Chapter 6, the harmonic structure of an ECG atrial signal was characterized using linear,
time-invarient band-pass filters centered around the peaks defining the AF DF and its harmonics.
Of note, for a perfectly regular oscillation, the harmonic frequencies are exact multiples of the
fundamental one, while for irregular oscillations, the expected harmonics deviate from the actual
ones on a long duration signal (typically, longer than 10 seconds). If the filter is too narrow, the
oscillations may escape from the filter passband, whereas a filter that is too large may render the
phase estimates unreliable. Hence a compromise must be made when setting the filter bandwidth,
whose reliability may be affected by the large temporal variations of AF waveforms. Figure 7.1
illustrates the limitations of using time-invariant band-pass filters as described in [59]. In this
example, a 60 sec signal from the dorsal electrode V6b of an LT patient was used. Following
QRST cancellation, the power spectrum (Figure 7.1a) was estimated as in [59] (Section 6.1.1
page 56). The estimate of the fundamental frequency (red square) was found to be f0 = 5.6 Hz,
and the first two harmonics (green diamonds) were located at f1 = 11.2 Hz and f2 = 16.9 Hz.
The filter response centered around f0 is shown in red, and the filter responses centered around
the harmonics are shown in green. On top of each filter the respective pass-band and stop-band
limits are displayed. Figure 7.1b shows the time-frequency representation of the same 60 sec
signal after QRST cancellation. The time-frequency was computed using the short-time Fourier
transform (Hamming window of 255 samples, and a segment length of 512 samples for the dis-
crete Fourier transform). The filter responses are plotted using the same colors as in Figure 7.1a.
At each sample, the instantaneous spectrum was extracted and the new corresponding fundamen-
tal and harmonic components were estimated using the same method as in [59], i.e., the one used
in Figure 7.1a. The lower yellow dots indicate the instants when at least one of the frequen-
cies ( f0 or fm,m = 1, 2) was outside of its corresponding filter. In total, this occurred 62.7% of
the time, meaning that during this 60 sec epoch only 37.73% of the time the fundamental and
harmonic components were correctly extracted by their corresponding filters. Therefore, using
time-invariant band-pass filters on a long duration segment appears less accurate for extracting
the AF components. However, note that these yellow segments are stable on a short duration
(< than 10 sec), which corresponds to the analysis duration set in [59]. Figure 7.1c shows a
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snapshot of the instantaneous spectrum at time t1 = 32.2 sec when all the instantaneous frequen-
cies were outside of their corresponding filter bandwidths. Note that the fundamental frequency
as well as its harmonic are too low to be extracted by their corresponding filter. We chose to
circumvent this limitation by using adaptive band-pass filters. Section 7.2 presents the adaptive
scheme used in our study.
7.2 Methods
7.2.1 Adaptive frequency tracking
The harmonic frequency tracking algorithm presented in this chapter is an extension of a
scheme exploited previously [75, 76], which has been originally proposed by our group [77].
First, the basic tracking scheme is briefly introduced before the extension for harmonic compo-
nents is described. These adaptive algorithms are presented within the complex-valued signal
framework which leads to a simplification of several computational aspects. Clearly, the ECG
signals are real-valued, but the presented methods are still applicable to their analytic represen-
tation obtained with the discrete Hilbert transform [78] (see Section A.2 of Appendix A for the
definition of the discrete Hilbert transform and for an introduction on the concept of instanta-
neous frequency). Reverting to real-value data is always possible as the real part of the analytic
representation is the original signal itself.
Single frequency tracking
The single frequency tracker (SFT) is composed of two elementary parts (Figure 7.2): a time-
varying band-pass filter for extracting the components and an adaptive mechanism controlling the
filter.
The input signal is considered to be a noisy cisoid,
x[n] = c[n] + v[n] = A0e jω0n + v[n], (7.1)
where A0 and ω0 are the complex amplitude and frequency of the cisoid, and v[n] is an additive
white complex centered noise. The output signal, y[n], is obtained by filtering the input signal
with a time-varying band-pass filter whose transfer function is given by:
H(z;ω[n]) =
1 − β
1 − βe jω[n]z−1 . (7.2)
The parameter β (0  β < 1) controls the bandwidth and ω[n] is the current estimate of the
instantaneous frequency that determines the central frequency of the filter. More specifically,
these parameters are respectively the modulus and argument of the pole of the transfer function.
The frequency response of the filter is shown in Figure 7.3 for three values of β when the central
frequency is set to ω[n] = 0.4pi. Importantly, this filter has unit gain and zero phase at ω[n]
ensuring that the extracted component is not distorted.
The adaptive mechanism is based on the complex discrete oscillator equation,
c[n] = e jω0 c[n − 1], (7.3)
which is satisfied for any cisoid at frequency ω0. From this equation, it is possible to estimate
the frequency of a noiseless cisoid with only two samples. However, in a noisy environment
and if the frequency can change over time, this is not applicable. Therefore, the estimation of
the instantaneous frequency is performed by minimizing the mean square error of the discrete
oscillator equation (7.3) for the filtered signal, y[n],
J[n] = E
{∣∣∣y[n] − e jω[n+1]y[n − 1]∣∣∣2} . (7.4)
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Figure 7.1: Illustration of the limitation of using linear, time-invariant band-pass filters for the
extraction of AF components on a long duration epoch. Following QRST cancellation, a 60 sec
signal from the dorsal electrode V6b of an LT patient was used. Figure (a) shows the power
spectrum estimate on the entire signal. The locations of the fundamental ( f0) and the first two
harmonics ( fm,m = 1, 2) were computed as in [59]. In this example, f0 = 5.6 Hz (red square),
f1 = 11.2 Hz and f2 = 16.9 Hz (green diamonds). The fundamental and harmonic components
are isolated by three linear, time-invariant band-pass Kaiser filters centered around the identified
peaks [59]. The pass-band and stop-band are given above each filter. The filter response for
isolating the fundamental component is plotted in red, while the filter responses for the harmonics
are plotted in green. Figure (b) shows a time-frequency representation of the 60 sec signal
after QRST cancellation. At each sample, the instantaneous spectrum was extracted and the
corresponding fundamental and harmonic frequencies were estimated. When the new values
were not fitting their initial corresponding filters, it was indicated by a yellow dot at the bottom
of the time-frequency representation. In total, these excursions occurred 62.27% of the time.
Figure (c) shows a snapshot of the instantaneous spectrum at time t1 = 32.2 sec where the
fundamental (red square, f0 = 3.8 Hz) and harmonic frequencies (green diamonds, f1 = 7.7 Hz
and f2 = 11.7 Hz) were outside of their initial corresponding filters response. In this particular
case, all three frequencies are outside the initial pass-bands/stop-bands.
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Figure 7.2: Structure of the SFT. Figure from [77].
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Figure 7.3: Response of the band-pass filter (7.2) for three values of β with the central frequency
set to ω[n] = 0.4pi. Figure from [77].
The optimal solution of this cost function is obtained by setting its derivative with respect to
ω[n + 1] to zero. The derivative with respect to ω[n + 1] is obtained as follows:
∂J
∂ω[n + 1]
= E
{
je− jω[n+1]y[n]y¯[n − 1] − je jω[n+1]y¯[n]y[n − 1]
}
= je− jω[n+1] E {y[n]y¯[n − 1]} − je jω[n+1] E {y¯[n]y[n − 1]}
= 2 Re
{
je− jω[n+1] E {y[n]y¯[n − 1]}
}
= −2 Im
{
e− jω[n+1] E {y[n]y¯[n − 1]}
}
.
(7.5)
where the upper bar in y¯ denotes the complex conjugate. The optimal value for ω[n + 1] is
therefore:
ω[n + 1] = arg
{
E {y[n]y¯[n − 1]} }, (7.6)
This solution cannot be obtained exactly in practice. Therefore, the expectation is replaced by an
exponentially weighted average [79], and the adaptive mechanism is now given by
Q[n] = δQ[n − 1] + (1 − δ)y[n]y¯[n − 1], (7.7)
ω[n + 1] = arg{Q[n]}, (7.8)
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where Q[n] is an internal variable and δ (0  δ < 1) is a forgetting factor. The convergence rate
of the SFT is directly determined by the parameter δ.
Harmonic frequency tracking
The SFT can be extended in order to estimate the instantaneous fundamental frequency and
extract the harmonic components. The basic idea behind this extension is to use one time-varying
band-pass filter (equation (7.2)) for the fundamental and one for each harmonic component.
Therefore, each harmonic component is extracted with the same type of time-varying bandpass
filter as in the SFT. An adaptive mechanism is used to estimate the fundamental frequency from
all the filtered components with a weighting procedure. Finally, in order to obtain a global
estimate, a linear combination is applied. The structure of the harmonic frequency tracker (HFT)
is illustrated in Figure 7.4.
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Figure 7.4: Structure of the harmonic frequency tracking algorithm. The figure shows one time-
varying bandpass filter for the fundamental and one for each harmonic component; x[n] is the
input signal, yk[n] are the filtered output signals, and ω[n] is the estimated instantaneous fre-
quency. The instantaneous frequency of each extracted component is estimated independently.
After this, a linear combination is used to obtain a global estimate. Figure from [77].
In this case, the input signal is defined as:
x[n] =
K∑
k=1
ck[n] + v[n] =
K∑
k=1
Ake jkω0 + v[n], (7.9)
where K is the number of harmonic components, {Ak} their complex amplitudes, ω0 is the fun-
damental frequency, and v[n] is the additive complex noise. Each harmonic component, yk[n],
is extracted with a band-pass filter whose central frequency is an integer multiple of the current
estimate of the fundamental frequency, k ·ω[n], k = 1, 2, . . . ,K. The filtered outputs are therefore
given by:
yk[n] = βe jkω[n]yk[n − 1] + (1 − β)x[n], k = 1, . . . ,K. (7.10)
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The adaptive mechanism of the HFT is more complex than the one of the SFT because in this
case the instantaneous frequency is estimated from all the filtered harmonic compoments, yk[n],
k = 1, 2, . . . ,K. First, an instantaneous estimate of the fundamental frequency is obtained for
each extracted component with the same approach as in the SFT (i.e., using the oscillator-based
recursion):
Qk[n] = δQk[n − 1] + (1 − δ)yk[n]y¯k[n − 1], k = 1, . . . ,K, (7.11)
ωk[n + 1] =
arg{Qk[n]}
k
, k = 1, . . . ,K. (7.12)
In order to obtain a global estimate of the instantaneous fundamental frequency all the estimates
are weighted. The weighting procedure favors the components for which the discrete oscillator
in equation (7.3) is best satisfied [80]. The output variance is used to yield a scale-independent
scheme. For this purpose, the cost function and variance of the instantaneous estimates are
computed with exponentially weighted averages:
Jˆk[n] = δJˆk[n − 1] + (1 − δ)
∣∣∣yk[n] − e jkω[n]yk[n − 1]∣∣∣2,
Sˆ k[n] = δSˆ k[n − 1] + (1 − δ)
∣∣∣yk[n]∣∣∣2,
for k = 1, 2, . . . ,K, where δ is the same forgetting factor as the one used in equation (7.7). Using
these two equations, the weights are defined as follows,
Wk[n] =
S k[n]/Jk[n]∑K
i=1 S i[n]/Ji[n]
, k = 1, . . . ,K. (7.13)
Finally, the global estimate of the instantaneous fundamental frequency is given by:
ω[n + 1] =
K∑
k=1
Wk[n]ωk[n]. (7.14)
It is also important to mention that although the HFT algorithm was presented for all harmonic
components k = 1, 2, . . . ,K, the tracking can also be performed on a restricted set of compo-
nents. For instance, the fundamental frequency can be estimated with the 1st and 3rd harmonic
component only when the signal under study has no 2nd harmonic component.
Performance analysis
The theoretical analysis of the performance of the SFT and HFT is widely detailed in the
work of Van Zaen et al. [77] in which the following aspects are studied in depth: the behavior of
the cost function (equation (7.4)), the frequency estimation bias and the variance of the adaptive
estimates. A brief summary is provided below.
SFT In the extreme situation when the oscillation is of low amplitude compared to the noise
level, the SFT is able to correctly extract the oscillation. This is mainly due to the fact that the
algorithm is scale-independent. Indeed, its cost function (equation 7.4) is specifically designed to
maximize the oscillatory behavior at the output, instead of, for instance, maximizing the output
power. Another important aspect of the SFT is its time-varying band-pass filter (equation 7.2)
which has unit gain and zero phase at the central frequency, avoiding therefore any distortion at
the filtered component.
The effect of each parameter on the performance of the algorithm was substantially analyzed
both through theoretical calculations and Monte Carlo simulations. In most situations, the bias
is negligible, as long as the filter is correctly adjusted and its bandwidth is sufficiently narrow.
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When the input signal is the analytic representation of a real signal, the discrete Hilbert trans-
form introduces long-term correlations in the noise process which in turn induce a bias, however
limited.
An important limitation has to be acknowledged. Since the SFT is an adaptive scheme, it
induces an adaptation delay that depends upon the update coefficients δ and the filter bandwidth
defined by β.
HFT As for the SFT, Monte Carlo simulations were used to measure the estimation bias and
variance of the HFT. The HFT is biased since the band-pass filters do not cancel the other har-
monic components. However, setting the filters bandwidth sufficiently narrow ensures a negligi-
ble bias. Compared to the SFT, the HFT produces a more accurate estimate of the instantaneous
fundamental frequency as additional information is contained in all harmonic components.
In this thesis, the HFT was always set to track the fundamental (i.e., the DF) and the first
harmonic components, as higher harmonics in ECG atrial signals have typically a very low am-
plitude. In addition, the bandwidth and update parameters of this adaptive tracking scheme were
set respectively to β = 0.95 and δ = 0.95. Using these parameter values, the convergence time of
the algorithm is less than than 50 samples for a sampling frequency of 50 Hz [77].
7.2.2 Measures of AF organization
Once the fundamental and the first harmonic components were extracted with the HFT, they
were used to derive two novel measures of AF organization.
Adaptive organization index
Similarly to the OI defined in Section 6.1.1 of Chapter 6, an adaptive OI (AOI) was defined as
the ratio between the power of the components (the fundamental and its first harmonic) extracted
with the HFT and the total power of the input signal. The local estimates of these powers were
computed by low-pass filtering the squared input and outputs with a Hamming window of length
L = 101, to ensure a good tradeoff between temporal resolution and estimation accuracy [81].
This yielded an organization measure localized in time. Whenever a global value was needed,
the local AOI was averaged over the whole signal duration.
This complexity measure quantifies the cyclicity of the oscillations of the fundamental and its
first harmonic and, by definition, is bounded between zero and one. The closer to one, the more
organized the atrial signal is, as most of the frequency content is concentrated in the components
extracted by the HFT (fundamental and its first harmonic). Conversely, an AOI close to zero
indicates that the frequency components are widely distributed across the whole spectrum of the
atrial signal.
Adaptive phase difference
The two outputs of the HFT represent the harmonic components of the AF waveforms. These
two signals were used to define a second organization index derived from the phase difference
between harmonic components. Similarly to the TIPD presented in Section 6.1.1 of Chapter 6, an
index characterizing the PD between the first harmonic and the fundamental component extracted
by the HFT was estimated following the same computational steps as for the TIPD. This index
was named the adaptive PD (aPD). For convenience, the procedure for estimating the aPD is
repeated here. The PD was estimated between the first harmonic and the fundamental component
extracted by the HFT, and its slope, the adaptive sPD, was locally estimated by a linear fit on
centered sliding windows (L = 101). The aPD was defined as the variance of the adaptive sPD.
The aPD characterizes the regularity of the oscillations between the components extracted by the
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HFT. Small values of aPD are indicative of organized AF oscillations since they correspond to
stronger couplings between the fundamental and its first harmonic.
7.2.3 Material
Synthetic signal
For illustration purposes, the complete analysis procedure (i.e., the extraction of the harmonic
components with the HFT followed by the computation of organization measures) was performed
on a synthetic signal inspired from [59] of duration 10 sec composed of two frequency-modulated
harmonic components:
x[n] = A1 sin
(
2pi f0n +
fd
fm
cos(2pi fmn)
)
+ A2 sin
(
2pi2 f0n +
2 fd
fm
cos(2pi fmn) − 4pi500n
)
+ v[n],
(7.15)
where A1 = 1 and A2 = 0.5 are the amplitudes, f0 = 8.9 is the fundamental frequency, fd = 1.78
is the frequency deviation, fm = 0.178 is the frequency of the modulation, and v[n] is an additive
white Gaussian noise with a signal-to-noise ratio (SNR) of 10 dB. The 2nd harmonic component
also included a linear phase drift.
Surface ECG
For comparison purposes, the analysis was performed on the same ECG signals as those
used in the time-invariant analysis (Section 6.1.2, page 57). For convenience, they are briefly
summarized here.
The analysis was performed on the DB f ull database. Durations of 10 to 60 seconds by steps
of 10 seconds were selected.
Importantly, QRST cancellation was performed as a first step (Appendix C, page 149). Once
the ECG was devoid of the ventricular activity, the atrial signals were down sampled to 50 Hz [57,
64].
Finally, only the ECG precordial chest leads were included in this study (i.e., from V1 to V6b,
where V6b denotes the dorsal electrode, see Section 2.2.1 page 18).
7.2.4 Statistical analysis
For purposes of comparison, the statistical analysis performed in this study was the same as
the one performed using the time-invariant analysis (Section 6.1.3, page 57). For convenience,
this statistical analysis is briefly repeated here.
First, the distribution of the mean values at baseline of the two indices was inferred on the
different epochs through the ANOVA framework (from 10 to 60 sec, by steps of 10 seconds).
Second, the results on the longest available epoch (60 sec) were selected to perform an advanced
statistical analysis. When the ANOVA p-value was significant for a given pair of index/lead, a
binary logistic regression was applied to the corresponding index/lead values. The performance
of the binary logistic regression model was evaluated using the odds ratio and its 95% confidence
interval. ROC curve analysis was also performed and the AUC and YI are reported. A LOOCV
was performed on the ROC curve parameters previously mentioned.
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7.3 Results
7.3.1 Illustrative examples
Synthetic signal
Figure 7.5 shows the different steps of organization measurements computation on the syn-
thetic signal defined in equation (7.15). The HFT is able to precisely estimate the instantaneous
fundamental frequency and to extract the harmonic components which are later used for measur-
ing the slope of the phase difference and its variance, the aPD of value 2.3 · 10−5 and the AOI of
value 0.7. Both aPD and AOI indicate a well-organized signal.
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Figure 7.5: Harmonic frequency tracking example on a synthetic signal. From top to bottom,
the input signal, the fundamental component, the first harmonic component, the instantaneous
estimates extracted with the HFT of the fundamental and its first harmonic on top of a short-time
Fourier transform of the input signal, the corresponding instantaneous AOI, and adaptive sPD.
The synthetic input signal is composed of two frequency-modulated harmonic components. Both
measurements of organization indicate a relatively well organized signal.
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AF signals
For comparison purposes, the AF signals used here are the same as those used in the illustra-
tive examples from the previous Chapter in Section 6.2.1, i.e., the recordings from one LT and
NLT patient of 60 sec duration from lead V1. After QRST cancellation, both adaptive measures
of AF organization (AOI and aPD) were estimated from the outputs of the HFT.
Figure 7.6 shows a time-frequency representation (top plot) estimated from the 60 sec ECG
from lead V1 after QRST cancellation for the LT (Figure 7.6a) and NLT (Figure 7.6b) patients.
For both figures, the time-frequency was computed using the short-term Fourier transform (255-
sample Hamming window, 512-sample segment length for the discrete Fourier transform). The
bandwidths of ±1 Hz for the OI computation (Chapter 6, Section 6.1.1) are represented by the
horizontal dashed lines (red for the DF, and green for the first harmonic H1). The instantaneous
frequencies estimated with the HFT are shown in red for the DF and in green for H1. The bottom
plot displays the instantaneous AOI during the 60 sec epoch.
For the LT patient (Figure 7.6a), the instantaneous frequency estimates (top plot) remains
stable between t = 4.5 and t = 43 sec. During this period, the values of the AOI (bottom plot) are
larger than 0.5 (highlighted in gray), which is indicative of a high spectral concentration within
the extracted components (apart for some short excerpts). Some limited excursions outside the
bandwidth limits are observed at 46 sec matching a drop in the AOI.
The NLT patient (Figure 7.6b) displays erratic instantaneous frequencies (top plot) over
time and repetitive excursions across the bandwidth limits (during the intervals [12; 17] and
[36; 52.5] sec. Consequently, the AOI (bottom plot) remains below 0.5 during the entire record-
ing.
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Figure 7.6: Examples of AOI index computed in an LT (a) and an NLT (b) patients. On both
figures the top plot shows the time-frequency representation of V1 after QRST cancellation. The
horizontal lines denote the bandwidth for the OI computation (red for the DF, and green for the
first harmonic H1). The instantaneous frequencies estimated with the HFT are shown in red for
the DF and in green for H1. The AOI over the entire epoch is shown in the bottom plot. Periods
when AOI ≥ 0.5 are emphasized in gray.
Figure 7.7 shows the adaptive sPD 1 (top plot) estimated from the outputs of the HFT. For the
LT patient (Figure 7.7a), there are four periods during which a phase-lock occurred (highlighted
in light gray), especially sustained between t = 14 and t = 42 sec. For comparison purposes,
the time-invariant sPD is also plotted (dashed dot line) as well as the corresponding periods of
phase-locks (dark gray). Interestingly, these periods constitute a subset of the long period of
1. For the recall, the sPD corresponds to the slope of the phase difference
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phase-lock observed on the adaptive sPD. The bottom plot shows an excerpt of lead V1 (blue)
and the atrial V1 devoid of QRST (black) between seconds 30 and 50, corresponding to this long
phase-lock episode. Note the regular morphology during the phase-lock observed on the adaptive
sPD on the left hand side of the recording transitioning into an irregular atrial ECG pattern at the
time of high adaptive sPD variations on the right hand side. The time-invariant sPD is not able to
catch the time spent in phase-lock during the regular AF waveforms. Moreover, the aPD index is
10−3 (rad/s)2, whereas the TIPD is twice as high 2 · 10−3 (rad/s)2 (see Chapter 6, Section 6.2.1
page 58 for the computation of the TIPD on the same atrial waveform).
For the NLT patient (Figure 7.7b) the adaptive sPD (top plot) appears erratic during the entire
duration resulting in a relatively high value of 9.7 ·10−3 (rad/s)2. Importantly, this value is much
higher than that for the LT patient. The atrial ECG morphology is irregular without any apparent
organization (bottom plot).
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Figure 7.7: Examples of aPD index computed in an LT (a) and an NLT (b) patients. On both
figures the top plot shows the adaptive sPD, and the bottom plot the corresponding input ECG
signals. The blue signal corresponds to the raw ECG and the black one to the ECG after QRST
cancellation. The highlights in light gray illustrate the time intervals during which a phase-
lock between the fundamental and the first harmonic component extracted with the HFT occurs.
For comparison purposes, the time-invariant sPD is also shown (dashed dot line) as well as its
corresponding episodes of phase-locks in dark gray (see Chapter 6, Section 6.2.1 page 58 for the
computation of the TIPD on the same atrial waveforms).
7.3.2 Epoch durations
Figure 7.8 shows the baseline p-values obtained when comparing LT and NLT patients for the
AOI and aPD computed from all ECG chest leads (x-axis) and on the different epoch durations
(y-axis). White squares denote non-significant differences between groups (p = ns). When the
difference was found significant, the square was filled with gray shades proportional to the level
of significance (from light, p < 0.05 to dark gray for p < 0.001).
AOI analysis Figure 7.8a reports the statistical significance levels for the AOI. From chest
leads V1 to V4, significant differences were found between LT and NLT groups on all epoch du-
rations. Interestingly, on lead V1, shorter durations (less than 30 sec, p < 0.001) were more
discriminative than longer periods (p < 0.005). On leads V2 and V3, the statistical significance
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levels were similar (p < 0.005, except for the 10 sec epoch duration on which p < 0.01). No
significant difference was found between the groups on chest lead V5 regardless of the epoch
duration (p = ns). Finally, the p-values estimated on the dorsal lead V6b were only significant for
recording of short durations (10 and 20 sec, p < 0.05).
aPD analysis Figure 7.8b shows the p-values estimated for the aPD. Lead V1 displayed signif-
icant p-values on epochs from 20 to 60 sec (p < 0.05). For chest leads V2, V3, and V5 and on
all epoch durations, no significant difference were observed between the groups (p = ns). Lead
V4 showed significant p-values on epochs from 40 to 60 sec (p < 0.05). Finally, on all epoch
durations, only chest lead V6b showed a significant difference between groups with a stronger
discrimination on 20 and 60 sec epochs for which p < 0.005.
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Figure 7.8: Statistical significance levels for all epochs durations (y-axis) and chest leads (x-
axis) for AOI (a), and aPD (b). White squares denote non-significant differences between groups
(p = ns). When the difference was significant, the corresponding square was filled with gray,
from light (less significant, p < 0.05) to dark (most significant, p < 0.001).
7.3.3 Group comparisons on the procedural outcome
Figure 7.9 reports the distribution of AOI (a) and aPD (b) on all chest leads for the LT (blue)
and NLT (red) groups. Mean and median values are displayed as circle and square respectively.
The vertical lines indicate ± one standard deviation. ANOVA was used to determine significant
differences between groups. The following annotations were used for the different level of sig-
nificance: ∗ : p < 0.05, ∗∗ : p < 0.01, † : p < 0.005 and ‡ : p < 0.001.
AOI analysis The AOI (Figure 7.9a and left column of Table 7.1) computed on leads V1, V2,
V3 and V4 revealed a significantly higher organization for the LT group than for the NLT one. On
the remaining leads the mean AOI was also higher for the LT group, but non-significantly. More
specifically, the significance level between groups was higher on leads V1, V2 and V3 (p < 0.005),
than on V4 (p < 0.05). Interestingly, among all significant leads in the LT group, V1 displayed
the highest organization with an average AOI of 0.45 ± 0.08, while on leads V2, V3 and V4 the
average was lower (0.36 ± 0.05, 0.34 ± 0.04 and 0.32 ± 0.05 respectively).
The binary logistic parameters estimated for all the significant leads are reported in Table 7.2.
Importantly, the odds ratio on all four leads was greater than one, which is indicative that the AOI
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Figure 7.9: Distributions of the baseline AOI (a) and aPD (b) for the LT (blue) and NLT (red)
groups computed on 60 sec epochs. The mean (circle) as well as the median (square) of each
group are shown. The vertical lines delimit one standard deviation. The following annotations
were used for the different level of significance: ∗ : p < 0.05, ∗∗ : p < 0.01, † : p < 0.005 and
‡ : p < 0.001.
on these specific leads was a strong predictor of AF termination. More specifically, the narrowest
associated 95% confidence interval and lowest p-value were found on lead V1, which is indicative
of a more reliable precision of the odds ratio for this lead ([1.0538 − 1.4011] with p < 0.01 for
V1, compared to [1.0589 − 1.646] with p < 0.05 for V2, [1.0772 − 1.9291] with p < 0.05 for V3,
and [1.036− 1.8852] with p < 0.05 for V4). The odds ratio was, however, lower on V1 compared
to the remaining leads (1.2151 for V1, 1.3202 for V2, 1.4415 for V3, and 1.3975 for V4). But
keeping in mind that the associated 95% confidence interval and p-values were lower on V1, we
can state with confidence that the AOI computed on V1 was the most effective in predicting AF
termination among the four significant leads.
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Lead
AOI aPD [·10−3(rad/s)2]
LT NLT LT NLT
V1
0.45 0.35 6.34 8.92
±0.08 ±0.08† ±2.75 ±2.18 ∗
(0.46) (0.34) (5.74) (8.54)
V2
0.36 0.31 6.11 7.04
±0.05 ±0.04† ±1.75 1.42
(0.36) (0.3) (5.97) (6.97)
V3
0.34 0.29 6 6.74
±0.04 ±0.03† ±1.22 ±1.4
(0.33) (0.29) (5.67) (6.65)
V4
0.32 0.28 5.61 6.69
±0.05 ±0.02 ∗ ±1.18 ±1.63 ∗
(0.31) (0.28) (5.55) (6.45)
V5
0.31 0.28 5.49 6.12
±0.04 ±0.03 ±0.95 ±1.46
(0.31) (0.28) (5.55) (6.09)
V6b
0.38 0.34 6.09 8.23
±0.06 ±0.04 ±1.32 ±1.84‡
(0.37) (0.34) (5.91) (8.23)
Table 7.1: Mean ± standard deviations and median (in brackets) of the AOI (left column) and
aPD (right column) before ablation computed on epochs of duration 60 sec. The following
annotations were used for the different level of significance: ∗ : p < 0.05, ∗∗ : p < 0.01,
† : p < 0.005 and ‡ : p < 0.001.
Figure 7.10 shows the ROC curves estimated for leads V1 (Figure (a)), V2 (Figure (b)), V3
(Figure (c)) and V4 (Figure (d)) while Tables 7.3a and 7.3b report the values of the estimated
AUCs and YIs as well as the results of the LOOCV respectively. Among the four leads, the high-
est AUC was obtained on V1 (0.86 for V1 compared to 0.81 for the remaining leads). Similarly,
the maximum YI was estimated on lead V1 (0.69 with 78% sensitivity and 91% specificity on V1,
as compared to 0.5 with 50% sensitivity and 100% specificity for V2, 0.6 with 78% sensitivity and
82% specificity for V3, and 0.64 with 82% sensitivity and 82% specificity for V4). Interestingly,
the cut-off value for separating LT from NLT patients was higher on lead V1 (0.43) as compared
to the cut-off values on the remaining leads (0.32). All the obtained estimates were corroborated
by the LOOCV in terms of average values and low standard deviations. These results suggest a
better classification performance for lead V1 than for leads V2, V3, and V4.
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aPD analysis The aPD values (Figure 7.9 and right column of Table 7.1) computed on leads
V1, V4, and V6b were significantly lower for the LT patients than that for the NLT patients, which
is suggestive of a higher coupling between the fundamental and the first harmonic extracted with
the HFT for the first group. The overlap between the groups is, however, less important on the
dorsal lead V6b leading to a higher significance level on this lead than on the other two (p < 0.001
for V6b vs. p < 0.05 for V1 and V4). Interestingly, on lead V1 the average aPD for the LT group
was significantly lower than for the NLT group. For both groups the standard deviations were
rather large ((6.34 ± 2.75) · 10−3 (rad/s)2 for the LT group and (8.92 ± 2.18) · 10−3 (rad/s)2 for
the NLT group, p < 0.05). On the dorsal lead V6b the average aPD for the NLT patients was
significantly higher than that for the LT patients suggestive of a larger degree of disorganization
((8.23±1.84)·10−3 (rad/s)2 compared to (6.09±1.32)·10−3 (rad/s)2 for the LT group, p < 0.001).
One can also observe that, for the NLT patients, the average aPD on leads V1 and V6b were similar.
On the remaining leads V2, V3, and V5, no significant difference was observed between the groups
(p = ns).
The binary logistic parameters estimated for leads V1, V4, and V6b are reported in Table 7.2.
On the three leads, the odds ratio are slightly smaller than one, with a maximum value on lead
V1 (0.96234 for V1 compared to 0.94307 for V4 and 0.90853 for V6b). Reciprocally, the associ-
ated 95% confidence interval is narrower on chest lead V1 ([0.93002 − 0.99578] as compared to
[0.88988 − 0.99944] for V4 and [0.84548 − 0.97627] for V6b). The related p-values indicated the
most significant level on the dorsal lead V6b on which p < 0.01, while on V1 and V4 p < 0.05.
Figure 7.11 shows the ROC curves estimated for leads V1 (Figure (a)), V4 (Figure (b)) and
V6b (Figure (c)) while Tables 7.3a and 7.3b report the values of the estimated AUCs and YIs as
well as the results of the LOOCV respectively. ROC curves parameters were similar for leads V1
and V6b but differed for lead V4. AUCs estimated on leads V1 and V6b were similar (for the dorsal
lead V6b the AUC was estimated to 84, while on V1 to 0.82). Conversely, the YI was slightly
larger on lead V1 as compared to lead V6b (0.69 with 77% sensitivity and 91% specificity for V1
vs. 0.63 with 90% sensitivity and 73% specificity for V6b). The cut-off value for separating LT
patients from NLT patients was similar on these two leads (≈ 7.5 · 10−3 (rad/s)2). Finally, lead
V4 showed lower classification performance, with a AUC of 0.69 and an YI of 0.37 with 82%
sensitivity and 55% specificity. Compared to V1 and V6b, the cut-off value was lower on V4, i.e.,
6.45 · 10−3 (rad/s)2). Finally, the values of the parameters estimated from ROC curves were cor-
roborated by the respective average estimates from the LOOCV, except for the cut-off threshold
on V4, for which the LOOCV indicated an average cut-off larger than the one estimated from the
ROC curve analysis.
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Lead Index Odds ratio 95% confidence interval p-value
V1
AOI 1.2151 [1.0538 − 1.4011] 0.0073402
aPD 0.96234 [0.93002 − 0.99578] 0.027617
V2 AOI 1.3202 [1.0589 − 1.646] 0.013558
V3 AOI 1.4415 [1.0772 − 1.9291] 0.013884
V4
AOI 1.3975 [1.036 − 1.8852] 0.028414
aPD 0.94307 [0.88988 − 0.99944] 0.047826
V6b aPD 0.90853 [0.84548 − 0.97627] 0.0089364
Table 7.2: Binary logistic regression parameters of the AOI and aPD indices/leads before ablation
computed on 60 sec epochs. The binary logistic model was estimated when ANOVA declared a
significant difference for a pair of index/lead. The table reports the corresponding odds ratio, its
95% confidence interval and associated p-value.
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Figure 7.10: ROC curves (black) for the AOI on lead V1 (a), V2 (b), V3 (c), and V4 (d) assessed
on recordings of 60 sec duration. The corresponding estimated AUCs and YI (pink) estimated
from the ROC curves are also reported. The average LOOCV ROC curve is plotted in gray.
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Figure 7.11: ROC curves (black) for the aPD on lead V1 (a), V4 (b), and V6b (c) assessed on
recordings of 60 sec duration. The corresponding estimated AUCs and YI (pink) estimated from
the ROC curves are also reported. The average LOOCV ROC curve is plotted in gray.
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Lead Index AUC
Youden index
Cut-off Value Sensitivity Specificity
V1
AOI 0.86 0.43 0.69 0.77 0.91
aPD 0.82 7.55 · 10−3 [(rad/s)2] 0.69 0.77 0.91
V2 AOI 0.81 0.32 0.5 0.5 1
V3 AOI 0.81 0.33 0.6 0.78 0.82
V4
AOI 0.81 0.32 0.64 0.82 0.82
aPD 0.69 6.45 · 10−3 [(rad/s)2] 0.37 0.82 0.55
V6b aPD 0.84 7.52 · 10−3 [(rad/s)2] 0.63 0.9 0.73
(a)
Lead Index
LOOCV
AUC Cut-off Youden index
V1
AOI 0.86 ± 0.02 0.43 ± 0.01 0.68 ± 0.02
aPD 0.82 ± 0.02 (7.56 ± 2.56 · 10−2) · 10−3 [(rad/s)2] 0.68 ± 0.02
V2 AOI 0.81 ± 0.01 0.32 ± 0.01 0.5 ± 0.02
V3 AOI 0.81 ± 0.02 0.33 ± 0.01 0.6 ± 0.03
V4
AOI 0.8 ± 0.02 0.32 ± 0.01 0.64 ± 0.03
aPD 0.69 ± 0.02 (6.99 ± 0.39) · 10−3 [(rad/s)2] 0.37 ± 0.03
V6b aPD 0.84 ± 0.01 (7.53 ± 2.14 · 10−2) · 10−3 [(rad/s)2] 0.63 ± 0.03
(b)
Table 7.3: ROC (a) and LOOCV (b) estimations for the AOI and aPD assessed on epochs of
60 sec duration. Results are reported for the leads which were declared significant through the
ANOVA framework: leads V1, V2, V3 and V4 for the AOI and leads V1, V4 and V6b for the
aPD. Table (a) reports the estimation from the ROC curve of the AUCs, YIs with respective
sensitivities/specificities as well as the cut-off thresholds for discriminating LT patients from
NLT patients. Table (b) reports the average AUCs, YIs and cut-off values assessed with LOOCV.
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In this chapter, an adaptive algorithm for extracting the harmonic components of ECG f-
waves was presented. The adaptive algorithm takes as input the ECG signal devoid of ventricular
activity and outputs two signals corresponding to the fundamental and first harmonic components
of the AF signal. From these outputs, two novel organization indices were estimated. The first
one, the AOI, quantifies the cyclicity of the oscillations of the harmonic components over time.
The second one, the aPD, quantifies the regularity of the PD between the harmonic components,
and is an indicator of the f-waves morphological regularity.
7.4.1 Relevance of the epochs durations
In this study, we found that the AOI yielded a better separation between LT and NLT groups
on shorter epoch durations. Significant differences on segments of duration ≤ 20 sec were ob-
served on all chest leads except for V5. Among the significant leads, V1 showed the highest level
of significance. For longer epochs, significant differences were observed on chest leads V1 to V4.
Interestingly, the aPD yielded more discriminative p-values between the two groups on longer
epoch durations. On segments of duration ≥ 40 sec, the average aPD was statistically different
between LT and NLT patients on leads V1, V4, and V6b. Among these leads, the highest level of
significance was observed on the dorsal lead V6b.
Thus, the AOI was statistically more robust on shorter epochs, in particular on lead V1. Con-
versely, the aPD was statistically stronger on longer epochs, notably on the dorsal lead V6b. In
terms of the relevance of the epochs duration, these two indices appear complementary.
7.4.2 Prediction of the procedural outcome before ablation
Other studies based on time domain analysis have shown that the procedural outcome of AF
catheter ablation can be predicted from the analysis of f-wave amplitude [82, 83]. Nault et al.
manually performed their analysis on individual leads; f-waves amplitudes were correlated to
clinical and echocardiographic variables and to ablation outcome [82]. The best correlation ac-
curacy was obtained using ECG electrodes V1 and II. High f-wave amplitude was shown to be
predictive of procedural termination. However, manual analysis carries an important limitation
due to operator’s subjectivity. Meo et al. used an automatic method taking into account the inter-
variability between ECG leads [83]. They found that a large spatial diversity is present in surface
ECG signals and that exploiting this feature increases the predictive power of the amplitude pa-
rameter.
In our study, the AOI showed a significant higher organization on leads V1 to V4 in patients
with AF termination compared to patients whose AF did not terminate. More specifically, the
best statistical performance of the AOI was achieved on chest lead V1. The discriminative cut-off
value was the highest on this lead compared to the remaining ECG electrodes. The aPD was
significantly lower on leads V1, V4, and V6b for the LT group compared to NLT patients. These
results also suggest that LT patients had a higher organization on these specific ECG leads as
compared to NLT patients. The highest statistical performance was achieved on leads V1 and
V6b, with a better discriminative power on the dorsal lead. Importantly, the aPD cut-off values on
leads V1 and V6b were lower than on lead V4.
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7.4.3 Comparison with time-invariant approaches
In the previous chapter, organization indices derived from time-invariant approaches for char-
acterizing the harmonic structure of the ECG f-waves were presented. The discussion below is
aimed at comparing the performance in predicting the procedural outcome of these time-invariant
measures with that of the adaptive indices presented the current chapter. A summary of the pre-
dictive power of the organization indices on the ECG precordial chest leads is provided in Ta-
ble 7.4 in which the comparison has been separated in short epochs (≤ 30 sec) and long epochs
(≥ 30 sec) durations. For each table cell, the indices are ordered from more predictive (top) to
less predictive (bottom).
AOI vs. OI The OI was not predictive of the outcome of catheter ablation, regardless of the
ECG leads and epochs duration. The results were in contradiction with those obtained with the
other organization indices since the average OI indicated a tendency of higher organization in
NLT patients than in the LT one. On the opposite, the AOI showed on several ECG leads a sig-
nificant higher organization in LT patients than in the NLT ones. Clearly, the AOI outperformed
the OI for predicting the procedural outcome of catheter ablation in long-standing persistent AF.
aPD vs. TIPD The computational steps for deriving an organization index based on the PD be-
tween the harmonic components were the same for the aPD and TIPD indices. These measures
were defined as the variance of the slope of the PD between the fundamental component and
its first harmonic. The prominent difference between these two indices resided in the schemes
for extracting the harmonic components from the ECG f-waves. On one hand, the TIPD was
assessed on the harmonic components extracted with linear, time-invariant filters. On the other
hand, the aPD was computed on the harmonic components extracted with the adaptive HFT al-
gorithm. The illustrative examples showed that the adaptive slope of the PD detected longer
periods of phase-locks than the PD slope estimated between the harmonic components extracted
with the time-invariant approach. The periods of phase-locks assessed with the latter scheme
were actually a subset of the phase-locks periods computed on the components extracted by the
adaptive HFT. Moreover, on shorter epochs durations (≤ 30 sec) the average TIPD and aPD were
statistically different between the two groups on leads V1 and V6b (except for the aPD on V1 for a
duration of 10 sec on which p = ns). On lead V1, for these epoch durations the level of statistical
significance was slightly higher for the TIPD than for the aPD. On the dorsal lead V6b, however,
the p-values were similar for the TIPD and aPD (except for a duration of 20 sec for which the
p-value was lower for the aPD than for the TIPD). On longer epoch durations (≥ 40 sec), the
average aPD was statistically different between the two groups on leads V1, V4 and V6b whereas
the average TIPD was discriminative on leads V1 and V6b. For these durations, the levels of
significance were slightly better on lead V1 for the TIPD, while on the dorsal lead V6b the aPD
was more discriminative. On 60 sec epochs, the performance of the binary logistic regression as
well as the ROC parameters on leads V1 and V6b were better for the aPD than for the TIPD, in
particular on the dorsal lead V6b.
Taking all these results together, the PD assessed between the harmonic components extracted
with the adaptive algorithm is more appropriate than the time-invariant one for predicting the ab-
lation outcome in patients with long-standing persistent AF, in particular on long epochs duration
and using a dorsal ECG lead.
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ECG leads
V1 V2 V3 V4 V5 V6b
Short epochs AOI AOI AOI AOI aPD
durations TIPD TIPD
(≤ 30 sec) aPD AOI
Long epochs AOI AOI AOI AOI aPD
durations TIPD aPD TIPD
(≥ 30 sec) aPD
Table 7.4: The predictive power of catheter ablation outcome of the equivalent indices derived
from the time-invariant approach (OI and TIPD) and the adaptive scheme (AOI and aPD) are
compared on all ECG precordial chest leads. The comparison has been separated in short epochs
(≤ 30 sec) and long epochs (≥ 30 sec) durations. For each table cell, the indices are ordered
from more predictive (top) to less predictive (bottom).
7.4.4 Conclusion
As ECG f-waves rapidly vary over time, the ability of classical organization indices to track
these variations and detect potential differences between patients appears limited. The organi-
zation indices derived from the adaptive algorithm presented in the current chapter are more
suitable for characterizing the temporal evolution of the harmonic components of ECG f-waves.
The AOI and aPD are complementary indices in terms of temporal and spatial performance. In-
deed, the AOI is statistically more robust on shorter epochs and on lead V1, while the aPD is
statistically more powerful on longer epochs and on the dorsal lead V6b.
After cancellation of the ventricular activity, the ECG f-waves reflect the global activity of
the atria. It has been observed separately for the DF, TIPD, AOI and aPD that the respective
cut-off values estimated for discriminating LT patients from NLT ones were not the same on
all ECG leads. Each ECG lead is positioned at a specific location on the patient’s thorax (or
in the back in the case of V6b). Hence, each ECG electrode is facing different parts of the left
and right atria. These observations suggest that the different amount of organization assessed
by the various organization indices computed from ECG leads are indicative of a heterogeneous
organization within both atria. Therefore, it would be of relevant information to correlate the
global activity assessed from the ECG with the activity measured inside the atria. This analysis
is performed in the next part of this manuscript.
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Part IV
Intracardiac Signal Processing

Dominant Frequency
Analysis 8
During AF, the intracardiac signals display complex and variable patterns. Time-invariant
spectral techniques have been widely used to characterize the periodic components embedded
into these complex signals. Similarly to ECG analysis, power spectral analysis is the most exten-
sively used approach to estimate the frequency of AF. The frequency corresponding to the peak
of highest amplitude is defined as the DF. The DF computed from intracardiac signals has been
used as an estimate of the local atrial activation rate. In Chapters 6 and 7, we showed that the
frequency content of AF ECG signals is characterized by important temporal variations, and that
classical time-invariant approaches are not suitable for tracking these variations. Hence, in this
chapter, a new time-varying approach for estimating the intracardiac instantaneous frequency is
proposed.
Several studies have shown that AF waves in ECG chest lead V1 adequately reflect the RAA
activity during AF [16, 20, 55, 57, 58, 65, 84–86]. During this thesis, we had the unique op-
portunity to extend these results by analyzing the contribution of the LAA and CS in addition
to the RAA, to the frequency content of the AF waves of ECG chest leads before ablation of
long-standing persistent AF. These contributions were investigated using time-invariant and time-
varying techniques.
Many electrophysiological studies have used the DF of intracardiac recordings as a tool for
understanding the pathophysiology and dynamics of AF in humans [13, 14, 87, 88]. One such
approach has been to map the activation rates in the frequency domain throughout the atria.
Most of these studies have used the DF in order to assess the change of AF dynamics during
catheter ablation and it was observed that a decrease in intracardiac DF was associated with AF
termination [67, 89, 90]. Lazar et al. observed that a left-to-right atrial frequency gradient was
present in patients with paroxysmal AF, but not in patients with persistent AF [91]. To the best
of our knowledge, very few studies investigated the baseline distribution of the DF as a tool
for predicting procedural outcome [90, 92]. Thus, we aimed at studying the distribution of the
baseline DFs assessed in several atrial segments prior to ablation for patients with long-standing
persistent AF.
This chapter is organized as follows. In Section 8.1, the classical time-invariant approach for
DF estimation is presented as well as a novel time-varying scheme for estimating the instanta-
neous DF. Then, in Section 8.2, the correlation between ECG and intracardiac DFs is investi-
gated. Finally, in Section 8.3, the distribution of baseline DFs is presented.
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8.1 Estimation of the intracardiac dominant frequency
8.1.1 Time-invariant approach
The following time-invariant spectral analysis was performed in order to estimate the intrac-
ardiac dominant frequency from the bipolar EGMs [93]. In the first step, the EGMs were rectified
(i.e., the absolute value of the signal was computed). Signal rectification is a crucial step because
all biphasic waveforms are transformed to monophasic waveforms, making the peaks and de-
flections after rectification closer to sinusoids [94]. Then, a band-pass Butterworth filter with
bandwidth [1 − 20] Hz was applied to the rectified signal in order to ensure that the estimated
frequencies lie within an admissible physiological range. Frequency spectra were estimated us-
ing fast Fourier transform. Finally, the intracardiac DF was defined as the highest peak within
the power spectrum between [3 − 15] Hz.
8.1.2 Time-varying approach
The signal processing steps for computing the instantaneous frequency of intracardiac EGMs
are described here. In the first step, the local activation time (LAT) was defined as the time of
the maximum positive peak of each detected activation wave using sliding windows of 150 ms.
False detections were removed using temporal and amplitude thresholding. The upper plot in
Figure 8.1 illustrates a 20 sec epoch acquired from the HRAd dipole placed within the RAA in
an LT patient with its detected LATs (red dot). The bottom plot shows an excerpt of two seconds.
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Figure 8.1: Intracardiac LATs and instantaneous frequencies. The top plot illustrates a 20 sec
epoch acquired from the HRAd dipole placed within the RAA in an LT patient with its detected
LATs (red dots). The bottom plot shows an excerpt of two seconds. The numbers displayed
between consecutive LATs indicate the corresponding instantaneous frequencies in Hz.
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Let LATk−1, LATk, and LATk+1 be three consecutive LATs in a given signal with a to-
tal of k = 2, · · · ,N − 1 LATs, as illustrated in the bottom plot of Figure 8.1. We denoted
fk−1 = 1/(LATk − LATk−1) as the instantaneous frequency between LATk and LATk−1. Likewise,
fk+1 = 1/(LATk+1 − LATk) was set as the instantaneous frequency between LATk+1 and LATk.
As displayed in the bottom plot of Figure 8.1, fk−1 = 6.33 Hz and fk+1 = 5.67 Hz.
The following set of data points was defined (Figure 8.2, bottom plot):xk = LATk,yk = ( fk+1 + fk−1)/2 (8.1)
where k = 2, · · · ,N − 1. The instantaneous frequency ( finst) was defined as the cubic inter-
polation of these data points at a sampling frequency of 50 Hz. The top plot of Figure 8.2 shows
the finst computed for the intracardiac signal shown in Figure 8.1.
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Figure 8.2: Example of an intracardiac instantaneous frequency signal, finst estimated from the
signal displayed in Figure 8.1.
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8.2 Intracardiac contribution to ECG fibrillation waves
8.2.1 Methods
Time-invariant approach
Synchronous baseline recordings from the RAA, LAA and CS were used (see Section 5.2.3
at page 47 of Chapter 5 for further details of the study protocol). For convenience, the data
recording setup is briefly repeated here 1:
1. the Lasso catheter was placed within the LAA for a duration of 20 sec.
2. the HRA catheter was placed within the RAA during the entire procedure. In this study,
the distal bipolar EGM was considered.
3. the CS-cath was placed within the CS during the entire ablation procedure, with the prox-
imal electrode CS9−10 placed at the ostium. All five bipolar EGMs were further analyzed.
The DF of each atrial location was computed using the time-invariant approach presented
in Section 8.1.1. The epoch duration of the study was set to 10 sec. Synchronous recordings
were considered for this analysis, and when more than two epochs of 10 sec were available for
a particular patient, the intracardiac DF was temporarily averaged. For the Lasso, when the DF
was computed on more than one dipole, the DF was spatially averaged.
The ECG DF was also estimated from the synchronous epochs corresponding to the intrac-
ardiac acquisitions. The method for computing the ECG DF has been presented in Section 6.1.1.
In short, the frequency spectra from all chest leads were computed from the ECG signals after
QRST subtraction and the DF was estimated as the frequency of the highest peak between 3 and
20 Hz in the PSD estimate for each lead. The ECG DF was then averaged for each patient on all
available epochs.
The relation between surface ECG and intracardiac baseline DFs was investigated using Pear-
son’s correlation coefficients, which were computed between each combination of ECG chest
leads and intracardiac bipolar EGMs, between each combination of ECG chest leads (i.e., V1
with the remaining ECG leads, V2 with the remaining ECG leads, etc...), and finally between
each combination of bipolar EGMs (i.e., averaged LAA with RAA as well as all CS bipolar
EGMs, and RAA with all CS bipolar EGMs).
Time-varying approach
The intracardiac instantaneous frequency finst was compared to the ECG instantaneous fre-
quency of the dominant component extracted by the adaptive HFT algorithm. Indeed, the adap-
tive scheme proposed in Section 7.2 takes as input an ECG signal devoid of ventricular activity,
and outputs estimates of the dominant component and its first harmonic. In this study, the esti-
mated instantaneous frequency of the dominant component was taken as the central frequency of
the filter tracking at each time instant the dominant component. Importantly, the delay induced
by the adaptive algorithm was compensated [77].
The method presented in Section 8.1.2 for computing the intracardiac finst is dependent on
the accuracy of LATs detection, and subsequently on the quality of the intracardiac signal. If the
EGM is fractionated, LATs may be inaccurate, which is typically the case for the CS-cath during
long-standing persistent AF, preventing the use of CS-cath dipoles for estimating their respective
finst. In contrast, the baseline signals recorded from the RAA and LAA rarely display fraction-
ation and are hence suitable for estimating finst. As a consequence, in this study, synchronous
baseline recordings of 10 sec from the HRAd and Lasso dipoles were included to estimate finst of
1. The technical characteristics of the catheters are presented in Section B.1 of Appendix B.
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the RAA and LAA respectively. Unfortunately, the number of synchronous recordings satisfying
the quality criterion for LATs detection was not sufficient to perform a robust analysis on the
entire population. As such, case studies were selected in order to investigate the correspondence
between the surface and intracardiac instantaneous frequencies.
8.2.2 Results
Time-invariant approach
Correlation values are reported in Table 8.1. Figure 8.3 shows the correlation between the
DF estimated from ECG chest leads V1 to V6b with that estimated from the LAA, RAA and CS
EGMs. The RAA DF (blue solid line) was best correlated with chest lead V1 (r = 0.9, p < 0.001),
and this correlation progressively dropped until V5 (r = 0.37, p < 0.05) with a moderate rise
for V4 and V6b (r = 0.56 and r = 0.73, p < 0.001). Interestingly, the LAA DF (green solid
line) showed the opposite pattern with the highest correlation in V6b (r = 0.90, p < 0.001) and
the lowest one in V2 (r = 0.09, p = ns). The correlation between the LAA DF and the one
estimated on V1 was moderate (r = 0.59, p < 0.005). Among the dipoles of the CS (dashed
lines), the correlation pattern with the ECG leads was divergent. Two groups of dipoles could be
identified. The first one was composed of the dipole CS9−10 (red dashed dot line) which was best
correlated with the precordial leads V1 (r = 0.58, p < 0.001) and V6b (r = 0.68, p < 0.001). The
remaining dipoles of the CS constituted the second group. These dipoles had similar correlation
coefficients on all ECG precordial leads, with the highest correlation on chest leads V1 and V6b
(r  0.5, p < 0.05 and r  0.6, p < 0.001 respectively).
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Figure 8.3: Pearson’s correlation coefficients between all ECG precordial leads (x axis) and
intracardiac sites LAA (green solid line with circle markers), RAA (blue squared marked solid
line) and CS (dashed lines).
The correlation values between each combination of ECG chest leads indicated a strong
correlation between the subgroup of leads V1, V2, and V3. Chest lead V4 was strongly correlated
with leads V1 and V3 (r = 0.73, and r = 0.66 respectively p < 0.001), while its correlation
with lead V2 was moderate (r = 0.49, p < 0.005). Interestingly, the dorsal lead V6b was highly
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correlated with chest lead V1 (r = 0.71, p < 0.001) and reasonably correlated with lead V5
(r = 0.55, p < 0.05).
Figure 8.4 shows the correlation between the DF estimated from the LAA (green line) and
RAA (blue line) with that from each CS dipole (x-axis). The correlation coefficient pattern
for both appendages appeared similar. The correlation coefficients on dipoles CS1−2 and CS3−4
were slightly higher for the LAA as compared to the RAA (for the LAA, r = 0.7, p < 0.001 and
r = 0.75, p < 0.001, while for the RAA r = 0.62, p < 0.001 and r = 0.7, p < 0.001 respectively).
As the CS dipoles were highly correlated with both appendages, we then tested whether the
LAA and RAA DFs displayed some correlation as well. The correlation coefficient between both
appendages was indeed high (r = 0.74, p < 0.001).
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Figure 8.4: Pearson’s correlation coefficients between all CS dipoles (x axis) and the LAA (green
line with circle markers) and RAA (blue squared marked line).
Time-varying approach
In order to illustrate the correspondence between the instantaneous frequencies estimated
from the surface ECG and that from both appendages, 10 sec recordings of two LT patients were
selected. Figures 8.5 and 8.6 illustrate the estimated instantaneous frequencies for the two case
studies. The correspondence between the instantaneous frequencies estimated from ECG lead
V1 and that from the distal dipole of the HRA catheter placed within the RAA is illustrated in
Figure 8.5a for the first case study and Figure 8.6a for the second one. Also, the correspon-
dence between the instantaneous frequencies estimated from the dorsal lead V6b and that from
the dipoles of the Lasso catheter placed within the LAA are displayed in Figure 8.5b for the first
case study and Figure 8.6b for the second one.
On all figures, the display is the following: the top plot shows the 10 sec recording of the
considered ECG chest lead in blue and the corresponding signal after QRST subtraction in black.
The middle plot displays the 10 sec recording of the intracardiac dipoles with their corresponding
LATs (circle markers). The bottom plot illustrates the instantaneous frequencies estimated from
the ECG chest lead ( finstECG , black solid line with square markers), and all intracardiac dipoles,
8.2 Intracardiac contribution to ECG fibrillation waves 103
V1 V2 V3 V4 V5 V6b RAA LAA
V1 - 0.67 ‡ 0.63 ‡ 0.73 ‡ 0.34 0.71 ‡ 0.90 ‡ 0.59 †
V2 0.67 ‡ - 0.79 ‡ 0.49 † -0.12 0.14 0.46 ∗∗ 0.09
V3 0.63 ‡ 0.79 ‡ - 0.66 ‡ -0.09 0.15 0.47 ∗∗ 0.36 ∗
V4 0.73 ‡ 0.49 † 0.66 ‡ - 0.37 ∗ 0.43 ∗ 0.56 ‡ 0.23
V5 0.34 -0.12 -0.09 0.37 ∗ - 0.55 † 0.37 ∗ 0.33
V6b 0.71 ‡ 0.14 0.15 0.43 ∗ 0.55 † - 0.73 ‡ 0.90 ‡
CS1−2 0.50 ∗∗ 0.12 0.21 0.24 0.41 ∗ 0.68 ‡ 0.62 ‡ 0.70 ‡
CS3−4 0.51 † 0.14 0.16 0.18 0.35 0.67 ‡ 0.70 ‡ 0.75 ‡
CS5−6 0.48 ∗∗ 0.18 0.23 0.24 0.36 ∗ 0.65 ‡ 0.64 ‡ 0.54 †
CS7−8 0.37 ∗ 0.07 0.18 0.17 0.37 ∗ 0.61 ‡ 0.53 † 0.54 †
CS9−10 0.58 † 0.31 0.40 ∗ 0.37 ∗ 0.21 0.68 ‡ 0.62 ‡ 0.65 ‡
RAA 0.90 ‡ 0.46 ∗∗ 0.47 ∗∗ 0.56 ‡ 0.37 ∗ 0.73 ‡ - 0.74 ‡
LAA 0.59 † 0.09 0.36 ∗ 0.23 0.33 0.90 ‡ 0.74 ‡ -
Table 8.1: Person’s correlation coefficients between the DF estimed at the CS, RAA, and LAA
and ECG precordial leads. The significance level of correlation is indicated (∗ : p < 0.05,
∗∗ : p < 0.01, † : p < 0.005 and ‡ : p < 0.001).
finstEGM . The time intervals highlighted in gray correspond to epochs where the absolute differ-
ence between finstECG and finstEGM was ≤ than 0.2 Hz, which is indicative of a good correspondence
between the ECG and intracardiac instantaneous frequencies.
For the first case study (Figure 8.5), an adequate match during the 10 sec window can be
observed between the instantaneous frequencies estimated from the ECG and those from both
appendages. More specifically, the correspondence between the instantaneous frequencies esti-
mated from the Lasso dipoles and the dorsal lead V6b was more consistent than those from the
HRAd dipole and ECG chest lead V1. Importantly, on both figures, the variations over time of
finstECG and finstEGM were highly similar. Interestingly, on Figure 8.5a, at t = 6.4 sec, finstHRAd
increased up to 5.9 Hz while finstV1 increased to 5.6 Hz. Then, at t = 7 sec, finstHRAd suddenly
dropped while finstV1 remained stable. However, at t = 7.3 sec finstV1 also dropped and matched
with finstHRAd . In Figure 8.5b, the finstEGM computed from the four dipoles of the Lasso within the
LAA increased to 5.6 Hz, while finstV6b decreased to 5.3 Hz at t = 7.3 sec.
For the second case study (Figure 8.6), periods of adequate match between the instantaneous
frequencies estimated from the ECG and those from both appendages were shorter than those for
the first case study. During the first three seconds, finstHRAd (Figure 8.6a) varied between 4.8 Hz
and 5.9 Hz with multiple maxima and minima, while the instantaneous frequency estimated from
the ECG lead V1 decreased almost monotonically from 5.7 Hz to 5.4 Hz. Then, the instantaneous
frequencies variations from lead V1 and that from HRAd matched until t = 5 sec, with a signif-
icant decrease in both values. Interestingly, this frequency drop was not perceived within the
LAA (Figure 8.6b) suggesting that the RAA was not remotely driving the LAA.
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Figure 8.5: Illustrative examples of the instantaneous frequencies estimated from the ECG and
intracardiac EGMs, first case study. Figure (a) illustrates the instantaneous frequency estimated
from ECG lead V1 and that from the HRAd placed within the RAA. Figure (b) displays the
instantaneous frequency estimated from the dorsal lead V6b and that from four dipoles of the
Lasso placed within the LAA. Top plots: 10 sec recording from the ECG lead (blue) after QRST
subtraction (black). Middle plots: synchronous recordings from the intracardiac dipoles. Bottom
plots: finstECG (black squared marked line) and finstEGM (colored lines). The periods in gray denote
when | finstECG − finstEGM | ≤ 0.2 Hz.
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Figure 8.6: Illustrative examples of the instantaneous frequencies estimated from the ECG and
intracardiac EGMs, second case study. Figure (a) illustrates the instantaneous frequency esti-
mated from ECG lead V1 and that from the HRAd placed within the RAA. Figure (b) displays
the instantaneous frequency estimated from the dorsal lead V6b and that from three dipoles of the
Lasso placed within the LAA. Top plots: 10 sec recording from the ECG lead (blue) after QRST
subtraction (black). Middle plots: synchronous recordings from the intracardiac dipoles. Bottom
plots: finstECG (black squared marked line) and finstEGM (colored lines). The periods in gray denote
when | finstECG − finstEGM | ≤ 0.2 Hz.
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8.2.3 Discussion
Time-invariant approach
Over the last two decades, many studies have established the correspondence between the
atrial activity measured from the surface ECG with that of various intracardiac segments. These
studies are summarized in Table 8.2.
Correspondence between surface ECG and intracardiac activity. All reported studies have
shown that RA activity during AF is a major contributor to the f-waves recorded from chest lead
V1 [16, 20, 55, 57, 58, 65, 84–86]. Dibs et al. have shown that the strongest correspondence
between RA activity and ECG chest leads was found on V2 and that the LA activity was mostly
correlated with that of chest leads V4 and V6 [65]. Petrutiu et al. extended these findings by
showing that posterior leads were best correlated with LA activity [55]. Recently, Guillem et al.
reported a detailed study of the correlation between intracardiac atrial and body surface DFs map
in patients with persistent AF [86]. They found a high correlation between the region covered by
lead V1 and RA DF, and the posterior paravertebral region and the LA DF. In our study, a strong
correlation was found between RAA activity and the DF measured on lead V1, and between LAA
activity and the DF of dorsal lead V6b, which is in line with the results of these recent studies.
Regarding the correspondence between the activity measured from the CS and that from the
surface ECG, the results reported in the literature are contradictory. On one hand, some studies
have shown a strong correlation between the activity of the proximal, mid-portion and distal
segments of the CS and that from chest lead V1 [14, 16, 58, 65, 95]. On the other hand, Holm et
al. found a poor correlation between the frequency content measured at the proximal part of the
CS and that of ECG chest lead V1 [57]. These results should be, however, interpreted with care
as the CS follows the curvature of the LA and of the left ventricle that might have "polluted" the
atrial signal. In our study, a moderate correlation was found between the DF estimated from the
proximal and distal dipoles of the CS-cath and that of ECG chest lead V1. In fact, the correlation
level of the proximal CS-cath dipole with V1 was similar to that of the LAA with V1. Importantly,
the correlation of all CS-dipoles was slightly stronger for the dorsal lead V6b as compared to the
remaining ECG chest leads.
Other correspondences. To the best of our knowledge, no study has investigated the cross-
correlation of intracardiac segments or the cross-correlation between the ECG chest leads. In
our study, we found that the DFs estimated from the proximal and distal dipoles of the CS-cath
were strongly correlated with the DFs from the RAA and LAA. The correlation was, however,
stronger on the distal dipoles of the CS-cath with the LAA than with the RAA.
The significant correlations obtained on the CS-cath with lead V6b and with several intracar-
diac segments might be slightly surprising. Indeed, the ECG lead V6b is not directly facing the
CS-cath. We hypothesized that these findings are a result of an indirect correlation from both
appendages.
Regarding the correlation between each combination of ECG lead, a significant correlation
was found between the first four precordial leads V1 to V4, as these leads are placed close to
each other on the patient’s chest. Surprisingly, the correlation between chest lead V1 and the
dorsal lead V6b was strong. In summary, we have the following; a) the correlation between
both appendages was high, b) the activity from V1 corresponded to the activity from the RAA,
and c) the frequency content from the dorsal lead V6b was strongly correlated with that of the
LAA. Thus, we hypothesized that the correlation observed between ECG leads V1 and V6b is a
consequence of their respective correlations with both appendages and the significant correlation
between the LAA and the RAA.
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Appendages
Leads Correspondence RAA LAA
V1
Strong
Holm et al. [57] Matsuo et al. [20]
Bollmann et al. [16] Platonov et al. [85]
Hsu et al. [84]
Petrutiu et al. [55]
Matsuo et al. [20]
Platonov et al. [85]
Raitt et al. [58]
Poor Hsu et al. [84]Petrutiu et al. [55]
V2 Strong Dibs et al. [65]
V4 Strong Dibs et al. [65]
V6 Strong Dibs et al. [65]
Posterior Strong Petrutiu et al. [55]Guillem et al. [86]
(a)
CS
Leads Correspondence Proximal Middle Distal
V1 Strong
Dibs et al. [65] Bollmann et al. [16] Walters et al. [14]
Raitt et al. [58] Husser et al. [95]
Walters et al. [14]
Poor Holm et al. [57]
(b)
Table 8.2: Studies on the correspondence of atrial activity measured from the surface ECG and
that from the atrial appendages (a) and from the CS (b).
Time-varying approach
In Chapter 7, a novel method for characterizing the dominant component of atrial ECG sig-
nals was presented. The output of the adaptive scheme estimates the ECG atrial f-waves dominant
component and its first harmonic. In the present chapter, a method for computing the instanta-
neous frequency of intracardiac signals was presented.
Typically, the frequency content of intracardiac signals is assessed by computing the DF us-
ing a time-invariant scheme. This approach, however, is not appropriate for characterizing the
variations of the intracardiac DF over time. We reported two study cases, in which the instanta-
neous frequencies were estimated from catheters placed within the RAA and the LAA. The ECG
instantaneous frequency was highly similar to the intracardiac instantaneous frequencies. More
specifically, the instantaneous frequency estimated from ECG leads V1 and V6b had similar val-
ues with that of the RAA and LAA respectively. Importantly, there was a high correspondence
in the temporal variations of the ECG and intracardiac instantaneous frequencies. Some discrep-
ancies were observed punctually between the ECG and intracardiac instantaneous frequencies
suggesting the existence of a remote driver located in another atrial segment and not perceived
by the ECG electrode.
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8.3 Baseline dominant frequency mapping
8.3.1 Methods
Sequential mapping of the LA was performed following the baseline acquisition protocol
described in Section 5.2.3 at page 47. For convenience, the sequential acquisition is briefly
repeated here.
Within the LA, the Lasso was placed consecutively in a stable position for a minimum dura-
tion of 20 seconds at thirteen different locations:
– The ostium of the four PVs.
– The base of the LAA.
– The anterior and posterior parts of the roof.
– The middle and inferior parts of the posterior wall.
– The mitral isthmus.
– The superior, middle and inferior parts of the septum.
In addition to these locations, the recordings acquired at baseline with the distal pole of the
HRA catheter placed within the RAA as well as the recordings from all dipoles from the CS-cath
were considered.
The DF of each bi-atrial location was computed as presented in Section 8.1. For the Lasso,
the DF was spatially averaged when computed on multiple dipoles. The epoch duration of this
study was set to 10 sec. The intracardiac DF was then temporarily averaged for each patient.
Finally, the mean and standard deviation DF values were estimated for the LT and NLT groups.
Two statistical analyses were performed. The first one assessed the statistical significance
between the average DF of the two groups using the ANOVA framework. Levels of statistical
significance were set to 0.05, 0.01, 0.005 and 0.001. The second statistical analysis was aimed at
studying the presence at baseline of an inter-atrial gradient within each group. More specifically,
the inter-atrial gradient between appendages was estimated as the DF difference between LAA
and RAA. Within each group, the significance level of the inter-atrial gradient was assessed
through a one-tailed t-test for values of DF gradients ranging from 0.2 to 1 Hz. The level of
statistical significance was set to 0.05.
8.3.2 Results
Baseline bi-atrial DF mapping
Table 8.3 reports the mean ± standard deviation of the DF computed on each bi-atrial seg-
ment. If the ANOVA test declared a significant difference, the corresponding level is indicated:
∗ : p < 0.05, ∗∗ : p < 0.01, † : p < 0.005 and ‡ : p < 0.001.
Figure 8.7 shows the distribution of DF values for the LT (blue) and NLT (red) groups for all
dipoles estimated within the CS. The average DF was significantly lower for the LT group than
for the NLT one on all CS dipoles (except CS1−2). The most significant difference was found on
the CS9−10 dipole.
Figure 8.8 shows the distribution of DF values for the LT (blue) and NLT (red) groups for
all mapped structures within both atria (RAA, LAA, and the four PVs). The average DF was
significantly lower for the LT group than for the NLT one in all mapped structures. Interestingly,
the level of statistical significance was more pronounced for the superior PVs than for to the
inferior ones. Concerning the atrial appendages, the most significant difference between the
groups could be observed within the RAA (p < 0.001, while for the LAA p < 0.05). For the
LT patients, one can observe that the average DF within the LAA (5.78 ± 0.66 Hz) was slightly
higher than the mean DF within the RAA (5.61 ± 0.66 Hz) suggestive of a possible LA driver.
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It was the opposite for the NLT group, as the average DF within the RAA (6.60 ± 0.55 Hz) was
higher than that of the LAA (6.49 ± 0.68 Hz), suggestive in this case of a possible RA driver.
Figure 8.9 shows the distribution of the DF values for the LT (blue) and NLT (red) groups for
all LA segments. The DF values of the LT patients were significantly lower than that of the NLT
patients for each LA segment, except for the inferior part of the septum.
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Figure 8.7: Distribution of the baseline DF within the CS for the LT (blue) and NLT (red) groups
(∗ : p < 0.05, ∗∗ : p < 0.01, † : p < 0.005 and ‡ : p < 0.001).
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Figure 8.8: Distribution of the baseline DF within the RAA, LAA and the four PVs for the LT
(blue) and NLT (red) groups (∗ : p < 0.05, ∗∗ : p < 0.01, † : p < 0.005 and ‡ : p < 0.001).
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Figure 8.9: Baseline left atrium DF mapping.
Dominant frequency [Hz] Dominant frequency [Hz]
LT NLT LT NLT
CS1−2 5.55 ± 0.93 6.15 ± 0.38 Anterior roof 5.61 ± 0.61 6.41 ± 0.56†
CS3−4 5.40 ± 0.84 6.14 ± 0.53∗ Posterior roof 5.66 ± 0.65 6.38 ± 0.44∗∗
CS5−6 5.47 ± 0.73 6.01 ± 0.60∗ Mid-posterior 5.62 ± 0.63 6.33 ± 0.47†
CS7−8 5.39 ± 0.66 5.91 ± 0.63∗ Posterior inferior 5.53 ± 0.50 6.23 ± 0.53†
CS9−10 5.17 ± 0.64 5.94 ± 0.51† Mitral isthmus 5.57 ± 0.67 6.34 ± 0.46†
RAA 5.61 ± 0.66 6.60 ± 0.55‡ High septum 5.58 ± 0.55 6.20 ± 0.55∗∗
LAA 5.78 ± 0.66 6.49 ± 0.68∗ Mid-septum 5.44 ± 0.64 6.05 ± 0.65∗
LSPV 5.72 ± 0.62 6.46 ± 0.40† Inferior septum 5.39 ± 0.56 5.79 ± 0.74
LIPV 5.76 ± 0.82 6.74 ± 0.35∗∗
RSPV 5.51 ± 0.74 6.42 ± 0.44†
RIPV 5.48 ± 0.74 6.18 ± 0.48∗
Table 8.3: Distribution of the baseline DF at various LA segments for the LT and NLT groups
(∗ : p < 0.05, ∗∗ : p < 0.01, † : p < 0.005 and ‡ : p < 0.001).
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Baseline inter-atrial frequency gradient
Figure 8.10 shows the statistical significance levels (p-values) of the inter-atrial DF gradient
for the LT (blue solid line) and the NLT (red solid line) groups as a function of the variations in
Hertz of the inter-atrial gradient denoted as ∇DF. The bottom green area represents a significant
statistical level < 0.05. For the LT (blue solid line) and NLT (red solid line) groups, no significant
LA-to-RA frequency gradient was observed. As the results of the bi-atrial DF mapping showed
that for the NLT group the average DF within the RAA was slightly larger than that within the
LAA, the same statistical analysis was performed, but the inter-atrial gradient was defined as the
DF difference between the RAA and the LAA as shown by the red dashed line. For the NLT
patients, no significant RA-to-LA gradient was observed.
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Figure 8.10: Statistical significances of the LAA to RAA DF gradient for the LT (blue solid line)
and NLT (red solid) groups as a function of the variations in Hertz of the inter-atrial gradient
(∇DF). The bottom green area represents statistical significance level < 0.05. The red dashed
line shows the statistical significance levels for the NLT group when the inter-atrial gradient was
defined as the difference between the RAA and LAA DFs.
8.3.3 Discussion
Baseline bi-atrial DF mapping
The intracardiac DF has been used as an estimate of the local underlying atrial activation rate
during AF. Many electrophysiological studies have used the DF of intracardiac recordings as a
tool for understanding the pathophysiology and dynamics of AF in humans [13, 14, 87, 88]. One
such approach has been used to map the activation rates in the frequency domain throughout the
atria. Sahadevan et al. reported a detailed study of intra-operative mapping in patients with long-
standing persistent AF [87]. These patients manifested a rapid, regular rhythm, most exclusively
located at the posterior wall of the LA, whereas the rest of the atria was characterized by irregular
electrograms, suggesting that local drivers (rotors) may be responsible for maintaining chronic
AF. Using an animal model, it was shown that the DFs of the rotors were of high frequency
values [88]. Moreover, in patients with persistent AF, a higher DF in the LA has been associated
to a greater degree of electroanatomical remodeling and slowing of atrial conduction [13, 14].
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More recently, the DF was used as a tool for assessing the change of AF dynamics during
catheter ablation [67, 89, 90, 96]. In [96], Sanders et al. showed that in patients with permanent
AF, sites of high frequency activity were localized in several segments of the atria, including RA
sites, and that ablation at these specific sites resulted in a significant slowing of the fibrillatory
process. Others reported that in patients with permanent AF, freedom from recurrent AF was
associated with a significant reduction in the DF measured from the CS [67, 89, 90].
To the best of our knowledge, studies investigating the baseline intracardiac DF as a predic-
tor of procedural AF termination are scarce, in particular for patients with non-paroxysmal AF.
In [90], the baseline DF measured from the CS in patients with persistent AF was similar, regard-
less of the procedural outcome during catheter ablation. Another study showed that in patients
with non-paroxysmal AF, a lower average DF acquired from the RA was associated with acute
AF termination by catheter ablation [92].
In our study, we measured the baseline DF in several segments of the atria including the
right and left atrial appendages, the CS, the four pulmonary veins, the mitral isthmus, the LA
roof, the posterior wall and septum. In all mapped atrial locations, we found that a significant
lower baseline DF was associated to termination of long-standing persistent AF during stepwise
catheter ablation. Patients in whom ablation failed to terminate AF had, on average, a signifi-
cantly higher DF as compared to patients in whom AF was terminated. These results suggest that
the electroanatomical remodeling in NLT patients was more important than that of LT patients.
Baseline inter-atrial frequency gradient
Lazar et al. showed that patients with paroxysmal AF displayed a significant LA-to-RA
frequency gradient of 1.1 ± 0.7 Hz, which was absent in patients with long-lasting persistent
AF [91]. The DF recorded within the RA was significantly higher for the chronic AF group
compared to the paroxysmal group. In another study, patients with persistent AF showed no
significant LA-to-RA DF gradient [55]. Conflicting results, however, were reported by Dibs et al
who observed a mean LA-to-RA DF gradient of 0.4± 0.2 Hz in patients with persistent AF [65].
In our study, no significant LA-to-RA frequency gradient was observed for the LT and NLT
groups. Moreover, for the NLT group, the average RA DF was slightly higher than that of
the LA, however, no significant RA-to-LA gradient for these patients was found. One possible
reason for our divergent results with those of Dibs et al. may come from differences in patients
characteristics. Our study population had on average an AF sustained for 19 ± 11 months, while
Dibs et al. included nine patients with sustained durations of AF varying between one month and
more than one year [65].
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In the first part of this chapter, we have shown that the contributions of the RA and LA during
AF can be independently determined using specific regions of the thorax, and that the main con-
tributors to the surface ECG f-waves come from the appendages rather than that from the smooth
parts of the atria such as the CS. We have also demonstrated that the temporal variations of the
ECG instantaneous frequency estimated from the outputs of the adaptive scheme corresponds to
a high degree with that of intracardiac instantaneous frequencies.
In the second part of this chapter, we observed that the electroanatomical remodeling in NLT
patients is higher than that in LT patients. Also, no inter-atrial DF gradient was observed in both
group. Taken together, these observations suggest that the frequency of the atrial activation rate
in long-standing persistent AF is predictive of the procedural outcome during stepwise catheter
ablation and that it is also an indicator of the degree of electroanatomical remodeling.
In conclusion, the analysis of intracardiac AF signals frequency spectra provides valuable
insights into its dynamics, and it appears as a promising clinical tool for predicting the procedural
outcome during catheter ablation of patients with long-standing persistent AF.
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Variability of Atrial
Activation Intervals 9
Prior studies on animals and humans have shown that during AF, the average interval between
local depolarizations, the so-called intracardiac AFCL, approximates the local atrial refractori-
ness [10–12]. A very good correlation was established between local atrial refractory periods
and the AFCL measured at the same atrial location [10–12]. Hence, the AFCL estimated from
various endocardial sites has been widely used as a useful clinical tool for monitoring the ef-
fect of substrate modification during AF catheter ablation [6, 49, 50, 97–100]. In all reported
studies, a gradual increase of the intracardiac AFCL during ablation was associated with AF
termination. Conflicting results were, however, reported regarding the ability of intracardiac
AFCL to assess AF organization before step-CA [6, 49, 100–103]. For instance, baseline AFCL
was found significantly longer in patients in whom long-standing persistent AF terminated dur-
ing step-CA [49, 101], while in persistent AF continuing despite PVI, the baseline AFCL did
not differ between patients whose long-standing persistent AF did and did not terminate [100].
Other studies reported that, in patients with persistent AF, the baseline intracadiac AFCL was not
predictive of the procedural outcome [99, 102]. Thus, in this chapter, we aim at characterizing
the intracardiac AFCL prior to ablation in patients with long-standing persistent AF.
According to the multiple wavelet hypothesis (Section 3.5.2 page 30), the presence of regular
reentrant circuits is associated to a higher degree of organization [35–37]. A longer mean AFCL
is suggestive of a high organization. During AF, intracardiac electrograms are characterized by
short and variable atrial intervals and, thus, display irregular activations. The AFCL is computed
as the average interval between local depolarizations and is therefore not suitable for reflecting
the variability of these intervals. In this chapter, we hypothesize that the temporal variability
of atrial activation wavefronts around the mean AFCL before ablation may help characterizing
the AF dynamics and furthermore, may help identifying patients whose long-standing persistent
AF will terminate within the LA during stepwise catheter ablation. This approach evaluates the
oscillations of time intervals between consecutive AF wavefronts similarly to that of heart rate
variability analysis [104].
This chapter is organized as follows. Section 9.1 presents the signal processing steps for
characterizing the variability of atrial activation waveforms and Section 9.2 presents the material
used for this study. The results are provided in Section 9.3. Finally, Secion 9.4 covers the
discussion for the current study.
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9.1 Characterization of the variability of atrial activation in-
tervals
The signal processing steps for characterizing the variability of atrial activation waveforms
are described here. First, the LAT was defined as described in the previous chapter in Sec-
tion 8.1.2. Namely, the LAT was set as the time of the maximum positive peak of each activation
wave detected using sliding windows of 150 ms. False detections were removed using temporal
and amplitude thresholding. The upper plot in Figure 9.1 illustrates a 20 sec epoch acquired from
the HRAd dipole placed within the RAA in an LT patient with its detected LATs (red dot). The
bottom plot shows an excerpt of two seconds.
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Figure 9.1: Intracardiac local activations times and instantaneous AFCL. The top plot illustrates
a 20 sec epoch acquired from the HRAd dipole placed within the RAA in an LT patient with its
detected LATs (red). The bottom plot shows an excerpt of two seconds. The numbers displayed
between consecutive LATs indicate the corresponding duration of interval in milliseconds.
Let N be the total number of LATs in a given signal. We set δk (Figure 9.1, bottom plot) as
the time difference between two consecutive LATs:
δk = LATk − LATk−1 (9.1)
where k = 2, · · · ,N. The value of δk corresponds to the instantaneous AFCL of the consec-
utive atrial activation waveforms k − 1 and k. In the example displayed in Figure 9.1, the values
of δk are not constant during this 20 sec epoch; faster intervals alternate with slower ones. In
the bottom plot, the numbers indicate the value in milliseconds of five consecutive δk. It can
be observed that at t ≈ 11.5 sec the instantaneous AFCL slows down to 262 ms and that three
wavefronts after, at t = 12.5 sec, δk = 169 ms.
The intracardiac AFCL is classically computed as the mean difference in LATs. In this ex-
ample, the estimated AFCL value was 179 ms. This value is much lower than the instantaneous
difference observed in Figure 9.1 at t ≈ 11.5 sec which can be therefore interpreted as a local
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Figure 9.2: Resampled instantaneous AFCL computed from the signal displayed in Figure 9.1.
The blue horizontal dashed-dotted line corresponds to the average AFCL.
slowing down of the instantaneous AFCL with respect to the average AFCL.
In order to characterize the variability of the instantaneous AFCLs around the average AFCL,
we defined the set of data points (Figure 9.2, bottom plot) as:xk = LATk + δk/2,yk = δk (9.2)
The resampled instantaneous AFCL (AFCLRI) was defined as the cubic interpolation of these
data points at a regular sampling frequency of 20 Hz. From equation (9.2), the mean of AFCLRI
corresponds to the AFCL. The top plot of Figure 9.2 shows the AFCLRI computed for the in-
tracardiac signal shown in Figure 9.1, while the bottom plot of Figure 9.2 displays an excerpt
of two seconds in the same interval as in the bottom plot of Figure 9.1. The blue horizontal
dashed-dotted line corresponds to the average AFCL. It can be observed that the local slowing
down of the instantaneous AFCL identified at time ≈ 11.5 sec is emphasized by an abrupt rise of
the AFCLRI which lies above the mean AFCL.
In order to characterize the variability of the atrial activation intervals, the AFCLRI PSD was
estimated using Welch’s method (Hamming window of length of 512 samples, 50% overlap).
Let L be the number of power spectrum density estimates, f and p be the vectors of frequency
and power spectral density estimates. Two indices were computed:
1. The mean frequency µ f :
µ f =
∑L
i=1 pi fi∑L
i=1 pi
[Hz] (9.3)
From equation (9.3), µ f quantifies the mean frequency at which the AFCL oscillates. Low
values of µ f are indicative of a slower temporal variability of LATs, and consequently of a
higher organization.
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Figure 9.3: PSD of the resampled instantaneous AFCL computed in Figure 9.2. The values of
µ f and σ2f are indicated.
2. The variance σ2f
σ2f =
∑L
i=1 pi( fi − µ f )2∑L
i=1 pi
[Hz2] (9.4)
From equation (9.4), σ2f characterizes the spread of µ f . Low values of σ
2
f are indicative
of a stable µ f , i.e., a more regular variability; conversely, large σ2f values reflect a more
erratic variability.
Figure 9.3 shows the PSD of the AFCLRI computed in Figure 9.2. In this example, µ f =
0.66 Hz and σ2f = 0.32 Hz
2.
9.2 Material
The average AFCL, µ f and σ2f were computed on 20 sec epochs duration from recordings
acquired at baseline from the HRAd placed within the RAA and from the Lasso placed within
the LAA 1. For the Lasso, when the computation was performed on multiple dipoles, the corre-
sponding indices were spatially averaged on all available dipoles. Then, for each measure, the
temporal mean was computed resulting in one value for each measure, subject and intracardiac
location.
The statistical significance between the two groups and within each group was assessed
through the ANOVA framework. Levels of statistical significance were set to 0.05, 0.01, 0.005
and 0.001.
1. It is important to mention that in this study, the signals acquired from the CS-cath were not used because for only a
few number of patients were signals of sufficient quality available for correctly detecting the LATs. Most of the patients
of our study population displayed a considerable amount of signal fractionation at the CS. Our scheme for detecting the
LATs is not appropriate in case of high fractionation.
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9.3.1 Illustrative examples
Figure 9.4 displays representative examples of AFCLRIs from an LT (blue solid line with
circle markers) and an NLT (red solid line with plus sign markers) patients 2. The mean AFCL
for the LT patient was of 179 ms, while for the NLT patient, the mean AFCL was smaller, 152 ms.
Note the presence of high frequency oscillations in the AFCLRI for the NLT patient. In contrast,
the AFCLRI for the LT patient appeared more regular, with less rapid oscillations.
Figure 9.5 shows the normalized AFCLRI PSD for the LT (blue solid line) and for the NLT
patient (red dashed line). The PSD estimates for the LT patient were mostly concentrated below
2 Hz with low values for µ f and σ2f (0.66 Hz and 0.32 Hz
2 respectively) as opposed to the NLT
patient displaying a widespread PSD distribution with higher µ f and larger σ2f (1.26 Hz and
0.87 Hz2 respectively).
As a parenthesis, for both patients, a predominant peak in the lower frequencies can be ob-
served (≈ 0.3 Hz for the LT patient and ≈ 0.08 Hz for the NLT patient). One might argue that
the presence of this peak is due to modulation induced by the respiration. However, all patients
underwent the ablation under general anaesthesia and consequently the respiration was regulated
by mechanical ventilation at a frequency of ≈ 0.2 Hz. Due to the lack of experiments describing
this modulation in anaesthetised patients, one cannot draw a clear interpretation as to the origin
of the oscillations around 0.3 Hz. The lower oscillations for the NLT patient could be a manifes-
tation of the fluctuations of the arterial pressure regulation [105]. However, this phenomenon has
not extensively been studied in anaesthetised patients. Therefore, no clear interpretation can be
drawn from these illustrative examples regarding the exact nature of these observations. It must
be noted that this aspect is clearly beyond the scope of the present work.
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Figure 9.4: Representative examples of AFCLRI signals for an LT (blue solid line with circle
markers) and an NLT (red solid line with plus sign markers) patients. The mean AFCL for the
LT patient is of 179 ms, while for the NLT patient, the mean AFCL is smaller, 152 ms.
2. The LT patient is the same as the one used in Section 9.1
120 Variability of Atrial Activation Intervals
0 1 2 3 4 5
0
0.2
0.4
0.6
0.8
1
Frequency [Hz]
N
or
m
al
iz
ed
 P
SD
 
 
LT (µF = 0.66 Hz, σF = 0.32 Hz
2)
NLT (µF = 1.26 Hz, σF = 0.87 Hz
2)
Figure 9.5: Representative examples of the AFCLRI power spectrum density of an LT (blue
solid line) and an NLT patient (red dashed line). Note the broader spectrum for the NLT patient
indicative of a lower AF organization as compared to the LT patient.
9.3.2 Clinical results
Figure 9.6 and Table 9.1 report the mean ± standard deviation and median values of µ f (Fig-
ure 9.6a), σ2f (Figure 9.6b) and average AFCL (Figure 9.6c) for the LT (blue) and NLT (red)
groups computed at baseline within the RAA and LAA.
On both appendages, all indices were on average significantly different between the LT and
NLT groups. Before ablation, LT patients displayed significantly longer bi-atrial AFCL for both
LA and RA appendages. Likewise, LT patients displayed significantly smaller µ f and σ2f values
on both appendages as compared to NLT patients. Interestingly, for all organization indices,
the most significant differences between the LT and NLT groups were observed within the RAA
(p < 0.001).
For the LT group, the mean AFCL computed from the RAA (180 ± 22 ms) was similar to
that from the LAA (178 ± 25 ms), suggestive of a similar organization within both appendages.
Likewise, the average σ2f was similar within both appendages (0.56 ± 0.16 Hz2 for the RAA and
0.58 ± 0.17 Hz2 for the LAA). However, a tendency for a higher LAA µ f (0.98 ± 0.2 Hz) as
compared to the RAA one (0.89 ± 0.14 Hz, p = ns) was observed, suggesting that wavefront
variability was lower within the RAA. Thus, for the LT group, the average indices characterizing
the variability of atrial activation wavefronts indicated a higher organization within the RA as
compared to the LA.
For the NLT group, the mean AFCL computed from the RAA (151± 11 ms) was also similar
to that from the LAA (153 ± 13 ms). The average µ f was similar within both appendages (1.2 ±
0.17 Hz for the RAA and 1.22 ± 0.22 Hz for the LAA). However a tendency of larger RAA σ2f
(0.89 ± 0.17 Hz2) as compared to the LAA (0.78 ± 0.23 Hz2, p = ns) was observed, suggesting
that the variance of the oscillations around the mean AFCL was on average higher in the RAA
than in the LAA.
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Figure 9.6: Mean (circles) ± standard devation and median (squares) of the baseline µ f (a), σ2f (b)
and average AFCL (c) for the LT (blue) and NLT (red) groups computed on 20 sec epochs. If the
ANOVA test declared a significant difference, the corresponding level is indicated (∗ : p < 0.05,
∗∗ : p < 0.01, † : p < 0.005 and ‡ : p < 0.001).
RAA LAA
LT NLT LT NLT
µ f [Hz]
0.89 ± 0.14 1.20 ± 0.17 ‡ 0.98 ± 0.2 1.22 ± 0.22 ∗∗
(0.86) (1.25) (0.97) (1.13)
σ2f [Hz
2]
0.56 ± 0.16 0.89 ± 0.17 ‡ 0.58 ± 0.17 0.78 ± 0.23 ∗
(0.56) (0.94) (0.58) (0.85)
AFCL [ms]
180 ± 22 151 ± 11 ‡ 178 ± 25 153 ± 13 ∗∗
(180) (153) (175) (153)
Table 9.1: Mean ± standard deviations and median (in brackets) of µ f , σ2f and average AFCL
before ablation computed on 20 sec epochs at the RAA and LAA. If the corresponding ANOVA
declared a significant difference, the corresponding level is indicated (∗ : p < 0.05, ∗∗ : p < 0.01,
† : p < 0.005 and ‡ : p < 0.001).
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9.4 Discussion
The AFCL estimated from various endocardial locations has been widely used as a useful
clinical tool to monitor the effect of substrate change during AF catheter ablation [6, 49, 50, 97–
100]. Typically, the AFCL was monitored in one or both appendages [6, 49, 98, 99]. Some
studies also assessed the AFCL from the CS [6, 50, 97, 99, 100]. In all reported studies, a
gradual prolongation of the AFCL has been observed prior to AF termination. Divergent re-
sults were, however, reported regarding the ability of intracardiac AFCL estimated from baseline
recordings (i.e., before any ablation) to predict the procedural outcome of AF catheter abla-
tion [6, 49, 100–103]. Some studies have shown that the baseline AFCL estimated from both
appendages was significantly longer in patients in whom AF was terminated within the LA by
catheter ablation [6, 49, 98, 101, 103]. In contrast, other studies observed that the baseline in-
tracardiac AFCLs estimated from the CS and from both appendages were not predictive of the
procedural outcome [99, 102]. In another study, after the exclusion of AF of shorter duration, the
AFCL measured within the CS failed to predict AF termination in patients whose AF continued
despite PVI [100]. All reported studies, however, included patients with paroxysmal, persistent
or long-standing persistent AF of variable durations with assessment of AFCL at different atrial
locations. No definite explanation can be given for these discrepancies but one may hypothesize
that the AFCL from the CS reflects the composite activation of neighboring structures includ-
ing the CS itself, the left ventricle and the LA [106]. In our study, however, we found that the
baseline AFCL was significantly longer in both appendages in patients in whom AF terminated
by stepwise catheter ablation within the LA compared to patients in whom AF continued despite
extensive ablation.
In this chapter, we proposed to extend the analysis of the intracardiac AFCL by measuring
its variability using novel indices. These indices characterized the mean frequency (µ f ) and
variance (σ2f ) of the oscillations around the mean AFCL. We observed that LT patients displayed
a significantly lower variability of atrial activation wavefronts as compared to NLT patients in
both appendages, with a more significant difference within the RA. These results are suggestive
of a high temporal stability of the activation wavefronts within the appendages, and in particular
within the RA.
A recent study has proposed an index of AFCL stability based on the histogram of the inverse
of intervals between consecutive atrial activation wavefronts [107]. The authors observed that
when AF terminated into SR, it displayed higher AFCL stability than that of unterminated AF
during step-CA. Our results extend these findings by showing that the frequency of variation
and range of variability of atrial activation wavefronts offer potential discriminative values that
deserve further clinical validation.
Conclusion 10
Over the last twenty years, an important effort has been made by the scientific community to
develop measures of AF organization with the goal to provide a better understanding of the AF
pathophysiological mechanisms. Organization indices, such as the AFCL or the DF, have been
successfully used in clinical studies for quantifying the electrical remodelling [13–15], and for
predicting the response to pharmacologial or non-pharmacological AF cardioversion [16–20].
Despite these achievements in quantifying AF complexity, important aspects of AF therapeutic
management remain unclear, in particular in the context of AF catheter ablation of long-standing
persistent AF. Indeed, the performance of these "classical" organization indices computed on
ECG signals for predicting the acute outcome of catheter ablation appears limited. There is an
obvious need of a close collaboration between cardiologists and scientists. As an engineer in
biomedical science, it is our role to develop organization indices that can predict AF catheter ab-
lation from the surface ECG and consequently to provide an upstream tool for the cardiologists
to help establishing the appropriate therapeutic strategy. Importantly, these measures of organi-
zation must remain interpretable from an electrophysiological viewpoint. This multidisciplinary
collaboration has been the core spirit of the ASPG, whose collaboration with the CHUV has
been ongoing for more than two decades. Moreover, the work presented in this thesis could not
have been developed without former PhD theses accomplished through this partnership [77, 108].
First, the thesis completed by Mathieu Lemay was used to retrieve the ventricular activity from
ECG signals [108]. Then, the second thesis, which was used for the time-varying analysis of
ECG signals, was carried out by Jérôme Van Zaen, who developed efficient schemes for adaptive
frequency tracking [77]. The present dissertation can be considered as a continuation of these
past developments.
During this thesis, the first step consisted in defining the ablation and data acquisition pro-
tocols. From a clinical viewpoint, care was taken in establishing a detailed record of the patient
population characteristics. Among other clinical characteristics, the duration of sustained AF
was significantly lower in LT patients than in NLT ones. It was shown recently that a longer
AF duration favors a higher degree of AF complexity [109]. Given that the average sustained
duration was longer for NLT patients, the novel organization indices developed in this work from
intracardiac as well as from surface ECG signals were in agreement with this clinical observation.
The baseline DF was estimated at several atrial segments. In all mapped atrial locations, a
significant lower baseline DF was found in LT patients. Patients in whom catheter ablation failed
to terminate AF had, on average, a significantly higher bi-atrial DF than patients in whom AF
terminated. These observations are in agreement with the hypothesis of a higher complexity in
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NLT patients. Moreover, in patients with persistent AF, a higher intracardiac DF has been asso-
ciated to a greater degree of electroanatomical remodelling [13, 14]. Hence, higher bi-atrial DFs
for the NLT patients suggest that the electrical remodelling in these patients was more advanced
than that of LT patients. Furthermore, in patients with long-standing persistent AF, the presence
of a LA-to-RA gradient has been poorly characterized [55, 65]. In our study, no significant
LA-to-RA frequency gradient was observed for the LT and NLT groups. Our results suggest that
for this particular type of sustained AF, the LA-to-RA DF gradient cannot be associated with the
procedural outcome. The remodelling induced by atrial fibrillation also engenders a structural
remodelling in which the atria are enlarged, in particular the left one. The average left atrial
volume in our study population was large, however, it was non-significantly different between
LT and NLT patients. Taken all together, these observations suggest that, in patients with long-
standing persistent AF, a higher degree of electrical remodelling, rather than a large left atrial
volume, is associated to failure of terminating AF by stepwise catheter ablation.
The intracardiac AFCL estimated within both appendages prior to ablation was significantly
longer for LT patients than for NLT ones. The organization indices derived from the analysis
of the temporal variations of the atrial activation wavefronts extended these results. It was ob-
served that LT patients displayed in both appendages a significantly lower variablity of atrial
activation wavefronts than NLT patients. These results suggest that for patients in whom AF was
terminated, the temporal stability of the activation wavefronts within the appendages was higher
than for patients in whom AF persisted. We can thus hypothesize that the drivers responsible for
maintaining AF displayed different characteristics in terms of average frequency and temporal
stability in our study population. For LT patients, these drivers had a lower frequency of acti-
vation as well as a higher temporal stability, and consequently a lower complexity than for NLT
patients.
The main objective of this thesis was to derive organization indices from surface ECG signals.
These signals, after cancellation of the ventricular activity, reflect the global activity of the atria.
However, a correspondence between the activity recorded from the surface ECG and that from
intracardiac segments is clearly of valuable information for interpreting any results derived from
the analysis of ECG signals. As such, we have shown that the contributions of the right and left
atria during AF can be independently determined using specific regions of the thorax, and that
the main contributors to the surface ECG f-waves come from the appendages. More precisely,
a strong correlation was found between the RA activity and the DF measured on lead V1, and
between the LA activity and the DF on the dorsal lead V6b.
The ECG organization indices presented in the current dissertation were derived using time-
invariant and time-varying approaches. In both schemes, we hypothesized that a quantification
of the harmonic structure of AF signals brings more insight into the AF complexity compared
to assessing the DF. In the first scheme, the harmonic components of AF f-waves were extracted
using linear time-invariant filters. Such an approach is largely affected by the rapid temporal
variability of AF waveforms. As such, the adaptive harmonic frequency tracking algorithm is
more suitable for extracting the harmonic components of AF f-waves. Indeed, we have shown
through illustrative examples that the temporal variations of the instantaneous frequency of the
DF component were matching that of the intracardiac instantaneous frequency. In both schemes,
two indices were developed each of which aiming at quantifying the regularity of the f-waves
oscillations (OI and AOI) and the morphological regularity of the f-waves (TIPD and aPD). We
have shown that the ability of the organization measures derived from the adaptive scheme were
more robust for discriminating LT from NLT patients than those derived from the time-invariant
approach. The AOI and aPD were significantly different between the two groups on more epoch
durations and ECG leads than the OI and TIPD. The AOI and aPD are complementary indices
in terms of temporal and spatial performance. Indeed, for discriminating LT from NLT patients,
the AOI was statistically more robust on shorter epochs and on lead V1, while the aPD was
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statistically more robust on longer epochs and on the dorsal lead V6b. More precisely, the aPD
measured on the posterior lead V6b was significantly lower in LT patients compared to NLT
patients. As the left atrial activity was best reflected on the dorsal lead V6b, our results are
suggestive of a higher LA organization in patients whose AF can be terminated within the left
atrium. Also, our findings of a higher coupling between the DF and its first harmonic in the LT
population might be indirectly indicative of the presence within the LA of highly organized AF
sources, such as rotors. We have also shown that LT patients were successfully separated from
NLT ones by the AOI measured on lead V1. As the right atrial activity was best reflected on chest
lead V1, this finding suggests that for LT patients, the organization within the RA was higher than
for NLT patients. The discriminative cut-off value for classifying LT from NLT patients estimated
for the AOI was highest on V1 than on the remaining ECG leads. This result suggests that, within
the RA the spectral organization over time of the cyclicity of the AF harmonic components is
higher than that within the LA and is associated to AF termination. The cut-off value for the aPD
was highest on leads V1 and V6b, suggesting that a higher coupling between the DF and its first
harmonic within both atria is associated to AF termination. One can hypothesize that in patients
in whom AF can be terminated by catheter ablation, a highly organized LA source will drive the
RA in a more organized manner.
10.1 Summary of achievements
The major achievements of this thesis are summarized below.
Cinical study
The patient population in the current thesis is extremely homogeneous. Indeed, all patients
suffered from long-standing persistent AF. Most of the clinical studies aiming at characterizing
sustained AF include persistent and long-standing persistent AF in their study population. As
AF is a progressive disease, the pathophysiological mechanisms might be different for these two
types of AF. However, this rigorous inclusion criteria had a severe impact on the total number of
the patients.
In this study, we report a success rate of long-standing persistent AF termination within the
LA of 67%. Among the clinical characteristics of the study population, only the duration of
sustained AF was significantly different between the two groups. However, AF can be asymp-
tomatic, and therefore this duration can be wrongly assessed or even unknown in clinical practice.
The importance of ECG leads placement
In this thesis, it was decided to use a modified placement of the standard 12-lead ECG. As
such, chest lead V6 was placed in the back of the patient with the desire to improve the spatial
recording of the posterior part of the atria. The main contributors to the surface ECG f-waves
came from the activity in the atrial appendages. More precisely, a strong correlation was found
between the RA activity and the DF measured on lead V1, and between the LA activity and
the DF on the dorsal lead V6b. Measuring the LA activity non-invasively is essential, since the
triggers as well as the drivers responsible for maintaining AF are predominantly present in this
atrium.
Predicting AF catheter ablation outcome from the surface ECG
The organization indices derived from the adaptive harmonic frequency tracking algorithm
were suitable to characterize the different AF dynamics in our study population in order to pre-
dict the outcome of AF catheter ablation. They were appropriate for quantifying non-invasively
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the higher complexity in patients in whom catheter ablation failed to terminate AF than in pa-
tients in whom AF was terminated. The organization indices derived from the adaptive harmonic
frequency tracking algorithm are complementary measures in terms of temporal and spatial pre-
dictive performance. The harmonic frequency tracking algorithm used is not computationally
expensive, and as such, the estimation of the AOI or aPD could be implemented for a real-time
application, or on embedded devices.
Baseline atrial frequency mapping
The higher bi-atrial DFs for patients in whom catheter ablation failed to terminate AF indi-
cated that the electrical remodelling in these patients was more important than that of LT patients.
No LA-to-RA frequency gradient was observed in our study population. The results obtained
from the baseline DF analysis suggest that a higher degree of electrical remodelling is associated
to failure of terminating long-standing persistent AF by catheter ablation.
Characterization of the variability of atrial activation intervals
The AFCL measured from intracardiac signals reflects the average regularity of the local AF
dynamic. The characterization of the temporal variations of atrial activation wavefronts around
the mean AFCL provides an extension for assessing the local AF dynamic. The results from
this study suggested that for LT patients, the drivers responsible for maintaining AF had a lower
frequency of activation as well as a higher temporal stability than for NLT patients.
10.2 Perspectives
The novel ECG organization indices presented in this thesis can be used in different types of
acquisition systems or biophysical signals.
The data acquired during this thesis are unique in the sense that, for each patient, the record-
ing was continuous during the ablation procedure and the events were meticulously timestamped
and annotated. As a matter of fact, this implies that for each patient, between two to four hours of
continuous recordings are available. Consequently, the databases constructed for off-line analysis
have a great potential for future work, in particular for studying the evolution of AF organization
during catheter ablation.
The phase difference measure for detecting sleep apnea
In this thesis, an index measuring the phase coupling between two waveforms was presented.
In the present work, the two waveforms were the components characterizing the DF and its first
harmonic, which were extracted from an ECG AF signal. This index quantifying the phase syn-
chronization between these two waveforms was computed as the variance of the slope of their
phase difference. But this phase coupling index can be computed on other types of biophys-
ical signals. For instance, in a recent work published by our group, the phase coupling was
assessed between the respiration signal and the respiratory sinus arrhythmia (RSA) 1 in order to
detect sleep apnea episodes [110] 2. The gold standard in detecting sleep apnea is to make use of
polysomnography performed at a sleep laboratory, where the subject sleeps while wearing mul-
tiple and uncomfortable sensors [111]. Over 20 physiological signals such as nasal airflow, ECG
and the electroencephalogram are acquired and later manually analyzed by a specialist in order
1. RSA is a natural modulation of the heart rate induced by the respiration. This phenomenon is visible on the ECG
as a subtle modifications in the R-R interval in relation with respiration.
2. A medical definition of the sleep apnea syndrome is provided in Section A.1 of Appendix A
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to detect episodes of sleep apnea. These cumbersome acquisitions can be performed only in a
clinical facility, precluding therefore a widespread tool for diagnosing sleep apnea. In contrast,
in our work [110], the ECG and respiration waveforms were acquired during a night sleep using
an instrumented t-shirt worn by the subjects [112]. During normal breathing, the respiration and
the RSA are mostly in phase opposition, as an inspiration corresponds with a shortening of the
R-R interval [113]. However, during an episode of sleep apnea, it is assumed that this relation-
ship is often disturbed as the respiration is altered. For this reason, the phase coupling index was
assessed between the respiration and the RSA. The results have shown that this coupling was
significantly lower during episodes of sleep apnea as compared to normal breathing [110].
These promising and encouraging results may have a potential and practical applications
in detecting sleep apnea episodes. As opposed to polysomnography, the acquisition process is
highly facilitated by the convenience of the instrumented t-shirt. Sleep apnea may be a patho-
physiological factor for developing hypertension, AF and other types of heart diseases, and most
often it is largely underdiagnosed. With this technology associated to the phase-coupling index,
one can envisage the development of an "at-home" monitoring product, avoiding therefore the
need of a bulky and uncomfortable diagnosis process.
Organization indices evolution during catheter ablation
The evolution of classical organization indices during catheter ablation has been the subject of
several studies. The most widely used measure of organization assessed during catheter ablation
is the AFCL estimated from various endocardial locations [6, 49, 50, 97–99]. In all reported
studies, a gradual prolongation of the AFCL was observed prior to AF termination. However,
in patients with long-standing persistent AF in whom AF continued despite PVI, AFCL did not
change during stepwise catheter ablation, while other indices based on large intracardiac dipoles
did [100]. There is thus a need to develop novel organization indices computed on intracardiac
recordings, which would provide a better spatio-temporal quantification of substrate modification
during catheter ablation. These measures would reflect the dynamical variations within the atria.
The novel ECG organization indices developed in the present thesis can also be used to assess the
global evolution of AF organization during catheter ablation. Ideally, these indices should predict
the additional amount of ablation to perform in order to terminate AF during the procedure.
During this thesis, two novel methods for quantifying the evolution of AF organization during
catheter ablation were developed [114, 115]. They were not presented in the current dissertation,
as it was entirely dedicated to the outcome prediction of catheter ablation. However a short
summary is provided below.
The first method was aimed at analyzing the structural and temporal evolution of the mor-
phology of bipolar intracardiac signals [114]. In this study, atrial activation times were estimated
by computing the local activation wave barycenters [116]. The morphological similarity between
two activation waves was defined as their cosine distance [117]. Recurring patterns in the mor-
phological regularity were assessed with recurrence plot analysis, from which three measures
of organization were derived. The first one reflected the average recurrence of morphological
similarity. The second one measured the percentage of consecutive activation waves that were
morphologically similar. The third one was computed as the Shannon entropy of the distribution
of the number of consecutive morphologically similar activations. The significance of these pa-
rameters was assessed using surrogate data and a one-sided rank-order test. Recordings acquired
within the RAA were used in this study. These parameters were compared to the local AFCL.
The relative evolution of the mean recurring parameters and AFCL were compared during PVI
vs baseline conditions. In our preliminary results, the AFCL did not change, while the recurring
parameters revealed positive and negative variations after PVI, suggestive of a greater sensitivity
to the modification of the left atrial substrate by catheter ablation. Hence, these measures appear
as promising parameters to titrate the amount of additional ablation required to restore long-term
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SR.
The second method aimed at analyzing the synchronization between nearby bipolar intracar-
diac electrograms [115]. In this study, the LAT was defined as the maximum positive peak from
each activation wave. Series of LATs were transformed into trains of impulses on which the
cross-correlation was computed. For multiple wavefronts, the cross-correlation presents several
peaks. Therefore, the peak concentration of the cross-correlation reflects the local complexity
of AF dynamics. From this cross-correlation, a novel organization index was computed on the
smoothed cross-correlation (Hamming window) on which the area around the largest peak was
divided by the sum of the components of the cross-correlation. Low values of this index are
indicative of a weak dominance of the largest peak, and consequently of a weak LAT synchro-
nization. In contrast, high values are indicative of a single sharp dominant peak and therefore
of a high coupling between LATs. Bipolar recordings acquired within the RAA were used for
estimating this synchronization index as well as the AFCL. The relative evolution of their mean
values was compared between PVI vs baseline conditions, CFAEs ablation vs PVI and the last
two steps preceding AF termination. The preliminary results have shown that the synchroniza-
tion measure was more sensitive than the AFCL for estimating changes of AF dynamics induced
by catheter ablation. These results, however, must be corroborated with simulated data provided
by a biophysical model of AF [118] in order to establish their electrophysiological significance.
Considering all these observations, the AFCL is not suitable for assessing the substrate mod-
ification induced by catheter ablation. The organization indices presented in Chapter 9 extend
the analysis of intracardiac AFCL by measuring its variability. These indices characterized the
mean frequency and variance of the oscillations around the mean AFCL. These measures might
be more sensitive in tracking the organization during stepwise catheter ablation "en route" to AF
termination and might help to titrate the amount of ablation required to restore SR.
Long-term outcome and termination mode of catheter ablation
In this thesis, the prediction of outcome was investigated on the acute termination of first-
time catheter ablation in patients with long-standing persistent AF. A logical continuation of
the present work is to study the long-term outcome (3, 6, and 12 months) of stepwise catheter
ablation in terms of AF recurrence. Acute termination of AF during catheter ablation does not
necessarily ensure a long-term SR maintenance. In fact, patients with long-standing persistent
AF may need several attempts of catheter ablation in order to ensure long-term SR maintenance.
Hence, this future work should investigate if the organization indices are still discriminative in
terms of AF recurrence in the long-term.
Moreover, as presented in Chapter 5, AF can be terminated according to one of these three
scenarios: 1) AF directly converts into SR; 2) AF converts to AT and subsequently to SR; and 3)
catheter ablation fails to terminate AF and DCC is delivered in order to restore a SR. In patients
with long-standing persistent AF, conflicting results were reported regarding the impact of the
termination mode during catheter ablation on the long-term SR maintenance [119–124]. On one
hand, some groups have shown that the termination mode had no impact on the long-term main-
tenance of SR [119, 120]. On the other hand, other groups have shown that AF termination into
SR had a better long-term clinical outcome [121, 122], whereas other studies have shown that AF
termination into AT was associated with a higher likelihood of SR maintenance [123, 124]. Asso-
ciated with the long-term prediction, the study should also investigate if the organization indices
are predictive of the impact of termination mode, and furthermore to establish their association
with the long-term SR maintenance.
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Multivariate analysis on a larger population
This thesis is mainly limited by the small size of the study population. Future work should
compare on a larger population the predictive performance of the new organization indices with
the duration of sustained AF (if known) to separate LT and NLT patients at baseline. This limi-
tation also prevented the completion of a multivariate statistical analysis. This kind of statistical
analysis would also pave the way for the development of a robust classifier for predicting AF
catheter ablation outcome.
Characterization of CFAEs
In human AF, fragmented potentials were first identified in 1997 by Konings et al. who
showed that they were largely present in atrial regions displaying either slow conductions or lo-
cations of wavelet pivots [125]. Later on, Nademanee et al. proposed the term of CFAE for
describing sites with continuous high frequency activities and showed that ablation of CFAEs
throughout the atria was associated with the restoration of SR in patients with long-standing per-
sistent AF [53]. During the ablation procedure, CFAEs are visually identified by the operator
which is challenging and highly subjective. CFAEs ablation results in extensive atrial lesions
that may preclude any recovery of atrial contractile function despite SR restoration. The exact
pathological mechanisms of CFAEs are not yet fully understood and are currently an open de-
bate in the medical community, which is reflected by the considerable number of publications on
this subject. Nonetheless, it has been shown that catheter ablation at sites displaying a greater
percentage of continuous activity or a temporal activation gradient is associated with slowing
or termination of chronic AF [7]. However, it is unknown if some proportion of ablated CFAE
sites that do not enable AFCL slowing or AF termination play a role in the AF perpetuation
process and if their ablation increases or decreases AF organization. Recently, algorithms for
time-domain analysis of CFAEs were implemented in the available electroanatomical mapping
systems. Despite these recent advances, physicians still do not have a tool to discriminate be-
tween culprit and non culprit CFAEs. To the best of our knowledge, to date, no study has been
undertaken on CFAE characteristics predictive of an organizational increase during AF. Using
the novel organization indices presented in the current thesis, these variations of organization
can be assessed globally (from the ECG) as well as within the atria. As such, it would possible
to determine whether some CFAE displaying specific characteristics play a hidden role in AF
perpetuation and ultimately to define a fully automated fractionation index estimation algorithm,
suitable for off-line and on-line electrogram analysis. Such an approach would be of benefit for
the physician and for the patients comfort. Indeed, the automated discrimination between culprit
and non-culprit CFAEs would greatly reduced the amount of useless ablation, and consequently
the procedural time.
From standard 12-lead ECG to body surface potential maps
One of the major drawback of the standard 12-lead ECG is that it was specifically designed
to follow the depolarisation and repolarisation of the ventricles, which renders difficult the esti-
mation of the spatial information of the atrial activity. In the present thesis, the precordial lead
V6 was placed in the patients back and this simple replacement has proven to be very useful in
assessing non-invasively the LA activity. Moreover, in the present work, the ECG results have
shown that lead V5 was useless in predicting the procedural outcome of catheter ablation. Hence,
one might think of using this electrode as an additional dorsal lead in order to improve the spa-
tial resolution of the posterior recording of the atria. However, another device is available for
increasing the spatial resolution of surface ECG recordings. This tool, known as body surface
potential maps (BSPM), is an adjustable vest made of an array of electrodes (between 32 to 300)
distributed anteriorly, posteriorly and on the lateral sides of the patients chest.
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In the context of AF catheter ablation, recent clinical studies have used BSPM combined
with anatomical information of the atria assessed by computed tomography [109, 126, 127].
From the imaging data, the precise position on the patients chest of each BSPM electrode is
acquired and a three-dimensional model of the atrial epicardial geometry is reconstructed. The
signals recorded from the BSPM are then combined with the geometrical information by the
use of specifically designed algorithms in order to estimate a map of atrial epicardial electrical
potentials. This process, also known as ECG imaging, was originally developed by Rudy’s group
for ventricular mapping in order to detect local heart rate variability and was later on adapted
to atrial mapping [109]. The main goal of these algorithms is to solve what is known as the
inverse problem. Importantly, solving the inverse problem is a non-trivial task, in particular when
studying the atrial epicardial dynamic during AF, and is hindered by three major characteristics.
First, the solution of the inverse problem is not unique. Indeed, the same set of surface recordings
could result from more than one source configuration. Typically, this difficulty is circumvented
by using simplified models of the cardiac current sources [128]. Second, the inverse problem
is by its very nature ill-posed, i.e., any small variations on the BSPM can cause an erratic large
modification of the equivalent source solution. This important issue mainly results from the
smoothing and attenuation of the electrical fields caused by the subject’s torso. The desired
solution is therefore unstable and highly sensitive to noise, or perturbation in the electrical input
data. Actually, this ill-posedness increases with the complexity of the assumed heart (or atrial)
model [128]. Bypassing the ill-posed nature of the inverse problem is very arduous and needs the
assumption of additional spatial and temporal constraints on the heart/atrial model parameters.
These relaxations may alter the estimation of the atrial epicardial electrical activity, providing
a possible solution, which can be different from the real electrophysiological dynamic. Lastly,
in the particular context of AF, as for the signals recorded on the standard 12-lead ECG, the
ventricular activity is predominant in BSPM recordings. The clinical studies using BSPM usually
circumvent this issue by acquiring segmented f-waves occurring between several consecutive
spontaneous or drug-induced QRS pauses [109, 126, 127]. The resulting sequential recordings
are of few seconds duration (typically < 10 seconds). As surface f-waves rapidly vary over time,
such approach may not be appropriate for assessing the temporal variations of AF dynamics.
Recently, Haïssaguerre et al. published a very interesting study in which ECG imaging was
used to identify atrial regions harboring AF drivers and to characterize them according to the
type of AF [127]. Epicardial fibrillatory driver density maps were estimated in order to iden-
tify the atrial sites possibly anchoring a source of AF. Then, sequential ablation started from the
region with highest density activity to the lowest one until AF termination. If AF was not termi-
nated, linear ablations were performed within the LA. The authors report AF termination in 75%
of patients with persistent AF, while for patients with long-standing persistent AF the success
rate dropped to 15%. Importantly, the authors noted that in patients with persistent AF, most
of the drivers were located in the PV-left atrium regions, while in patients with long-standing
persistent AF sources were found beyond the PV region. Although their method clearly sug-
gested time-critical mechanisms for persistent AF, it did not reveal different dynamical behaviors
in patients in whom AF was terminated compared to those whose AF was not terminated. The
method proposed by Haïssaguerre et al. has raised a call for more understanding within the
medical community. First, the process of solving the inverse problem inevitably adds critical as-
sumptions on the atrial model, and cannot take into account the presence of fibrosis for instance.
Second, a recent study from Verheule et al. has shown that AF must be considered as a three
dimensional arrhythmia characterized by an electrical dissociation between the epicardial layer
and the endocardial bundle network [129]. In [127], the drivers are located on an epicardial map,
while the ablation is performed within the atria. Hence, the site of ablation does not correspond
to the activity estimated on the epicardial density map. Finally, some authors have suggested
that a more refined evaluation of AF dynamics is required in order to improve the understanding
of AF [130]. Such improvement was achieved by the study of Guillem et al. in which spectral
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analysis of body surface recordings during AF helped to characterize the global distribution of
the atrial DFs and to identify non-invasively the atria with the highest frequency [86].
As a perspective for the ECG processing schemes presented in the current thesis, a similar
approach to that proposed by Guillem et al. of BSPM recordings could be performed. In addi-
tion to classical spectral analysis, the computation of the organization indices derived from the
adaptive frequency tracking algorithm would enhance the assessment of AF complexity. Indeed,
the AOI and aPD have shown to be more robust than time-invariant measures in predicting the
procedural outcome of catheter ablation in patients with long-standing persistent AF. Combined
with the high spatial resolution provided by BSPM, the amount of organization in different atrial
segments could be characterized non-invasively with a better spatial accuracy.
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Definitions A
This appendix aims at providing medical and mathematical definitions. First, various medical
definitions are presented (Section A.1). Then, the concept of instantaneous frequency and the
discrete Hilbert transform are explained (Section A.2). Finally, the binary logistic regression
model (Section A.3) as well as the receiver operating characteristic curve analysis are described
(Section A.4).
A.1 Medical definitions
– Thromboembolism: a thromboembolism is a condition in which a clot (thrombus) in the
blood is formed and carried from its site of formation, leading to the obstruction of a blood
vessel.
– Body Mass Index (BMI): is a measurement of relative weight, based on an individual’s
mass and height. In other words, it quantifies the relative percentages of fat and muscle
mass in the human body. More specifically, it is defined as the individual’s body mass in
kilogram divided by the square of the height in meters. The unit of the BMI is therefore
kg/m2. By convention a BMI < 18.5 kg/m2 is categorized as underweight. A BMI in the
range 18.5 − 25 kg/m2 is considered as normal. Overweight is when the BMI is in the
interval 25 − 30 kg/m2. Finally, a BMI > 30 kg/m2 is considered as obese.
– Hypercholesterolemia: refers to the presence of high level of cholesterol in the blood.
– Sleep apnea syndrome: is a serious type of sleep disorder in which breathing is charac-
terized by pauses (lasting from at least ten seconds up to several minutes), or instances of
shallow or irregular episodes. Many studies have established a link between atrial fibrilla-
tion and sleep apnea, however the interplay between the two diseases is complex.
– CHA2DS2 VASc score: is a risk factor for patients with non-valvular AF used as a clin-
ical prediction rule. The meaning of the acronym CHA2DS2 VASc is the following:
[Congestive heart failure, hypertension, age ≥ 75, diabetes, stroke, vascular disease, age
65− 74, and sex category]. The score is computed on a point system in which 2 points are
given for a history of stroke, or age ≥ 75; and one point is assigned respectively for age
65 − 74 years, a history of hypertension, diabetes, recent cardiac failure, vascular disease,
and female sex [4]. The maximum CHA2DS2 VASc score is therefore 9.
135
136 Definitions
– Dilated cardiomyopathy: is a progressive disease of the heart muscle in which the ventri-
cles are importantly enlarged, which consequently alters the efficient pumping of the blood
throughout the body.
– Hypertrophic cardiomyopathy: is a disease in which the heart muscle (and in particu-
lar the ventricular walls) becomes abnormally thick. Despite this thickening, the ventricle
size often remains normal. This thickening may, however, block the blood flow out of the
ventricles.
– Congestive heart failure: occurs when the heart is unable to pump sufficient blood in
order to maintain a normal flow to meet the needs of the body. A heart failure happens
when the heart muscle cannot pump properly the blood out of the ventricles (in this case
it is called a systolic failure), or when the muscles are stiff and do not fill up with blood
correctly (in this case it is called a diastolic heart failure).
– Left ventricular fraction ejection: measures the percentage of blood being pumped out
of the left ventricle each time the heart contracts. A left ventricular fraction ejection of
≥ 55% is considered normal, while ≤ 50% is considered reduced.
– Beta-blockers: or β-blockers, are a class of drugs that block the action of the sympa-
thetic nervous system of the heart, thus reducing the stress on the heart. Consequently,
these drugs slow down the heart beat and decrease blood vessel contraction in the heart.
β-blockers are used to treat certain cardiac arrhythmias as well as hypertension.
– Calcium channel blockers: also called calcium channel antagonists, are a group of medi-
cation that disturbs the movement of calcium through calcium channels. More specifically,
these drugs prevent the calcium from entering the cells of the heart and blood vessel walls.
These types of drugs are mainly used against hypertension.
– Amiodarone: is an antiarrhythmic medication commonly used for different types of ven-
tricular and atrial cardiac arrhythmias. The amiodarone prolongs phase 3 of the cardiac
action potential (i.e. the repolarization phase, see Section 2.1.3 of Chapter 2).
– Enzyme conversion inhibitors: is a pharmacological drug primarily used for the treat-
ment of hypertension and congestive heart failure.
– Angiotensin receptor inhibitors: are medication commonly used to treat high blood pres-
sure, diabetic nephropathy (kidney damage due to diabetes), and congestive heart failure.
– Statins: are a class of drugs used to lower the cholesterol level.
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A.2 Instantaneous frequency and the Hilbert transform
This section presents a brief introduction on the concept of instantaneous frequency 1. Then,
the discrete Hilbert transform is briefly explained in A.2.2.
A.2.1 The concept of instantaneous frequency
Frequency is defined as the number of oscillations observed per unit of time. In contrast,
the instantaneous frequency is the frequency at a given time. In many applications, the spectral
characteristics of a given signal vary over time. Such signals are referred as non-stationary. For
these particular signals, the concept of instantaneous frequency reflects a time-varying parameter
which defines the location of the signal spectral peaks as they vary over time [131].
The concept of instantaneous frequency was originally introduced by Carson and Fry who
defined it as the rate of change of phase angle at a given time [132]. The authors argued that the
concept of instantaneous frequency is a generalization of the definition of constant frequency.
Later, van der Pol [133] provided an extension of this definition by considering amplitude- and
frequency-modulated sinusoids of the following form:
x(t) = a(t) cos(φ(t)), (A.1)
where a(t) and φ(t) are the time-varying amplitude and phase respectively. In their work, the
authors showed that the instantaneous frequency is defined as the derivative of the phase with
respect to time:
ωi(t) =
dφ(t)
dt
. (A.2)
In order to extract the phase from any types of signals, Gabor proposed a method for generating a
unique complex signal from a real one, known as the analytic signal [60]. His method consisted
first in taking the Fourier transform of the real signal. Then, the amplitudes corresponding to
negative frequencies were set to zero and the amplitudes corresponding to positive frequencies
were multiplied by two. Finally, in order to obtain the analytic signal, the modified spectrum was
transformed back to the time domain. Gabor showed that this procedure was equivalent to the
following time-domain procedure:
xa(t) = x(t) + jH{x(t)} = x(t) + jxh(t) = a(t)e jφ(t). (A.3)
where a(t) and φ(t) are the instantaneous amplitude and phase, xa(t) is the analytic signal, x(t) is
the real signal, H{·} denotes the Hilbert transform, and xh(t) is the Hilbert transformed original
signal defined as:
xh(t) = H{x(t)} = 1
pi
p.v.
∫ ∞
−∞
x(τ)
t − τ dτ, (A.4)
where p.v. denotes the Cauchy principal value of the integral [131]. Moreover, the Hilbert trans-
form can be seen as the convolution of x(t) with the function 1
pit . Indeed, in order to compute the
Hilbert transform, due to the integration interval, knowledge of x(t) over the entire time domain
is required. However, the main contribution of the integral defined in equation A.4 comes from
the region around a particular time t. As such, the Hilbert transform is expressed in the Fourier
domain as:
Xh( f ) = F
{
1
pit
}
· X( f ). (A.5)
Using the following Fourier transform pair [134],
1
t
F←→ − jpi sgn( f ), (A.6)
1. For a more detailed introduction on the concept of instantaneous frequency see [131].
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Xh( f ) can be expressed as
Xh( f ) =

jX( f ) for f < 0,
0 for f = 0,
− jX( f ) for f > 0.
(A.7)
Thus, the Hilbert transform consists in performing a phase shift of − pi2 (respectively pi2 ) for every
positive (respectively negative) frequencies. In other words, the imaginary part of the analytic
signal corresponds to the original signal delayed by a phase of pi2 . As such, the analytic signal of
an harmonic oscillation x(t) = A0 cos(ω0t) is xa(t) = A0 cos(ω0t) + jA0 sin(ω0t).
Finally, based on the previous works of Carson and Fry [132], van der Pol [133], and Ga-
bor [60], Ville went further in defining the instantaneous frequency as the derivative of the in-
stantaneous phase φ(t) of the analytic signal xa(t) with respect to time:
ωi(t) =
d
dt
arg{xa(t)}. (A.8)
A.2.2 The discrete Hilbert transform
The concept introduced previously were presented for continuous-time signal. However, the
approach is also applicable to discrete-time signals. The most classical method is based on the
discrete Hilbert transform which is briefly explained 2.
For a discrete-time signal x[n], the analytic signal xa[n] is defined as:
xa[n] = x[n] + jxh[n] = a[n]e jφ[n], (A.9)
where xh[n] is the discrete Hilbert transform of x[n]. Similarly to the continuous case, the discrete
Hilbert transform can be computed by convolving a signal with the discrete-time Hilbert filter:
xh[h] = h[n] ∗ x[n] [81]. This infinite impulse filter is given by:
h[n] =
0 for n even,2
pin for n odd.
(A.10)
However, in practical situations, the Hilbert filter A.10 can be approximated with a finite impulse
response. In the frequency domain, the discrete Hilbert transform can also be computed as:
Xh(e jω) = DTFT {xh[n]} = DTFT {h[n] ∗ x[n]} = H(e jω) · X(e jω), (A.11)
where the discrete-time Fourier transform (DTFT) of the Hilbert filter (A.10) is defined as
H(e jω) =

j for −pi < ω < 0,
0 for ω = 0,
− j for 0 < ω < pi.
(A.12)
Thus, the discrete Hilbert transform is obtained by performing a phase shift for the components
of positive (respectively negative) frequencies by − pi2 (respectively by pi2 ).
In practice, the DTFT is not applicable, and consequently the discrete Fourier transform
(DFT) is used instead. As such, the frequency response of the Hilbert filter of length N is given
by
H[k] =

0 for k = 0,
− j for 1 ≤ k ≤ N2 − 1,
0 for k = N2 ,
j for N2 + 1 ≤ k ≤ N − 1,
when N is even, (A.13a)
2. For a more thorough presented on the discrete Hilbert transform see [81]
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and
H[k] =

0 for k = 0,
− j for 1 ≤ k ≤ N−12 ,
j for N+12 ≤ k ≤ N − 1,
when N is odd. (A.13b)
Then, Xa[k] is computed directly from the DFT of a real signal of length N [78]:
Xa[k] =

X[0] for k = 0,
2X[k] for 1 ≤ k ≤ N2 − 1,
X[N/2] for k = N2 ,
0 for N2 + 1 ≤ k ≤ N − 1,
when N is even, (A.14a)
and
Xa[k] =

X[0] for k = 0,
2X[k] for 1 ≤ k ≤ N−12 ,
0 for N+12 ≤ k ≤ N − 1,
when N is odd. (A.14b)
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A.3 Binary logistic regression and odds ratio
In medical studies, when a set of variables are to be used for prediction, the most commonly
employed technique is the logistic regression. The logistic regression (also called the logit re-
gression) models the relationship between the explanatory variables and the outcome, so that an
outcome can be predicted for a new set of explanatory variables. More specifically, the outcome
of the explanatory variables is binary (or dichotomous, i.e., only two outcomes are possible, for
example "treatment success" or "treatment failure"). The goal of the logistic regression is to
find the best fitting model describing the relationship between the outcome variable and a set of
independent (explanatory) variables.
Let X1, . . . , XN , be a set of N explanatory variables and Y be a dichotomous variable. For
example, Y can be defined as:
Y =
1 for treatment success,0 for treatment failure.
The goal is to model the probability that Y takes the value 1 as a function of the explanatory
variables X. In other words, the aim is to derive an equation to predict the probability of the
occurrence of the outcome of interest. This conditional probability of Y given X is denoted as
pi(X). The logistic regression fits the probability distribution of the following form:
pi(X) =
exp(β0 + β1X)
1 + exp(β0 + β1X)
(A.15)
where β0 and β1 are the regression coefficients to be estimated. The most commonly used
technique to estimate these parameters is maximum likelihood, in which the estimate of a param-
eter maximizes the probability of the observed data. For more details about the estimation of the
regression coefficients, see [135].
The Equation defined in (A.15) describes a family of sigmoid curves. Figure A.1 illustrates
several regression curves for different parameter values. As it can be observed, as x → −∞,
pi(X) → 0, conversely, as x → ∞, pi(X) → 1. The model given in equation (A.15) satisfies
therefore the important requirement that 0 ≤ pi(X) ≤ 1. The parameter β1 controls how fast pi(X)
rises from zero to one. The value of X at which P(Y = 1) = 0.5 is given by −β0/β1 and provides
useful information. For example, if the output is either "success" or "failure" of a particular
medical treatment, this would reflect the level such that there is a 50 − 50 chance that, for a
certain patient, this specific treatment will be effective.
From Equation (A.15), it follows that pi(X)/(1 − pi(X)) = exp(β0 + β1X), and thus:
log
(
pi(X)
1 − pi(X)
)
= β0 + β1X (A.16)
Since Equation (A.16) results from using a logistic transform (also called a logit transform),
the model described above is called a binary logistic regression model. The left side of Equa-
tion (A.16) is called the log odds ratio. Moreover, from Equation (A.16), β1 represents the
amount by which the log odds changes per unit change in X. It is somewhat more meaning-
ful, however, to state that a one-unit increase in X increases the odds by the multiplicative fac-
tor exp(β1) (by exponentiating both sides of Equation (A.16)) [135]. Therefore, the expression
exp(β1) represents the odd ratio. A property of logistic regression is that this ratio remains con-
stant for all values of X. Thus, the odds ratio represents the change in the odds of the outcome
by increasing X by one unit.
Odds ratio are commonly used to compare the relative odds of the occurrence of the outcome
(e.g., "treatment success" or "treatment failure"), given exposure to the variable of interest (e.g.,
age, health characteristics, organization indices). Moreover, the odds ratio can also be used to
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Figure A.1: Examples of different regression curves.
determine whether the value of a particular explanatory variable (e.g., age > 80) , also called
exposure, is a risk factor for a particular outcome (e.g., "treatment success). More specifically:
– exp(β1) = 1: the exposure does not affect the odds of outcome. In other words, β1 = 0 and
therefore the odds and probability are at the same level for all X.
– exp(β1) > 1: the exposure is associated with higher odds of outcome. In other words,
β1 > 0 and therefore the odds and probability increase as X increases.
– exp(β1) < 1: the exposure is associated with lower odds of outcome. In other words,
β1 < 0 and therefore the odds and probability decrease as X increases.
In other words, the odds ratio shows the strength of association between a predictor and the
response of interest.
Associated with the odds ratio, the 95% confidence interval is used to estimate the precision
of the odds ratio. This confidence interval is closely related to the confidence interval for β1
which is obtained as [β1 ± zα/2σβ1 ], where zα/2 denotes the standard normal deviate with a tail
area of α/2 and σβ1 is the standard error of the estimation of β1 [135]. A large confidence interval
is indicative of a low precision of the odds ratio and conversely, a small confidence interval is
indicative of a high precision of the odds ratio.
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A.4 Receiver operating characteristic curve analysis
Training data are used to construct the classification rule. Once the classification rule (or
model) has been established, it is of interest to know how effective it will be in assigning future
objects to classes. Let us suppose that the studied population is composed of N patients and that
a binary classification is performed in which the outcomes are labelled as positive (P) or negative
(N). There are four possible outcomes from a binary classifier:
– True positive (TP): the prediction outcome is positive and the actual outcome is positive.
– True negative (TN): the prediction outcome is negative and the actual outcome is negative.
– False positive (FP): the prediction outcome is positive and the actual outcome is negative.
– False negative (FN): the prediction outcome is negative and the actual outcome if positive.
Classification effectiveness is measured by the number of TP and TN relative to the total
number of cases. These two ratios are used to define the two complementary measures of the
classification performance and they are known as sensitivity and specificity. Therefore:
Sensitivity =
TP
TP + FN
(A.17)
Specificity =
TN
FP + TN
(A.18)
The receiver operating characteristic (ROC) curve is defined as a graphical plot of sensitivity
vs. (1 − specificity) for a binary classifier model as its discriminant threshold varies. Figure A.2
shows an example of a hypothetical ROC curve. The best prediction method would yield a point
in the upper left corner at coordinate (0, 1), representing 100% sensitivity (no FN) and 100%
specificity (no FP). A complete random guess would yield a point along the diagonal (also called
the chance diagonal). Intuitively, it can be observed that points above the diagonal represent
good classification results (i.e. better than random), and conversely points below the diagonal
represent poor classification results (i.e. worst than random). Following this observation, two
indices are commonly used for characterizing the ROC curve, and therefore the classification
performance.
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Figure A.2: Examples of a ROC curve. AUC: Area under curve (gray area); YI: Youden Index
(pink dash-dotted line). Data from [136].
The first measure for characterizing the ROC curve is the area under the curve (AUC). The
AUC measures the average true positive rate, taken uniformly over all possible false positive
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rates in the range (0, 1). The closer to 1 the AUC is, the more unbalanced the ROC curve is, im-
plying that both sensitivity and specificity of the classification are high. In Figure A.2, the AUC
corresponds to the gray area and is equal to 0.89, indicative of a good classification performance.
The second measure is the Youden index (YI), which is defined as the maximum difference
between the TP and FP rates. In Figure A.2, the YI is illustrated by the pink diamond marker.
As illustrated in Figure A.2, the point on the ROC curve corresponding to the YI is therefore
the most distant from the diagonal. Thus, the YI is the distance of the farthest point [(1 −
specificity), sensitivity] on the ROC curve from the diagonal. Moreover, the threshold at the
point on the ROC curve corresponding to the YI is often taken to be the optimal classification
threshold.
In summary, the ROC curve provides an assessment of the classifier performance over the
whole range of potential threshold values.
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Devices B
In the first part of this appendix, technical details on the catheters are provided (Section B.1).
For each ablation procedure four different catheters were used, consisting of one ablation catheter
(Section B.1.1) and three mapping catheters (Section B.1.2). Section B.2 presents the system
used for the recording and export of the ECG and EGM signals.
B.1 Catheters
B.1.1 Ablation catheter
The ablation was performed with a NaviStar R© ThermoCool R© catheter from Biosense Wester.
The cooling system is of the type open-loop providing therefore a uniform cooling (see Sec-
tion 4.1.2 in Chapter 4). Figure B.1a illustrates the tip electrode of the ablation catheter. During
ablation, a saline solution is passed through the holes as shown Figures B.1a and B.1b. The RF
current is delivered to the tip electrode.
(a) (b)
2 5 2 
1 2 3 4 
MAPd MAPp 
(c)
Figure B.1: (a) electrode tip and cooling; (b) NaviStar R© ThermoCool R© ablation catheter
(Biosense Wester R©); and (c) illustrates the spacing between the electrodes (distances are in-
dicated above the catheter). The numbers in italic below the catheter correspond to the electrode
number. Images from: https://www.biosensewebster.com/thermocoolsf.php.
The tip is deflectable, which facilitates the electrophysiological mapping of the atria and the
transmission of the RF current to the tip electrode. The size of the tip electrode is 3.5 mm (elec-
trode number 1 in Figure B.1c).
In total the catheter has four electrodes. Typically, for deriving bipolar EGMs, recordings be-
tween adjacent electrode pairs are used (e.g. between electrodes 1−2, 2−3 and 3−4), with a dis-
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tance of 1 to 5 mm between electrodes. The electrode spacing of the NaviStar R© ThermoCool R©
ablation catheter is 2−5−2 mm, as illustrated in Figure B.1c. Table B.1 summarizes the technical
specificities of the NaviStar R© ThermoCool R© ablation catheter. The two bipolar signals MAPd
and MAPp are derived from the pair of electrodes 1 − 2 and 3 − 4 respectively and represent the
most distal and proximal pairs of electrodes of the catheter. In this manuscript, this catheter is
denoted as the MAP catheter.
Tip electrode Electrode spacing Number of electrodes Bipolar signals labels
3.5 mm 2 − 5 − 2 mm 4 MAPd, MAPp
Table B.1: Characteristics of the NaviStar R© ThermoCool R© ablation catheter.
B.1.2 Mapping catheters
Lasso catheter
The Lasso R© 2515 variable circular mapping catheter from Biosense Webster (Figure B.2)
was used during the baseline acquisition to map the LA; during the PVI step to localize the
earliest activation at each PV antrum and to monitor the LAA AFCL once each PV was elec-
trically isolated; and finally during post-PVI for a constant monitoring of the LAA AFCL (see
Section 5.2.3 of Chapter 5 for the description of the ablation protocol).
2 
6 
Figure B.2: Lasso R© 2515 variable circular mapping catheter (Biosense Wester R©). Picture from
http://www.stryker.com
Table B.2 summarizes the technical specificities of the Lasso R© 2515 variable circular map-
ping catheter. The Lasso R© 2515 catheter has a variable loop allowing it to adjust and fit any
vein antrum of size between 15 and 25 mm. The catheter has 20 electrodes with a spacing of
2 − 6 − 2 mm (Figure B.2 and Table B.2). This catheter is specifically designed to facilitate the
electrophyisological mapping of the atria.
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Diameter Electrode spacing Number of electrodes Bipolar signals label
15 − 25 mm 2 − 6 − 2 mm 20 Lasso1−2, Lasso3−4,
Lasso5−6, Lasso7−8,
Lasso9−10, Lasso10−11,
Lasso11−12, Lasso13−14,
Lasso15−16, Lasso17−18,
Lasso19−20
Table B.2: Characteristics of the Lasso R© 2515 variable circular mapping catheter.
Coronary sinus catheter
The Biosense Webster Coronary Sinus with EZ Steer R© Bi-directional Technology was placed
within the coronary sinus during the entire duration of the ablation procedure. This catheter is
specifically designed to map the electrical activity within the coronary sinus. The catheter has a
tip electrode of 2 mm and 10 electrodes with a spacing of 2−8−2 mm (Table B.3). The catheter is
also bi-directionally deflectable in order to facilitate an accurate positioning of the catheter at the
desired location. For each patient, the electrode CS9−10 was placed at the CS ostium in order to
avoid inter-patient spatial variability. In this manuscript, this catheter is denoted as the CS-cath
catheter.
Tip electrode Electrode spacing Number of electrodes Bipolar signals labels
2 mm 2 − 8 − 2 mm 10 CS1−2, CS3−4, CS5−6,
CS7−8, CS9−10
Table B.3: Characteristics of the Coronary Sinus with EZ Steer R© Bi-directional Technology
catheter.
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Quadripolar catheter
The Supreme R© Quadripolar Electrophysiology catheter from St. Jude Medical R© was placed
within the RAA during the entire procedure for a constant monitoring of the RA. As illustrated
in Figure B.3, this catheter has four electrodes with a spacing of 5 mm. Table B.4 summa-
rizes the technical specificities of the Supreme R© Quadripolar Electrophysiology catheter. In this
manuscript, this catheter is denoted as the HRA catheter.
5 5 5 
HRAd HRAp 
Figure B.3: The Supreme R© Quadripolar Electrophysiology catheter (St. Jude Medical R©). Pic-
ture from http://www.sjm.com .
Electrode spacing Number of electrodes Bipolar signals labels
5 − 5 − 5 mm 4 HRAd, HRAp
Table B.4: Characteristics of the Supreme R© Quadripolar Electrophysiology catheter.
B.2 Siemens AXIOM Sensis XP
All the ECG and EGMs signals were recorded and exported through the AXIOM Sensis XP R©
(Siemens R©) at a sampling frequency of 2 kHz. Because of the electrical interference induced by
the common AC current, a notch filter was applied at the frequency of 50 Hz reducing therefore
all undesired noise at this frequency. Moreover, specific bandpass filters were applied in with
respect to the input signal:
– all signals from the ECG were filtered with a passband of [0.05 − 200] Hz.
– all signals from the HRA catheter were filtered with a passband of [40 − 400] Hz.
– all signals from the MAP, CS-cath and HRA catheters were filtered with a passband of
[30 − 400] Hz
Ventricular Activity
Cancellation C
The signals recorded from the surface ECG reflect the global activity of the heart, so both
ventricular and atrial components are present (Chapter 2, Section 2.2). In studies aiming at
characterizing the atrial activity (AA) during AF from the ECG, the major problem is that the
ventricular component is of much higher amplitude than the atrial one. Moreover, in the spectral
domain, the atrial and ventricular components overlap. Therefore, extracting the atrial signal
cannot be achieved using classical linear filters and thus requires nonlinear signal processing
techniques. A few approaches have been proposed, among which source separation [137], aver-
age beat subtraction (ABS) [57, 138, 139], and single beat subtraction (SB) [56].
Approaches based on source separation schemes exploit the property that the AA and ven-
tricular activity (VA) arise from different biolectrical sources, each of which exhibiting different
statistical properties. The main hypothesis is that ECG signals can be considered as a weighted
sum of atrial and ventricular sources, noise and artifacts. Source separation algorithms try to find
uncorrelated components using principal component analysis, or to find independent components
using independent component analysis [137]. In principal component analysis, the VA is charac-
terized in terms of intrabeat correlation. The principal component analysis projects each beat on
the "ventricular subspace," and a QRST waveform can be estimated and removed by subtracting
a linear combination of the "ventricular" eigenvectors [140]. The performance of this method is
critically dependent on the algorithm being employed for subspace identification and in the case
of a poor identification, the extracted AA contains undesired components. When algorithms base
on independent component analysis are used, it is assumed that the ECG signals are a mixture of
various single point sources such as the AA, VA and extracardiac activity. The signals obtained
with source separation algorithms cannot therefore represent the complete spatial information
contained in a standard 12-lead surface ECG. These schemes may not be the ones with the best
performance for extracting the AA from the ECG.
One of the most widely used techniques for the AA extraction from the ECG during AF is the
ABS [57, 138, 139]. This approach relies on two main hypotheses; during AF, 1) the AA is un-
coupled with the VA and 2) in the same patient, ventricular complexes generally exhibit a limited
number of shapes. Typically, an average beat (a template), representative of the ventricular cycle
during the period of recording, is subtracted from a single ECG lead in order to remove the VA.
Ideally, the resulting signal would be devoid of any VA and would only contain the fibrillatory
waveforms. Obviously, when using this approach, a large number of beats is desirable in order to
increase the performance of the cancellation. In [139], this technique was refined by adding two
major features to the standard ABS approach: reduction of the fibrillatory wave and spatiotem-
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poral alignment. One of the major problem of ABS approaches is that the template estimation
becomes unreliable when the fibrillatory waves are complex and disorganized, which is often the
case in long-standing persistent AF. Also, several beats for each morphology are needed to create
the templates. Therefore, the ABS approach is more suitable when the ECG contains a sufficient
number of ventricular complexes and when the ventricular complexes are highly regular. In this
thesis, patients with long-standing persistent AF were studied. This type of AF is extremely ir-
regular, and therefore an ABS approach was not suitable.
The SB approach also subtracts the QRST complex from the ECG, but unlike the ABS tech-
nique, it treats each cardiac cycle in an independent manner [56]. The SB method is more
appropriate when the morphology of the ventricular complexes is variable. Most importantly,
this approach does not depend on the duration of the ECG recording.
The purpose of this appendix is to briefly present the SB method originally proposed by
Lemay et. al [56]. In Section C.1, the pre-processing including the fiducial point detection and
baseline correction are presented. In Section C.2, the SB approach is exposed. For more details
about cancellation techniques, the reader should refer to [108].
C.1 Pre-processing
C.1.1 Fiducial point detection
Among the six bipolar limb leads of the standard 12-lead ECG, only two of them are linearly
independent, i.e. VRA and VLA (see Section 2.2.1). This justifies the expression of the pertinent
information contained in the 12-lead ECG by an T -by-8 matrix X that comprises T samples
from eight leads: two limb leads (VRA and VLA) and six precordial leads (V1 to V6). The re-
maining limb leads are recovered by the appropriate linear combination of leads VRA and VLA.
A derivative-based method is applied to the root mean square (RMS) signal to detect ventricular
complexes [141]. In the ith cardiac cycle, as illustrated in Figure C.1, let:
– qi denotes the timing of the onset of the ventricular depolarization,
– ri denotes the timing of the R wave (defined as the middle point between the closest sam-
ples on either side, below 50% of the maximum value of the RMS curve),
– ki denotes the timing of the subsequent T wave,
– ji denotes the local minimum of the RMS curve between ri and ki.
This RMS signal from which the fiducial points are derived, is defined as:
RMS (t) =
√√
1
8
8∑
l=1
xl(t)2, t = 1, . . . ,T, (C.1)
where xl(t) denotes the sample t of the lth lead signal.
C.1.2 Baseline correction
On each of the eight lead signals, a baseline correction is applied by means of a cubic spline
interpolation anchored on the onset points qi [142]. The fiducial point detection presented pre-
viously and the baseline correction are iteratively applied until no further changes in the various
timings were observed. Finally, the eight resulting ECG signals are smoothed by applying a zero-
phase fifth-order lowpass Butterworth filter with a cutoff frequency of 50 Hz [108]. Figure C.2
shows an example of a raw excerpt on lead V2 and its cleaned version after baseline correction.
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Figure C.1: Fiducial points defined on a RMS signal of duration 2 seconds. The timing of the
onset of the ventricular depolarization, the R wave timing, the T wave peak and the J point
timings are denoted as qi, ri, ki and ji respectively. The Ai segment indicates the location of the
QRS complex, the Bi segment defines the JQ interval, and the Ci segment corresponds to the
cardiac cycle. Figure adapted from [108].
2 mV 
2 sec 
(a) Excerpt on lead V2 of duration 10 sec recorded during AF.
2 mV 
2 sec 
(b) Cleaned up version of (a) after pre-processing.
Figure C.2: Example of a raw excerpt of duration 10 sec on lead V2 (a) and its cleaned version
after baseline correction (b). Figures from [108].
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C.2 Single beat cancellation
The main idea of the SB approach is that each cardiac cycle is treated independently. More-
over, the ventricles depolarization (QRS complexes) and repolarization (T and U waves) are
treated separately. The two main steps consist in cancelling the repolarization waves using
dominant T and U wave, and estimating the AA located in the QRS complexes. A flowchart
summarizing the SB scheme is shown in Figure C.3.
Cardiac cycle (i)
matrix A
Estimation of dominant
T and U functions
( f (t) in Eq.C.3 and g(t) in Eq.C.4
based on the Tdom signal in Eq.C.2)
1st and 2nd deritvatives of f (t)
( f ′(t) and f ′′(t))
Estimation of the coefficient
matrix W Eq.C.6
representing for each lead the weighted
sum of f (t), f ′(t), f ′′(t) and g(t)
T and U waves cancellation
C − UWT
where matrix U is composed of
f (t), f ′(t), f ′′(t) and g(t)
JQ interval +
cardiac cycle
matrices Bi−1 + Ci
Sinusoidal
representation of AA
Eq.C.7
AA Estimation in the
QRS complex
Eq.C.9
Lowpass filtering
50 Hz
ECG devoid of VA
Preprocessed
ECG (Section C.1)
Figure C.3: Flowchart of the single beat cancellation scheme. Figure adapted from [108].
T and U waves cancellation
It has been observed that the T wave morphology is quite similar in different leads. This
observation has been referred to as the dominant T wave and is useful for representing individual
T waves [143]. Let the V-by-8 matrix Φ contains the V samples of the eight ECG leads during
the S T − T interval. The 8-vector e represents the first eigenvector associated with the largest
eigenvalue of the estimated covariance matrix of Φ. The dominant T wave may be estimated by
the first principal component over the S T − T interval as such:
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Tdom = eTΦT, (C.2)
Tdom represents therefore Tdom(t) over the S T − T interval.
In order to provide a flexible representation of each individual T wave, the dominant T wave is
defined as a linear combination of the function Tdom(t) [144]. However, in the context of AF, it
was found that taking third-order derivatives generally resulted in components that could hardly
be distinguished from noise. Therefore, in the current framework, derivatives up to the second-
order only are included [108]. For this purpose, it was necessary to first fit a smooth analytical
function to the eigenvector and then to compute the time derivatives from the fitted function.
This function is the product of two logistic functions [145]:
f (t) = p1
(
p2 +
1
1 + ep3(t−p5)
· 1
1 + ep4(t−p5)
)
, (C.3)
where p1 is an overall scaling factor, p2 defines the initial amplitude, p3 and p4 are parameters
for the positive and negative slopes respectively, and p5 sets the timing of the dominant T wave
apex [108].
During AF, most ECGs may contain U waves and, thus, due to this occasional presence of U
waves, an additional function may be incorporated. It has been observed that the shape of these
U waves is similar to that of a Gaussian function. Correspondingly, the general dominant shape
of the U wave can be expressed as:
g(t) = p6 e−[(t−p8)/p7]
2
, (C.4)
where p6 is an overall scaling factor of the U wave amplitude, p7 represents its width, and p8
is the timing of its apex [108].
The VA cancellation in the JQ interval is therefore based on the two dominant functions f (t)
and g(t). The eight parameters pi, i = 1, . . . , 8 are found by fitting the function f (t) + g(t) to the
function Tdom. A nonlinear optimization method (the Levenberg-Marquadt algorithm [146]) is
used to estimate these parameters.
Finally, the lth lead is modelled as a linear combination of the function f (t), f ′(t), f ′′(t) and g(t)
which was fitted to the observed data matrix B (for recall, the matrix B contains the JQ interval,
see Figure C.1). The time series x(t) of the lth lead can therefore be expressed as:
xl(t) = w0,l f (t) + w1,l f ′(t) + w2,l f ′′(t) + w3,lg(t) (C.5)
where w0,l, . . . ,w3,l denote the weight coefficients for the lth lead. Equation (C.5) constitutes
a linear parameter estimation problem for one lead, which can also be expressed in the matrix
form as follows:
W = (UTU)−1UTB, (C.6)
where the matrix W represents the weight for the individual leads, and the columns of the
matrix U are the functions f (t), f ′(t), f ′′(t) and g(t) over the JQ interval. Within the JQ interval,
the AA estimate is thus produced by the difference B − UW.
Figure C.4 illustrates on a single cardiac cycle recorded on lead V2 (Figure C.4a) the vari-
ous steps described previously (Figures C.4b, C.4c, C.4d and C.4e), as well as the final result
(Figure C.4f).
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Figure C.4: Illustrative example of the various steps involved in the T and U wave cancellation.
Figure (a) shows one cardiac cycle on lead V2. In Figure (b), the estimated Tdom over the JQ in-
terval is represented by a solid line while its dominant function f (t) is represented by a blue line.
Figure (c) displays the first f ′(t) (solid blue line) and second f ′′(t) (solid red line) derivatives of
f (t). In Figure (d), the dominant function g(t) representing the U wave in Tdom is plotted. Fig-
ure (e) displays the original signal (solid green line) as well as the final estimate of the ventricular
repolarization (solid black line). Finally, Figure (f) shows the signal after the cancellation of the
T and U waves. Figures from [108].
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Atrial activity estimation during the QRS intervals
Within the JQ intervals, the ventricular involvement in the QRS interval Ai remains to be
treated. In the scheme of Lemay, et al., rather then using a cancellation method, the AA in
segment Ai was estimated from the AA observed in the neighboring cleaned up segments Bi−1
and Bi [108]. This approach assumes that over one cardiac cycle, the AA signals are stationary.
The AA signal over a given QRS interval Ai of a single lead can be expressed as a finite sum of
sinusoids:
s(t) =
P∑
k=1
sk(t) =
P∑
k=1
αk cos(2pi fkt) + βk sin(2pi fkt). (C.7)
where P defines the number of cosine and sinus functions which fit the AA in the neighboring
cleaned up segments Bi−1 and Bi, the frequencies fk are uniformly distributed at P values between
0 and 10 Hz, and the P coefficients αk and βk define the linear combination of sines and cosines
at the frequencies fk which can be determined using leasts square estimation.
Equation (C.7) can be extented to the complete set of leads as such:
Ai = SiEi, (C.8)
where the matrix Si contains the P cosine and P sinus functions during the interval Ai, and
the matrix Ei contains the P parameters αk and βk of each lead (and is therefore of size 2P-by-8).
The matrix Ei can be computed as:
Ei = S†i B
C
i , (C.9)
where S†i is the pseudoinverse of S
C
i , which contains the P cosine and P sinus functions during
the neighboring segments Bi−1 and Bi, and the matrix BCi is the concatenation of the JQ matrices
Bi−1 and Bi.
Finally, the atrial signal is obtained by concatenating the neighboring JQ intervals with the
sinusoidal signal perviously obtained. Because the concatenated signal may contain void seg-
ments at the interval boundaries, a low-pass Butterworth filter with a cutoff frequency of 50 Hz
was applied.
Figure C.5 illustrates an example of the AA estimation during the QRS interval.
As an illustrative example of the performance of the SB scheme, an excerpt of 10 seconds on
lead V2 is shown in Figure C.6a, the resulting signal after baseline correction is shown in Fig-
ure C.6b, while Figures C.6c and C.6d show the results obtained by the ABS and the SB methods
respectively. In this example, the SB technique produces considerably smaller QRS residues than
ABS does. A theoretical analysis on simulated and clinical ECGs of the performance of the ABS
and SB methods is detailed in [108]. Moreover, clinical results have demonstrated that the SB
approach produced significantly smaller QRS residues than the ABS method.
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Figure C.5: Estimation of the atrial activity located within the QRS intervals. Figure (a) displays
an excerpt of a ith QRS complex from lead V2 from the timing of the J point ji−1 to the timing of
the following onset of the Q wave (qi+1). The solid lines constitute the estimated AA located in
the i− 1th and the ith JQ intervals after cancellation of the T and U waves. The Aith QRS complex
is plotted in a blue line. In Figure (b), the solid lines are the magnified AA estimated segments
after cancellation of the T and U waves located in the i − 1th and the ith JQ intervals, while
the red line represents the AA estimated segments by the sum of sinusoids (P = 50). Finally,
Figure (c) shows the magnified AA estimates of the entire signal after filtering at 50 Hz. Figures
from [108].
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Figure C.6: Example of the ventricular activity cancellation. Figure (a) displays an excerpt of 10
seconds acquired on lead V2 while Figure (b) shows the resulting signal after baseline correction.
Figure (c) shows the estimated AA with an ABS approach where the 3rd and 11th QRS residues
were considered significant. Figure (d) displays the estimated AA obtained with the SB scheme
where no QRS complex residue was considered significant. Figures from [108].
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